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Abstract 
 
Unlike the inner-membrane, the outer-membrane of Gram-negative bacteria cannot be 
energised by a proton gradient and the periplasmic space is absent of ATP. This poses a 
significant problem for active processes such as transport against concentration 
gradients. TonB-dependent transporters (TBDT) are a class of outer-membrane proteins 
responsible for the scavenging and import of scarce metallo-organic complexes from the 
environment. They are structurally characterized by a 22-stranded β-barrel with the 
lumen occluded by an N-terminal globular ‘plug’ domain which contains a conserved 
binding motif known as the Ton box. Upon substrate binding, the Ton box becomes 
exposed to the periplasmic space where it forms a non-covalent complex with the C-
terminus of a cytoplasmic membrane protein, TonB. The transport process requires 
energy from a proton motive force coupled with an inner membrane complex TonB-
ExbB-ExbD. Regardless of a wealth of structural information, current models of the 
TonB-dependent transport mechanism are speculative. Conversely, despite no current 
experimental evidence, it is generally accepted that the plug domain must undergo a 
large conformational change facilitated by mechanical force exerted onto the Ton box 
tether by TonB.   
In this thesis, force spectroscopy, protein engineering, molecular dynamics and bacterial 
growth assays are used to investigate the effects of force on TonB:TBDT complexes from 
E. coli. These experiments demonstrate that the channel of the vitamin B12 transporter 
(BtuB), reconstituted into synthetic liposome, can be opened by the application of force 
onto the plug domain via the non-covalent binding partner, TonB. Using wild-type BtuB 
and several of its mutants together with a related receptor (FhuA), the extent of plug 
remodelling is found to be highly controlled and determined by the cargo the receptor 
has evolved to transport. For both receptors, the plug domain can be regarded as 
comprising a mechanically weak channel forming sub-domain, and a mechanically 
strong sub-domain used both for allosteric signalling and to limit the size of the channel 
to allow passage of molecules no larger than its cargo. 
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Alongside these findings, structural and biophysical analysis of the periplasmic spanning 
protein TonB reveals conformation within the proline-rich linker domain, which allows 
speculation of the origin of the pulling force used for plug remodelling. 
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1 Introduction 
Using a homemade single-lensed microscope, the first single cell organisms were 
discovered in rainwater by Antonie van Leeuwenhoek in 1675. The organisms swam 
swiftly in random directions and were estimated to be around 3 µM in size. 
Leeuwenhoek named the organisms ‘animalcules’ (from Latin animalculum = "tiny 
animal")1. 340 years after this landmark discovery, our understanding of animalcules 
(bacteria) has progressed tremendously. Over this time the advent of advanced 
microscopy, genetics, molecular biology, biochemistry, structural and biophysical 
analysis have helped reveal, in molecular detail, their central importance to human 
health and disease2. 
1.1 The outer-membrane of Gram-negative bacteria 
During the 19th century, the Danish bacteriologist Christian Gram developed a 
revolutionary staining procedure that allowed the classification of nearly all bacteria into 
two large groups: bacteria that retain the crystal violet-iodine complex stain, designated 
Gram-positive, and those that did not, designated Gram-negative. The stain retention 
was due to differences in the structure of the bacterial cell envelope. Gram-positive 
bacteria retain the crystal violet due to an external peptidoglycan cell wall, whilst in 
Gram-negative bacteria, the peptidoglycan is shielded by an additional envelope, the 
outer-membrane (OM). The presence of the Gram-negative OM was not fully recognised 
until the advancement of electron microscopy in the 1950’s. 
The first clear demonstration that the plasma membrane and ‘cell wall’ of E. coli were 
composed of two separate entities were shown by Kellenberger and Ryter in 19583 using 
electron microscopy on specially fixed and stained phage infected cells. The separated 
‘cell wall’ was found to exhibit a three layered structure, consisting of two dense outer 
layers separated by a less dense layer, with a total thickness of 60 to 90 Å (Figure 1.1).  
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Figure 1.1 - The first observation by electron microscopy of the composition of the cell wall in E. 
coli. Left) x100,000 magnification of a T2 phage infected E. coli, no phage are visible, however 
the vegetative phage DNA is shown (n). The cytoplasmic membrane (m) and ‘double structured’ 
cell wall (w) are visible. Right) cartoon schematic of the organisation of the observable double 
envelope with measurements shown. Images taken from reference 3. 
It is now accepted that the three principal layers observed by Kellenberger and Ryter in 
Gram-negative bacteria are; the outer membrane (OM), the peptidoglycan cell wall, and 
the cytoplasmic or inner membrane (IM). The compartment between the IM and the 
OM was coined the periplasmic space by Peter Mitchell in 1961 which was later found 
in 1967 to contain a distinct set of hydrolytic enzymes including nucleases and 
phosphatases4. The periplasmic space occupies around ~10 % of the total cell volume, 
and has been described as a highly viscous environment due to the high content of 
soluble proteins, with little free space available5. The periplasm is also an oxidising 
environment and contains protein disulfide isomerases6, therefore protein folding 
occurs within this space, and interestingly the periplasm is completely void of ATP. 
Importantly the periplasmic space also hosts the peptidoglycan cell wall, which 
contributes to cell shape and protects the cell from lysis. The peptidoglycan is covalently 
linked to the OM by Braun’s lipoprotein7 which will be discussed in more detail later. 
The two membranes in Gram-negative bacteria differ in composition completely. The 
lipid component of the IM is exclusively composed of phospholipids (both inner and 
outer leaflet), namely phosphatidylethanolamine (~70–80%), phosphatidylglycerol and 
cardiolipin. The OM on the other hand is asymmetric with respect to the inner and outer 
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leaflets, while the inner leaflet of the OM has the same lipid composition as the IM, the 
outer leaflet consists of glycolipids, principally lipopolysaccharides (LPS)8.  
1.1.1 Lipopolysaccharide  
Bacterial smooth LPS (produced by many Gram-negative bacteria including the families 
Enterobacteriaceae and Pseudomonadaceae) typically consists of a hydrophobic 
domain known as lipid A, a “core” oligosaccharide domain, and a distal polysaccharide 
(named the O-antigen)(Figure 1.2)9.  
Lipid A is a glucosamine-based phospholipid that contains six or seven 14/12 carbon acyl 
chains that anchors the LPS to the outer leaflet of the OM. The architecture of lipid A is 
highly conserved across Gram-negative bacteria and is detected at picomolar 
concentrations by Toll-like receptors of the innate immune system10.  
The core oligosaccharide is divided into two regions, the inner core (directly attached to 
lipid A) and the outer core (attachment site for the O-antigen). The inner core typically 
contains Kdo (keto-deoxyoctulosonate) (1-3 units) and heptose (L-glycero-D-
mannoheptose) (2-3 units). Kdo is found in all known cores and is linked to lipid A by a 
ketosidic bond. The minimal LPS required for the growth of E. coli consists of lipid A and 
Kdo (deep-rough phenotype). The inner core can also be phosphorylated and modified 
with pyrophosphorylethanolamine or phosphorylcholine. The outer core is more 
structurally diverse than the inner core, for example E. coli has been found to display 
five core types, the preference of which is dependent on the infectious strain. The outer 
core is composed of branched hexose unts (including: D-glucose, D-mannose, D-
galactose) that are attached to the preceding heptose of the inner core. LPS that 
includes lipid A and a complete core oligosaccharide (inner and outer) is known as rough 
LPS. The O-antigen is ligated directly to a hexose unit within the outer core.  
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Figure 1.2 – Simplified cartoon structure of the organisation of lipopolysaccharide with the 
individual components (lipid A, the inner and outer core and the O-antigen) highlighted in 
different colours with labels. 
The structural diversity of the O-antigen is extraordinary; with more than 60 different 
monosaccharides and 30 noncarbohydrate components recognised. The repeating 
glycan units (homo- or heteropolyers), the position and stereochemistry of the O-
glycosidic linkages, the presence or absence of noncarbohydrate substituents, the 
various number of units, branching and nonstoichiometric modifications (such as O-
acetylation or glycosylation) make the possible O-antigens conformations almost 
infinite. If an LPS extract is run on an SDS-PAGE from a smooth LPS containing strain, 
laddering is observed due to the extensive heterogeneity of the O-antigen. The number 
of unique O-antigens within a species can vary considerably, for example. E. coli 
produces around 170 O serotypes. As the O-antigen is fully exposed to the environment, 
its major role is the protection of the cell. In pathogenic Gram-negative species, the O-
antigen and its chain length play a role in the evasion of the host immune system, in 
particular the complement cascade membrane attack complex11 and neutrophil 
bactericidal/permeability-increasing protein12. The presence of the O-antigen also 
provides the bacterium with a protective barrier from hydrophobic molecules including 
antibiotics (macrolides, erythromycin and rokitamycin)13. To serve as an efficient barrier, 
the negatively charged LPS molecules bind avidly to each other laterally, especially if 
neutralising cations are present. The acyl chains in lipid A are mostly saturated and are 
tightly packed as a result. The combination of these LPS properties decreases the fluidity 
of the OM (described as ‘gel-like’14) creating a very effective barrier for hydrophobic 
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molecules. Alongside protection, the O-antigen also has roles in the colonisation, 
invasion, inter- and intracellular spreading of infectious species9. 
1.1.2 Biogenesis of the OM 
The synthesis of LPS occurs at the cytoplasmic side of the IM; therefore it is a remarkable 
feat how this amphipathic molecule with large hydrophobic (lipid A) and  hydrophilic 
domains (O-antigen) is transported through the IM, across the periplasmic space and 
through the OM, irrespective of the type of LPS. For a long time it remained a mystery 
how the bacteria achieved the asymmetric OM, however in 2004 the discovery of the 
first component of the Lpt (LPS transport) system in N. meningitides (ΔlptD resulted in a 
reduction of LPS at the cell surface15) paved the way to a better understanding into the 
molecular mechanism. LptD exists as a complex in the OM with a lipoprotein LptE which 
is inserted into the lumen of the LptD 26 anti-parallel stranded β-barrel (Figure 1.3B)16,17. 
Other components of the Lpt system include the periplasmic protein LptA, integral IM 
proteins LptC (which contains a large soluble periplasmic domain), and LptFG and a 
cytoplasmic component LptB (sequence suggests a nucleotide binding domain), which 
is anchored to the IM complex in a stoichiometry of 2:1:118 (Figure 1.3A).  
LptA and LptC have been shown to bind LPS, with LptA exclusively binding to lipid A19. 
When the crystal structure of LptA was determined (16 stranded antiparallel β-strand, 
with a slightly twisted β-jelly roll topology (typically eight β-strands arranged in two four-
stranded antiparallel β-sheets) (Figure 1.3B)20), it was initially surprising that there was 
no hydrophobic cavity to accommodate lipid A, however, LPS cross linking experiments 
located a LPS binding groove inside of the jelly roll. Interestingly, LptD has a periplasmic 
N-terminal extension which shares structural homology to LptA. The current model 
(Figure 1.3A) predicts that this N-terminal periplasmic extension is in continuum with a 
polymer of LptA (forming a trans-envelope machine) in which LPS is shuttled from the 
IM to the OM15. LptA has been shown to form oligomers which are long enough to span 
the length of the periplasmic space and interacts with the periplasmic domain of LptC 
and N-terminal periplasmic domain of LptD (all sharing the same fold). Therefore LPS in 
the outer leaflet of the IM (flipped by MsbA) is thought to be extracted from the IM by 
LptFG using the ATPase activity of LptB, transferred to LptC where it is passed onto a 
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chain of LptA which crosses the periplasmic space and enters LptD via the N-terminal 
extension. The LPS is thought to exit the LptD barrel laterally through the first and last 
strands, as cross-linking these strands yields a lethal phenotype16.  
 
Figure 1.3 – LPS transport, the Lpt system A) Cartoon schematic for LPS transport with individual 
components labelled, figure adapted from reference 15. LPS (gold and brown) is initially flipped 
across the IM by the ATP-binding cassette transporter MsbA, LptBFG then extracts the LPS from 
the IM and it is transported across the periplasm via a bridge of LptC, LptA and the periplasmic 
domain of LptD. It is then inserted into the outer leaflet of the OM by the integral membrane 
domain of LptD and lipoprotein LptE. B) The crystal structures of the Lpt components (labelled), 
the structure of LptA contains two subunits and the LptC structure is of the periplasmic domain 
only. (PDB: 5IV9, 2RI9 and 3MY2 for LptDE, LptA and LptC respectively). 
Despite the huge advance over the last two decades in our understanding in molecular 
detail of how Gram-negative bacteria insert LPS into the outer leaflet of the OM, it is 
surprising that almost nothing is known about the transport of glycerophospholipids to 
the inner leaflet of the OM. 
1.1.3 Lipoproteins of the OM  
More than 100 lipoproteins are predicted to be present in E. coli. Although most 
lipoproteins have no known functions, they are expected to play various important 
activities in the periplasm that include signalling, chaperones, OM integrity and 
biogenesis21. Lipoproteins are attached to either the IM or OM by an N-terminal N-acyl-
diacylglyceryl cysteine, which is transferred onto the protein in the IM by the enzyme 
Lgt (phosphatidylglycerol diacylglyceryl transferase). The signal sequence is cleaved by 
signal peptidase II and the amino terminus of the cysteine is N-acylated by Lnt 
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(phospholipid transacylase) generating the mature lipoprotein (Figure 1.4), this process 
is highly conserved in all Gram-negative bacteria22.  
Lipoproteins destined for the OM are identified by a lack of an amino acid retention 
signal (Asp at +2, (+1 being the lipidated Cys) and Asp, Glu or Gln at +3) flanking the 
lipidated cysteine. Lipoproteins lacking this signal are recognised and transported to the 
inner leaflet of the OM by the localisation of lipoproteins (Lol) system. In E. coli Lol is 
composed of 5 components (LolA-E), LolCDE is an ATP binding cassette complex found 
in the IM which extracts the lipoprotein from the IM to the periplasmic chaperone LolA. 
LolE recognises and binds the OM destined lipoprotein, LolC recruits LolA and LolD is the 
cytoplasmic ATPase which is tethered to the IM by LolC and E (Figure 1.4A). LolA contains 
a large hydrophobic cavity to accommodate the acyl chain of the lipoprotein substrate 
(Figure 1.4B), and delivers the lipoprotein to the final component of the system, LolB. 
LolB is an OM lipoprotein and also contains a large hydrophobic cavity with a higher 
affinity to the acyl chain than LolA. The mechanism of how LolB incorporates 
lipoproteins into the OM is currently unknown22.  
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Figure 1.4 – Lipoprotein transport, The Lol system A) Simplified cartoon schematic of the 
lipoprotein maturation and export pathway by the Lol system (components in blue), figure 
adapted from reference 22. The lipoprotein (pink) is synthesised in the cytoplasm with the N-
terminal signal sequence (SS) (red) which targets the lipoprotein for translocation by the Sec/Tat 
translocon (grey). The lipoprotein initially remains anchored to the IM by the SS and Lgt adds a 
diacylglyceryl to the cysteine residue. LspA then cleaves the SS from the lipoprotein and Lnt adds 
another acyl chain to the new N-terminus. The LolCDE complex then powers extraction of the 
lipoprotein from the IM by ATP hydrolysis and forms a complex with the chaperone LolA which 
delivers the lipoprotein to the OM acceptor protein LolB. Finally LolB inserts the lipoprotein into 
the inner leaflet of the OM. B) Crystal structures of LolB and LolA (PBD: 1IWM and IUA8 
respectively). 
Two of the best studied lipoproteins in E. coli are Lpp (also known as Braun’s 
lipoprotein/murein lipoprotein) and Pal (Peptidoglycan-associated lipoprotein), both 
function (as the names imply) in connecting the OM to the peptidoglycan (PG) cell wall. 
Lpp is the most abundant lipoprotein in E. coli, with an estimated 500,000 copies per 
cell. It is a small 6 kDa protein and is found either covalently cross-linked to the 
peptidoglycan (by the C-terminal Lys ϵ-amino group to the diaminopimelate in the PG23) 
or in a ‘free form’. Pal, in contrast, interacts with the PG by a non-covalent interaction. 
Lpp and Pal have been shown to contribute to the OM stability as knockouts lead to OM 
vesiculation, release of periplasmic proteins and increased sensitivity to detergents22. 
Pal is a member of the Tol system, where TolAQR are IM proteins with TolA having a 
large periplasmic spanning domain and TolB is found in the periplasmic space24. TolA has 
been shown in vivo to use the pmf (using TolQR) to interact with Pal via TolB and stabilise 
the OM25,24. Not all lipoproteins in the OM have connections to the peptidoglycan, LptE 
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(part of the LPS transport system) is vital in the folding and assembly of the integral β-
barrel LptD. Similarly, BamC (part of the barrel assembly machine complex (see Section 
1.2.2)) is thought to help stabilise other components of the complex. 
1.2 Outer-membrane proteins (OMPs) 
The OM, like all biological membranes contains a bilayer of lipids which has little 
permeability for hydrophilic solutes including most nutrients required for survival. To 
overcome this barrier, the OM contains integral channel-forming proteins for the 
purpose of nutrient uptake. The proteins of the OM can be divided into two classes, 
lipoproteins and β-barrel proteins23. Strictly speaking, the term outer-membrane 
protein (OMP) refers to the integral β-barrel (various numbers of β strands wrapped into 
cylinders that traverse the OM) proteins only. The OMPs either facilitate passive 
diffusion of small molecules (also called porins), specific diffusion or active transport of 
large scarce ligands (known as the TonB-dependent transporters). There are also 
enzymatic OMPs such as PagP, OmpT and PldA which function as a lipid A 
palmitoyltransferase, aspartyl protease and phospholipase respectively26-28. OMPs also 
have roles in adhesion, assembly machinary and act as virulence factors for infectious 
Gram-negative species29. The details of the different types of OMPs involved in substrate 
transport and their insertion into the OM will be covered in the following sections. 
1.2.1 Structural features of OMPs 
The first non-specific activity of the OMP ‘porin’ channels were shown in 1976 by 
reconstituting OMPs into lipid vesicles, which were found to be permeable to a variety 
small compounds and sugars with a molecular weight less than 700 Da30. The ‘porins’ 
were soon found in all species of Gram-negative bacteria and even the mitochondrion31. 
The most significant advance in the study of OMPs was the elucidation of the structures 
of PhoE and OmpF by X-ray crystallography in 199232, which revealed the antiparallel β-
barrel architecture and the trimeric nature of the porins. Before the structural 
determination of β-barrels, the protein sequences of OMPs baffled researchers due to 
predominant polar residues and a lack of hydrophobic rich regions, which are usually 
found in integral membrane proteins. It is now postulated that the OM is populated with 
β-barrels because proteins rich in hydrophobic residues would become stuck in the 
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inner-membrane or aggregate in the periplasmic space33. The wealth of OMP crystal 
structures now available have revealed that the main structural differences within the 
β-barrel is the number of β-strands (ranging from 8 to 26 (Figure 1.5)) and the shear 
number, which is a measure of the stagger between strands. Structural analysis found 
that these two parameters determine the geometry of the barrel, such as the tilt angle 
(angle of the β-strands against the barrel axis, ranging from 30-60 ˚) and the radius 
(ranging from ~7-20 Å (excluding FimD and LptD)) (Table 1.1)34. As the β-barrels have a 
right-handed β-twist, the shear is slightly larger than the strand number; also the shear 
value is always even and positive due to the hydrogen bonding between strands (Table 
1.1). The shape of the lateral cross-section of the β-barrels also shows considerable 
variation that is dependent on the interior of the barrel (domains, peptide segments or 
inward facing side chains).  
Name β-strands Shear Radius (Å) Strand tilt (˚) Trimer 
OmpX 8 8 7.2 37 no 
OmpA 8 10 7.9 43 no 
OmpT 10 12 9.5 42 no 
OmpF 16 20 15.5 43 yes 
PhoE 16 20 15.5 43 yes 
LamB 18 20 17.1 40 yes 
ScrY 18 20 17.1 40 yes 
FhuA 22 24 19.9 39 no 
FepA 22 24 19.9 39 no 
Table 1.1 – Analysis of β-barrel structural information such as strand number, shear, radius, tilt 
and oligomerisation34.  
The type of cross-sections observed have been: circular (OmpA), ellipsoid (OmpT) or 
bean-shaped (FimD) (Figure 1.5). Another interesting feature of OMPs is the aromatic 
girdles which are found at both periplasmic and extracellular sides of the protein. The 
aromatic girdle is defined as outward facing aromatic residues found near the polar head 
groups of the lipid bilayer. The girdle was originally proposed to stabilise and anchor the 
β-barrel in a vertical position with respect to the membrane35, which was later 
confirmed by mutagenesis36,37.  
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Figure 1.5 – Cartoon representations of the X-ray crystal structures of integral OMPs with 8-26 
antiparallel β-barrels from the OM of Gram-negative bacteria. Globular plug domains are found 
within barrels greater than 18 strands (shown in red). For the enormous 26 stranded barrel of 
LptD, a separate lipoprotein (LptE) occludes the lumen, which is shown in blue. The monomeric 
unit of the LamB trimer is shown for simplicity. The proteins shown function as: a non-specific 
diffusion pore (OmpA), proteases (OmpT and EspP), fatty acid transporter (FadL), 
haemagglutinin transporter (FhaC), specific diffusion pore (LamB), vitamin B12 transporter 
(BtuB), pilus biogenesis usher (FimD) and LPS transporter (LptDE) (PDB codes shown). 
The exterior of the β-barrel in contact with the non-polar groups of the lipid bilayer 
contains few charged residues (2.8 %) whilst aromatic and non-polar residues make up 
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29.3 and 49.2 % respectively, as expected33. The β-barrel interiors are much more polar. 
The β-strands are connected by short turns at the periplasmic side (1-12 residues), 
however on the extracellular side, long (up to ~46 residues), highly mobile and 
hydrophilic loops are often found, which have exceptionally high sequence variability 
between OMPs (due to environmental exposure)38. In fact, the entire sequence 
variability of OMPs is high in comparison to soluble proteins. The external loops are 
involved in the biological function of the OMPs, such as substrate binding (especially in 
the case of TonB-dependent receptors). In OmpF loop 3 folds inside of the β-barrel 
which narrows the lumen of the barrel enough to allow sugar diffusion32. Not all OMPs 
exist as trimers (Table 1.1), the trimeric OMPs (examples from E. coli: OmpF, OmpC, 
PhoE, and LamB) form a non-polar core at the three fold-axis. The hydrophobic trimer 
interface adds to the robustness of trimeric OMPs, as removal of specific monomer 
interactions results in reduction of thermodynamic stability39. 
The membrane embedded β-barrel structure of OMPs makes them extremely 
thermodynamically stable (some OMPs resist denaturation in the presence of 5 M 
guanidium hydrochloride or 2 % SDS at 70 °C33), which is intuitive as they are exposed 
to often harsh environmental conditions. When an OMP is inserted into the OM, their 
removal requires an energy that does not exist in the periplasmic space, therefore the 
cell cannot remove OMPs after insertion. Bacteria recycle OMPs by migrating them to 
the poles during cell division and passing old OMPs to daughter cells40. As folded OMPs 
are so stable, a large energy barrier must be overcome to insert them into the OM. The 
only essential OMPs found in E. coli are LptD (a huge 26 stranded β-barrel with a crucial 
role of inserting LPS into the OM41) and BamA (16 stranded β-barrel, part of a large 
complex with a crucial role in binding, folding and inserting β-barrel proteins into the 
OM). The latter will be discussed in more detail in the following section. 
1.2.2 Folding OMPs into the OM 
Like all proteins in Gram-negative bacteria, OMPs are initially synthesised in the 
cytoplasm by ribosomes. Therefore proteins destined to the OM must traverse the 
hydrophobic IM, navigate through the aqueous and crowded periplasmic space and then 
be correctly folded into a functional state at the OM. This must be achieved without 
 13 
 
aggregation and maintaining the protein in a suitable unfolded state for OM insertion. 
To make matters more complicated, the bacteria also have to accomplish this 
extraordinary feat in the absence of chemical energy in the periplasm and OM. As 
mentioned in the previous section, two OMPs are essential for Gram-negative bacterial 
physiology, LptD (covered in Section 1.1.2) and BamA. BamA is a highly conserved 16-
stranded β-barrel and is a component of the β-barrel assembly machinery (BAM) 
complex, which as the name suggests, is involved in the insertion of OMPs into the OM. 
The BAM complex contains five components, BamA, the integral membrane protein 
component which also contains a N-terminal periplasmic region called the POTRA 
(polypeptide transport-associated) domain, which contains five individual folded 
domains. The other components (BamB, BamC, BamD, BamE) are all lipoproteins 
anchored to the inner leaflet of the OM (Figure 1.6). BamA and BamD form the core of 
the complex (both components are essential42) with BamD and BamB interacting directly 
with BamA, whilst BamC and BamE directly interact with BamD43. The presence of all 
five components is required for the most efficient OMP insertion, despite only BamAD 
being essential. The structure of each component of the BAM complex has been solved 
by X-ray crystallography, and also the structure of the entire complex 
(BamABCDE)(Figure 1.7) with and without BamB44. Despite a wealth of structural 
information, the exact mechanism of how the BAM complex folds OMPs independent of 
ATP is not clear. Structural insight from the BamA component and cross-linking studies 
has led to speculations that client OMPs are released into the OM by a lateral gating 
mechanism. Cross-linking the first and last β-strands (which are only weakly associated) 
of the BamA barrel yields a lethal phenotype, and MD simulation demonstrated free 
opening of these strands45. The crystal structures of both BamABCDE and BamACDE 
complexes show a laterally open BamA barrel44. Other models of BAM insertion include 
thinning and destabilisation of the membrane near the lateral opening site, which would 
lower the kinetic energy barrier of insertion46. The signal that the BAM complex is 
thought to recognise is the C-terminal strand of OMPs, which all contain a terminal 
phenylalanine47. 
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Figure 1.6 – Simplified cartoon showing OMP biogenesis, regulation and insertion into the OM 
of Gram-negative bacteria  (image adapted from reference 43). Prefolded OMPs (maroon line) 
are initially synthesised in the bacterial cytoplasm and cross the IM by the SecYEG translocon. In 
the periplasmic space, the unfolded OMP can then be delivered by the primary pathway (1) by 
SurA or a secondary pathway (2) by Skp to the BAM complex (BamA (green) with POTRA domains 
(hexagons), BamB (red), BamC (blue), BamD (orange) and BamE (pink)) for OM insertion. If the 
OMP becomes misfolded (3), it is targeted by DegP for degradation. 
The BAM complex serves the function of OMP insertion into the OM, where periplasmic 
chaperones aid the passage of the unfolded OMP through the periplasmic space, which 
unfortunately is less well understood than OM insertion. The most thoroughly studied 
and essential chaperones for OMP biogenesis present in E. coli are Survival protein A 
(SurA), Seventeen kilodalton protein (Skp) and DegP (Figure 1.6)43. SurA is a peptidyl-
proline isomerase which facilitates the correct folding of OMPs, and was first identified 
for its crucial role in cell survival during stationary growth phase. Variants of SurA have 
been found to reduce the amount of OMPs in the OM and also increase the bacterial 
sensitivity to detergent and antibiotics (likely due to the phenotypical impact of reduced 
OMP activity, such as LPS export)  which is a classic sign of OMP misfolding48. Phage 
display demonstrated that SurA preferentially recognises the sequence repeat motif Ar-
X-Ar (Ar = aromatic, X = any)49, which is commonly found in the C-terminus of OMPs and 
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is also thought to target the OMPs to BAM. The structure of SurA (Figure 1.7) is 
composed of 4 domains, an NT and CT domain (N and C terminal) which have been 
shown to bind to OMPs specifically and two prolyl isomerase (PPIase) domains which 
are non-essential for OMP biogenesis50. Interestingly in vitro experiments have 
demonstrated that SurA does not directly fold OMPs into lipid bilayers and an 
interaction with BamA has been identified51. The current hypothesis is that SurA delivers 
the OMP to the BAM complex in an ‘insertion-competent’ state43.  
 
Figure 1.7 – Cartoon representations of the crystal structures of the components of the OMP 
biogenesis pathway. The entire BamABCDE OM complex (PDB: 5D0O) with individual 
components coloured and labelled. Chaperones SurA (PDB: 1M5Y missing regions built using 
MODELLER) and Skp (PDB: 1U2M, missing regions built using PyMol) are shown in grey and blue 
respectively. Image taken and adapted from reference 52. 
Skp is a jellyfish-like trimer (Figure 1.7) that has a large central cavity between the three 
helical ‘legs’ and is believed to be an antifolding chaperone, which does not facilitate 
OMP folding directly. In the unfolded state, OMPs preferentially bind to the hydrophobic 
cavity of Skp where they are shielded from the aqueous environment of the periplasmic 
space. Skp is specific for the unfolded β-barrel domain of OMPs only53 and NMR has 
shown the unfolded OMP to be highly dynamic within the Skp cage54. Skp has an 
electrostatic dipole with the ‘head’ of the jelly-like structure being highly positively 
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charged. As the POTRA domains of BamA contain patches of negative charge, there is a 
possibility that the POTRAs attract Skp to deliver the unfolded OMP to the BAM 
complex43. It has been recently demonstrated that Skp acts as a multivalent chaperone, 
where the size of the unfolded OMP substrate is dependent on the copies of Skp 
required to prevent folding. For example a Skp/Omp ratio of 4:1 is required for 16 
stranded OMPs, whilst a 2:1 ratio was sufficient for 8 stranded barrels227.10.  
The final periplasmic component to be discussed is the serine protease DegP, which is 
responsible for the clearance of misfolded, aggregated OMPs by cleaving between pairs 
of hydrophobic residues. DegP exists as homo-multimers (6, 12 and 24-mers) where 
misfolded substrates trigger oligomerisation into cage-like structures, activating the 
DegP protease cleavage site (by removal of a regulatory loop). DegP has homologs in 
eukaryotic chloroplasts and mitochondria, therefore the presence of DegP in organisms 
and organelles with an intermembrane space suggest an important role in the regulation 
of OMP biogenesis55. Where surA knockout mutants cause an impairment of OMP 
biogenesis, knockouts of degP and skp have a lesser effect. Even double knockouts of 
skp degP display cellular viability56; therefore Skp and DegP have been suggested to not 
be directly involved in OMP biogenesis like SurA, but act in a secondary pathway, such 
as quality control (Figure 1.6). 
1.3 OMP transporters 
1.3.1 Non-specific diffusion, the porins 
Porins (by strict definition, a nonspecific diffusion channel14) are highly abundant in the 
bacterial OM with up to 104-106 copies per cell depending on the bacterial species and 
the environmental conditions33. The first to be discovered in E. coli were OmpC and 
OmpF, which are 16-stranded β-barrel trimers (Figure 1.8) and are termed the “classical 
porins”. They consist of water-filled channels and serve as general pathways for the 
influx of small hydrophilic molecules with a molecular weight cut off of ~700 Da, 
excluding the size of many antibiotics. The classical porins show no particular substrate 
specificity, however they display some selectivity for either cations or anions33, for 
example OmpC is slightly more cation-selective than OmpF despite sharing 60 % 
sequence homology. This observation was originally predicted to be due to a smaller 
 17 
 
pore size in OmpC14, however when the E. coli OmpC structure was solved, the structure 
was found to be identical to OmpF (RMSD = 0.78 Å)57 with the electrostatic potential 
mediated by residues lining the pore determining the physiological differences. A key 
feature in OmpC, OmpF and PhoE (a classical porin with selectivity for anions) is the 
presence of a conserved extracellular loop (L3), that folds into the channel creating a 
constricted pore (known as the eyelet) approximately half way through the channel. A 
‘carboxyl cluster’ positions L3 into the barrel interior by electrostatic interactions with 
luminal facing Arg/Lys residues from the barrel. Acidic residues in L3 and basic residues 
in the opposing β-strand create an electrostatic field that regulates the diffusion of 
molecules through the constricted region. The eyelet of the classical porins therefore 
contributes significantly to the permeability properties, such as the exclusion limit and 
ion selectivity of the pore. Another selective filter which gives individual porins their 
unique substrate preference is the overall charge of the channel mouth58.  
 
Figure 1.8 – Cartoon representation of the X-ray crystal structure of the nonspecific OmpF porin  
(PDB 1MPF). A) The trimeric state of OmpF shown from above the plane of the membrane. B) 
The L3 ‘eyelet’ of OmpF is shown in red which restricts the size of the channel’s lumen (surface 
representation).  
It is not surprising that environmental conditions have a strong influence on which 
classical porins are upregulated. For example OmpC has been shown to be preferentially 
expressed at high osmolarity, whereas OmpF is expressed in low osmolarity59. As OmpF 
allows permeation of slightly larger solutes than OmpC, it would be detrimental to have 
high OmpF expression at high osmolarity. Low pH is another condition that increases 
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OmpC levels while decreasing OmpF levels and phosphate deprivation leads to the 
upregulation of PhoE which has a slight preference for phosphate uptake. The classical 
porins serve as the main route into the cell through the OM for small hydrophilic 
antibiotics including β-lactams, tetracycline, chloramphenicol and fluoroquinolones14 
and antibiotic resistance due to reduction in porin expression or a change in the porin 
upregulated has been reported for a range of Gram-negative bacteria60. 
1.3.2 Substrate-specific diffusion 
Size and charge is not the only solute filter the OMPs passively facilitate. Channels have 
evolved for the specific diffusion of substrate into the periplasmic space and the best 
studied example is the maltose transporter LamB from E. coli (often referred as 
‘maltoporin’, but named LamB due to the prior observation of it being the receptor for 
λ –bacteriophage). Maltose is less than 600 Da in molecular weight and therefore can 
diffuse through the classical porins, however as diffusion rates rely on a concentration 
gradient across the membrane, when the environmental maltose is below the millimolar 
range, uptake by OmpF/C is greatly diminished. As maltose is the major breakdown 
product from starch in the intestine, the efficient uptake of this carbon source is vital for 
bacterial survival14. The X-ray crystal structure of LamB was elucidated in 1995 revealing 
a trimer of 18 stranded β-barrels, which like the classical porins contains an extracellular 
loop (L3) that enters the interior of the barrel creating a narrow central constriction61. 
The constricted region is narrower than the classical porins and the pore is further 
occluded by inward folding of loops 1 and 6. Soaking LamB crystals in maltose, 
maltotriose, and maltohexaose revealed the substrate binding site as a row of aromatic 
residues arranged in a helical manner that are opposed by polar residues from L3 
(named the greasy slide and ionic track respectively (Figure 1.9)). It is proposed that the 
hydrophobic face of the sugar residues are in van der Waals' contact with the greasy 
slide, while hydrogen bonds are formed between the sugar hydroxyls and the side chains 
of the ionic track. 
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Figure 1.9 – Cartoon representation of a single unit of the LamB trimer with the residues of the 
greasy slide (W74*, Y41, Y6, W420, W358, F227 and Y118) shown as green spheres and the ionic 
track from L3 (which restricts the channel) shown in red. Image taken from reference 62. 
Therefore the sugars ‘slide’ along the aromatic residues while continuous disruption and 
formation of hydrogen bonds are made with the ionic track. It should be noted that 
LamB does not solely transport maltose; however sugars containing fructose (such as 
sucrose) are prevented. A transporter called ScrY (from Salmonella typhimurium) has 
been found to be specific for sucrose and differs from LamB at the restriction site (LamB 
is more restricted than ScrY)33. 
Not all OMP passively diffuse their substrates, active transport is required for larger 
substrates such as iron-siderophore complexes, heme or vitamin B12. The receptors 
involved in active transport belong to the TonB-dependent transporter family and are 
the main focus of this thesis. 
1.4 TonB-dependent transporters 
1.4.1 Discovery  
The Ton system was initially discovered by seminal work in 1943 by Luria and Delbrück 
when a virus-resistant strain of E. coli B was isolated that was resistant to bacteriophage 
T163. The resistant strain contained mutations in genes which were subsequently named 
tonA and tonB (Ton being named after the T one phage). This was the first 
demonstration that inheritance (in this case viral resistance) in bacteria follows 
 20 
 
Darwinian principles and genetic mutations can occur randomly in the absence of a 
selection pressure.  
It was not until 1973 that developments in biochemical techniques allowed Braun and 
colleagues to purify the tonA gene product from the OM envelope of E. coli64, the second 
protein ever to be isolated from the OM (the first being Braun's lipoprotein). The purified 
protein was able to bind T5 phage and colicin M (another ligand for TonA) and was 
shown by electrophoresis to be a polypeptide chain of around 85 kDa. During the same 
year as the isolation of TonA, two more OMPs were purified from the OM, the lambda 
phage receptor LamB65 (which was later shown to transport maltose66) and the receptor 
of colicin E367 (later found to be transporter for vitamin B1268), BtuB. TonA was renamed 
to FhuA (for ferric hydroxamate uptake) after the discovery that TonA also facilitates the 
transport of ferrichrome (an iron-complexing hydroxamate siderophore)69.  
The initial finding that mutation within tonA (FhuA) and tonB prevented T1 phage uptake 
suggested a functional relationship between the two gene products. In 1951, T1 
infection was shown to occur in two distinct steps, an initial reversible step (requiring 
tonA) followed by an irreversible step (requiring tonB) upon which the phage could not 
be eluted from the cell by agitation or dilution70. The irreversible step was proposed to 
require an energised cell, which was confirmed by Hancock and Braun, who found that 
an energised inner-membrane (provided by the electron transport chain/ATP hydrolysis) 
was required for the irreversible step71.  
FhuA is a highly diverse receptor for the phages T5, T1, and ϕ80, colicin M and 
ferrichrome. It was found that T5 phage can infect cells independent of TonB function, 
however ferrichrome uptake, colicin M killing and infection with T1 and ϕ80 phages 
requires both functional FhuA and TonB72. By the late 1970s, tonB had been shown by 
numerous studies to be essential for the lethal actions of colicins B, I, and M, the uptake 
of iron chelates73 and vitamin B1274. The requirement for both tonB and an energised 
inner-membrane led to the hypothesis that they are coupled. Hantke and Braun tested 
this and found that TonB is required for the transport function for a class of OM 
receptors, as tonB deficient cells were resistant to T5 phage killing when ligand 
(ferrichrome) was present, therefore blocking the T5 binding site of the receptor with 
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bound untransported ligand73. Thus the term ‘TonB-dependent transporters’ (TBDTs) 
was coined for receptors that require TonB to facilitate transport.  
1.4.2 Interaction with TonB: discovery of the Ton box binding motif 
During the 1980’s when cloning and DNA sequencing was becoming more achievable, 
an explosion of DNA sequences became available, including the DNA sequences of the 
TonB-dependent receptors BtuB75, FhuA76, IutA77 and FepA78 which had all been 
mapped, cloned and sequenced by 1986. After sequencing the FepA gene, Lundrigan 
and Kadner performed a multiple sequence alignment to uncover regions of homology 
in the receptors78. It was discovered that the sequences shared high homology near their 
N-termini. A BtuB variant had been studied by Heller and Kadner that was able to bind 
but not transport vitamin B1275. Therefore the authors suspected that this mutant was 
TonB binding deficient. The sequence of this BtuB mutant (named btuB451) contained 
a leucine to proline substitution at position 8 (L8P), located in the highly homologous N-
terminus. It was thus proposed that this region interacts with TonB and was named the 
‘TonB box or Ton box’. Interestingly it had also been shown that the sequences of colicins 
B and M also contained the Ton box motif38. In 1989 the Kadner group performed 
extensive mutagenesis (32 substitutions) within the Ton box region (residues 6-13) of 
BtuB to find the residues necessary to transport vitamin B1279. They found that only 
mutations L8P and V10G/P were completely transport defective, whilst other mutants 
(T7N, L8R, V9G, V9P, T11N and N13T) exhibited significantly reduced transport 
efficiency. A similar finding was observed by the Braun group who performed a 
mutagenesis screen on the Ton box of FhuA (I9P analogous to BtuB L8P had a reduced 
transport phenotype but was still T5 sensitive)80. The conclusion from both studies was 
that TonB likely interacts with the receptor by a secondary structure facilitated manner 
(prolines being the most disruptive) rather than a sequence specific manner and that 
TonB interacts with other residues other than just the residues within the Ton box. 
During the 1990s to mid-2000s, multiple biochemical and biophysical studies were 
carried out to find whether TonB does indeed interact with the Ton box motif. Tuckman 
and Osburne demonstrated a synthetic Ton box pentapeptide (Glu-Thr-Val-Ile-Val) could 
inhibit the growth of Escherichia coli in low iron medium, prevent killing by colicin B and 
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Ia and stop Bacteriophage phi-80 infection, presumably by blocking the TonB binding 
site81. The Postle group used a combination of in vivo formaldehyde cross-linking and 
Western-blotting to show that TonB interacts with  TonB-dependent receptors by 
forming a high molecular weight species of 195 kDa, which was absent when fepA was 
knocked out82. They also created C-terminal truncations in TonB and found that the final 
48 residues were essential for an interaction with FepA83. Similar formaldehyde cross-
linking experiments showed that the TonB interaction with FecA was enhanced by the 
presence of the FecA ligand (ferric citrate)84. In 1999, Cadieux and Kadner demonstrated 
by engineering cysteines at specific positions within TonB (Q160C, Q162C and Y163C) 
and each residue within the Ton box of BtuB (6DTLVVTA12) that specific residues 
preferentially reacted with each other. This demonstrated that the Ton box of BtuB 
assumes a β-strand structure with alternating residue side chains in the same direction 
relative to TonB (ie. a parallel β-strand augmentation). The disulfide bridge formation 
was also enhanced by the presence of vitamin B12, suggesting that the Ton box is 
exposed upon substrate binding85. In 2005, NMR chemical shift perturbations were used 
to analyse the structural changes when synthetic Ton box peptides derived from FhuA, 
FepA, and BtuB interact with TonB86. Large chemical shifts all occurred within the same 
region of TonB (along the β3-strand, specifically residues Gln160, Ala167, Gly174, Ile232, 
and Asn233), indicating a common binding site. Isothermal calorimetry between the 
structured C-terminus of TonB and the FhuA Ton box peptide (FepA and BtuB Ton boxes 
were insoluble at high concentrations) revealed a relatively weak binding (KD) of 36 ±7 
μM86. The weak binding was unexpected as the NMR spectrum for the protein-peptide 
interaction was in the slow exchange regime, a feature of tight binding. However the 
authors suspected this was due to a slow association and dissociation rate and that TonB 
may undergo structural rearrangement of the previously hidden β4-strand revealed in 
the solution structure (discussed in the next section) before binding the Ton box. In 
2006, X-ray crystal structures of the C-terminus of TonB in complex with FhuA87 and 
BtuB88 were solved at 3.3 and 2.1 Å resolution respectively (Figure 1.18C), confirming 
that the Ton box interacts with TonB by a parallel β-strand addition augmentation as 
predicted by Cadieux and Kadner. The complex revealed that hydrogen bonds are 
formed between residues 6-12 of BtuB and residues 226-232 of TonB (Figure 1.10D). A 
salt-bridge between conserved TonB residues Arg166 and Arg158 with FhuA-Glu56 and 
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BtuB-Asp7 respectively was also observed. This salt-bridge was proposed to be 
important for the initiation of the intermolecular β-strand between TonB and receptor.  
As the Ton box is essential for transport, it is important to understand how the substrate-
bound TBDT signals to TonB to facilitate the binding. Crystallographic studies have 
demonstrated that the conformation of the Ton box does not correlate well with the 
presence of substrate89. However, electron paramagnetic resonance spectroscopy (EPR) 
studies from the Cafiso group were able to demonstrate that substrate binding to BtuB 
resulted in an disordered Ton box, whereas in the apo state the Ton box displays a 
refolded conformation, forming part of the plug domain90. It was also shown that 
reagents used in protein crystallisation can prevent this conformational switching91. 
1.4.3 TonB, a multi-domain periplasmic spanning membrane protein 
TonB is present (with equivalent forms) in all Gram-negative bacteria and has been 
postulated as an energy transducer between membranes since the mid-1970s. Little was 
known about the gene product until 1983 when Postle and Good cloned the tonB gene 
and acquired the DNA sequence92 revealing a protein of approximately 26 kDa (239 
amino acids) with a 17 % proline content. The high proline content gave an anomalous 
mass by SDS-PAGE of 36-40 kDa. The proline-rich region (residues 66-100) was found to 
contain an unusual amino acid sequence (EP)4-IPEPPKEAPVVIE-(KP)6, a synthetic peptide 
of this sequence was subsequently studied by proton NMR revealing an extended 
conformation, which was proposed to have a periplasmic spanning function93. In 1988, 
direct evidence emerged that TonB remains associated with the IM (found in the 
spheroplast fraction)94, in agreement with the DNA sequence which showed a 
hydrophobic N-terminus95. Fusions of periplasmic protein β-lactamase to the TonB C-
terminus were still active, suggesting that the C-terminus of TonB remains in the 
periplasmic space96, rather than being associated with both the inner and outer-
membrane. IM attachment of TonB has also been shown to be necessary for TonB-
dependent function, as deletion of the N-terminal transmembrane (TM) domain of TonB 
(TonBΔ1-32), engineering a peptidase cleavage site near the TM domain or by 
substituting the TM domain with a tetA or penicillin-binding protein 3 TM domain97 
abolishes TonB activity. The residues within the TM anchor of TonB associate with an 
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additional IM protein named ExbB (see next section) and conserved residues Ser16 and 
His20 were found to be essential for TonB activity and TonB:ExbB heterodimer 
formation98. The spacing residues between (16SXXXH20) can be substituted but not 
deleted, implying a spacing function only98.  
Residues 66-100 are described as the proline-rich region of TonB, functioning to span 
the periplasmic space as a 10 nm rigid rod93, despite this, deletion of residues within the 
proline-rich domain (TonBΔ(66–100)) is fully capable of irreversible φ80 adsorption99. 
However in high saline growth conditions (which results in an expanded periplasm), the 
irreversible step was inhibited in TonBΔ(66–100) but not in wild-type TonB. A more 
recent spin-label EPR double electron–electron resonance (DEER) study was used to 
make long range distance measurements within the proline-rich domain of TonB100. Six 
double cysteine mutants were engineered between residues 56-126 of TonB (59/69, 
59/76, 69/76, 69/84, 88/106, and 106/120) for spin label attachment. This resulted in 
an average spin-label distance of 0.26 nm per residue and a full length of 14.4 nm. With 
a periplasmic space size of ~20 nm (under physiological conditions)101, this length would 
be sufficient for TonB to reach the OM when the structured C-terminal domain is 
included. Circular dichroism of TonB residues 56–126 shows a strong signal for a 
polyproline type II (PPII) helix, which were also in agreement with the EPR 
measurements. The EPR data also indicated some flexibility of the proline-rich domain, 
rather than a completely rigid rod.  
The C-terminal domain of TonB (residues 150-239) that interacts with the outer-
membrane receptors85 has been studied by X-ray crystallography and NMR. The first 
structure of TonB (residues (165-239) solved in 2001102 revealed a strand-exchanged 
dimer (Figure 1.10A), however this was later found to be a consequence of construct 
truncation within the structured region of the domain103. In 2005 a TonB construct 
(residues 150-239) was solved by X-ray crystallography104 and solution NMR86, which 
were almost identical (RMSD 0.9 Å)(Figure 1.10B and Figure 1.10C) and they both 
contained a 3-stranded antiparallel β-sheet packed against an α-helix. The difference 
was that the NMR structure was monomeric and contained an addition β-strand (β4, 
residues 235–239 (Figure 1.10C)) that folds back onto the Ton box binding site (β3). The 
same region in the crystal structure (residues 220–236) extends outwards and hydrogen 
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bonds to an adjacent β3 from another molecule of TonB, forming a homodimer (Figure 
1.10B). Interestingly the crystal structure of TonB (residues 153-233 are visible) in 
complex with BtuB lacks electron density for the final C-terminal 6 residues that are 
visible in the NMR structure. This suggests that the β4-strand from the NMR structure 
has been replaced by the Ton box of BtuB (purple strand, Figure 1.10D), implying a 
conformational rearrangement before Ton box binding, explaining the low binding 
affinity (36 ± 7 μM) found by isothermal calorimetry86.  
 
Figure 1.10 – Cartoon representations of the various X-ray crystal and solution NMR structures 
of the C-terminal domain (CTD) of TonB. A) The first crystal structure of a truncated TonBCTD 
(residues 165-239), the individual subunits of the intertwined dimer are coloured in orange and 
purple (PDB: 1IHR). B) Crystal structure of TonBCTD (residues 150-239) which formed dimers in 
the crystal environment (PDB: 1U07). C) NMR solution structure of monomeric TonBCTD (residues 
150-239), the additional β4 is resolved (PDB: 1XX3). D) Crystal structure of monomeric TonBCTD 
(residues 150-239, yellow) bound to BtuB (Ton box shown in purple) (PDB: 2GSK), β4 in the NMR 
structure has been replaced by the Ton box. 
TonB dimerisation has been proposed to have physiological relevance in vivo105 despite 
a monomeric solution structure86, monomeric forms in the crystal structures bound to 
BtuB and FhuA72,73, and the authors of the crystal dimer structure (residues 150-239 
(Figure 1.10B)) show that the dimer was only present in the crystal environment, not in 
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solution104. Double electron-electron resonance (DEER) has demonstrated that a 
significant population (~50 %) of dimeric TonB (residues 33-239, missing only the TM 
domain) exists in solution, however when associated with the TBDT the dimer is 
converted to the monomeric form106. This monomer-dimer inter-conversion has also 
been proposed to be important in the transport cycle shown by in vivo formaldehyde 
cross-linking107. In vitro studies investigating a full-length TonB construct (including the 
TM domain) are yet to be reported, therefore the biological relevance of the TonB 
homodimer still remains questionable. 
1.4.4 The accessory proteins ExbB and ExbD 
While TonB has clearly been shown as the energy transducer, two additional IM 
proteins, ExbB and ExbD have been shown to be important for energy transduction in 
TonB-dependent processes. Exb functions of E. coli are related to TonB as the presence 
of Exb enhances TonB-dependent functions. Exb was initially identified in E. coli resistant 
to colicin B and reduced sensitivity to group B colicins108. The Exb locus of E. coli was 
cloned and sequenced in 1989, revealing two open reading frames (named ExbB and 
ExbD), which encoded proteins of 244 (26 kDa) and 141 (17.8 kDa) amino acids 
respectively109. The proteins were found to contain homology to the TolQ and TolR gene 
products110 which are involved in the uptake of colicins A, E1-3 and K. The sequence of 
ExbB/D revealed extensive hydrophobic regions implying that both are integral IM 
proteins which was confirmed by cellular fractionation109. The transmembrane 
topologies of both proteins have been determined with ExbD possessing a single 
transmembrane (TM) domain near the N-terminal (similar to TonB)111 whilst ExbB has 
three TM domains, oriented so the majority of the protein located in the cytoplasm 
(Figure 1.11)112. 
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Figure 1.11 – Simple schematic of the transmembrane topologies of the TonB energy 
transduction complex in the IM, the N- and C-terminal domains are shown by the residue 
number (image taken from reference 113). 
Early evidence indicated that ExbB/D and TonB are found as a complex114,115, with ExbB 
appearing to stabilise both TonB and ExbD. The existence of a membrane complex was 
further supported by in vivo formaldehyde cross-linking experiments which found TonB 
interacts with ExbB by its transmembrane domain116 and both the periplasmic domains 
of ExbD and TonB interact113. Point mutations within ExbD revealed that when the single 
charged residue in the TM domain (D25) was mutated to D25N, Ton related activity was 
lost115. The D25 residue is believed to be responsive to the pmf. 
The only structural information currently available on ExbB/D is the periplasmic domain 
of ExbD, where the NMR solution structure revealed that residues 64 to 133 form a well-
defined folded globular domain (two alpha-helices that are located on one side of a 
single beta-sheet) where the surrounding residues (43 to 63 and 134 to 141) are 
unstructured117. The structure was solved at pH 3 due to a high propensity to aggregate, 
therefore the physiological relevance is questionable. Using the ExbD construct studied 
by NMR, peptides representing the TonB PE (residues 70–83) and PK (residues 84–102) 
repeats, along with the TonB C-terminal domain (residues 150-239) were tested for 
binding by chemical shift perturbations. Only weak binding was found in the PE peptide 
to the structured domain of ExbD. In contrary to this, in vivo disulfide cross-linking 
experiments have shown the periplasmic domains of ExbD and TonB to interact118 and 
the absence of TonB favours ExbD homodimer formation119.  
Despite no structural information available, ExbB has been shown to have a functional 
role in the stabilisation of TonB and ExbD120, acting as a scaffold for the TonB:ExbD/B 
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complex formation121, and does not utilise the pmf122. ExbB TM domain (TMD) 1 
interacts with TonB TM domain, whilst ExbB TMD2 and TMD3 (highly conserved) are 
believed to be involved in signal transduction from the cytoplasm to the periplasmic 
space122. Quantification of the stoichiometry of the TonB:ExbB:ExbD complex has been 
performed by several research groups yielding different ratios. The first quantification 
used both iron-rich and iron-depleted growth conditions where the complex was found 
to exhibit a stoichiometry of TonB1-ExbD2-ExbB7123. More recently, the full 
TonB:ExbB:ExbD complex was co-purified and analysed in DDM detergent by size 
exclusion chromatography with multi-angle laser light scattering (SEC-MALLS) revealing 
a stoichiometry of TonB1-ExbB4-ExbD1. This reported stoichiometry was further 
complimented by a low resolution negative stain EM topology structure124.  
A study by mass spectrometry found the formation of subcomplexes of ExbBD without 
TonB, with major species being ExbB6ExbD1 and ExbB6 (with a minor amount of 
ExbB5ExbD1 also observed). Importantly, ExbD dimers were never observed125. Despite 
these findings, in vivo formaldehyde cross-linking has shown the presence of ExbD 
homodimers, and ExbD homodimerisation has even been suggested to be of functional 
importance to the transport cycle107. Therefore the exact stoichiometry remains 
uncertain, although the presence of multiple copies of ExbB and a single copy of TonB 
in the complex is consistently observed. 
1.4.5 Structural features of TonB-dependent transporters 
The first crystal structures were solved in the late 1990s of two E. coli TBDTs, the 
ferrichrome transporter (FhuA126,127) and ferric enterobactin transporter (FepA128), 
which revealed that TBDTs contain a 22-stranded β-barrel with a  unexpected globular 
plug domain folded into the interior of the barrel occluding the large (≈35–40 Å 
diameter) pore of the barrel (Figure 1.12).  
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Figure 1.12 - Revealing the novel structure of the TonB-dependent transporters: the first X-ray 
crystal structure of FhuA (blue and pink cartoon) in complex with ferrichrome-iron and a 
molecule of LPS (stick representations, with labels) (PDB: 2FCP). A) Strand residues 621 to 723 
are hidden to allow visualisation of the interior globular plug domain (pink), the extracellular 
loops involved in substrate binding are shown at the top of the barrel, encaging the ferrichrome-
iron ligand. The dashed lines indicate the positions of the upper and lower aromatic girdles 
which sit on either side of the lipid bilayer. B) Top view of FhuA126. 
In 2005, a comprehensive structural analysis of four TBDT structures from E. coli (FhuA 
(apo/liganded), FepA, BtuB (apo/liganded) and FecA (apo/liganded)) was performed129. 
The four TBDTs contained the same domain architecture with ligand binding sites in the 
long extracellular loops of the β-barrel and extracellular facing residues of the plug 
domain. The Ton box was located N-terminally and is found at the periplasmic side of 
the plug domain either folded within the barrel or disordered and not visible in the 
structures (ligand bound FecA and both apo and liganded FhuA). The ordering of the Ton 
box did not correlate well with either substrate bound or apo forms from 
crystallographic studies89. A structure-based sequence alignment has revealed that most 
of the conserved residues were found at the plug barrel interface and this interface is 
also highly solvated resembling a transient protein complex (Figure 1.13B). Barrel 
strands β1-8 show no sequence conservation; whilst β9-18 contain some strongly 
conserved residues, most of which face the lumen of the barrel. An interesting feature 
of the barrel was revealed, loop 7 (of strands β13 and 14, named the β-cantilever (Figure 
1.13A, blue strands)) folds towards the barrel lumen breaking the regular inter-strand 
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hydrogen bonding of the barrel and forms extensive interactions with the ‘latch region’ 
of the plug domain (Figure 1.13A and Figure 1.14). The latch region tightly interacts with 
conserved residues within strands β9-13. 
 
Figure 1.13 - Comparative structural analysis of TonB-dependent transporters  (images taken 
directly from reference 129). A) Membrane and extracellular view of the the vitamin B12 receptor 
BtuB. The β-cantilever (strands 13 and 14, blue) tilting from strands 11 and 12 (red) and the latch 
motif within the plug domain (yellow) are shown. B) Intracellular view of the structures of BtuB, 
FepA, FhuA, FecA (labelled) with bridging (green, protein-water-protein hydrogen bonds) and 
non-bridging (blue) waters at the plug–barrel interface. 
Some highly conserved motifs other than the Ton box were discovered within the plug 
domain which are also noted in a more recent structure-based sequence alignment of 
12 unique TBDTs89. These include the TEE, PGV, IRG box, LIDG box, RP box, latch and 
Hβ4 (Figure 1.14). The PGV motif forms three backbone hydrogen bonds to the IRG box 
(PGV and IRG are strictly conserved in TBDTs), forcing a substrate-binding loop 1 (SB1) 
of the plug domain to extend toward the extracellular side of the transporter. Similarly 
the IRG motif forms a sharp turn producing the second substrate-binding loop (SB2). 
Substrate binding loop 3 (SB3) is formed by the LIDG-box. Hβ4 (Hatch (alternative name 
for the plug domain) β-strand 4) forms the hydrophobic core of the plug domain.  
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Structure motif Sequence BtuB FepA FhuA FecA 
Ton box DTLxxTAN 6-12 12-18 7-13 80-86 
TEE TxEE 30-33 32-35 54-57 108-111 
PGV box PGV 50-52 53-55 74-76 128-130 
SB1 Gly G 58 64 82 139 
IRG box IRG 68-70 74-76 92-94 149-151 
LIDG box LIDG 79-82 85-88 105-108 163-166 
RP box RxEφφRGP 106-113 121-128 128-135 191-198 
latch xYG 117-119 132-134 139-141 202-204 
Hβ4 GGVVNxxT 124-131 139-146 146-153 209-216 
x = non-conserved, φ = hydrophobic 
Figure 1.14 - Comparative structural analysis of TonB-dependent transporter plug domains  (plug 
domain schematic taken directly from reference 129). The table shows structurally conserved 
motifs within the plug domain and a 2D secondary structure schematic (β-strands as purple 
arrows, α-helices as cylinders and substrate binding loops in red) of the plug domain of TBDTs 
with conserved motifs highlighted. 
There are currently (May 2016) 58 X-ray crystal structures of TonB-dependent 
transporters, representing 15 unique transporters, substrate-bound or apo forms and in 
complex with TonB87,88 or colicin E2130 and E3131. All share the features highlighted 
above, however despite a wealth of structural information, the exact transport 
mechanism still remains uncertain.  
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1.4.6 Proposed mechanisms of transport 
Despite structural and biochemical evidence of the TonB interaction with the TonB-
dependent transporters, it is still unclear how this interaction results in the transport of 
the substrate. The first hypothesis (Figure 1.15) was proposed in 1980 by Bradbeer when 
both TonB and the pmf were known to be required for the uptake of vitamin B12 through 
BtuB in E. coli and TonB was also known to be an IM protein. TonB was proposed to use 
the pmf to either generate a secondary messenger, or a pmf-dependent efflux of a 
secondary messenger into the periplasmic space. The hypothetical secondary 
messenger molecule then antiports exchanges with vitamin B12 or energises BtuB for 
substrate transport132. 
 
Figure 1.15 – Diagram of the first suggested model of TonB-dependent transport of cobalamin 
(Cbl, black hexagons) before structural or genetic information of the gene products were 
available (image taken from reference 132) X represents a hypothetical messenger molecule 
generated in the periplasm by TonB using the pmf, the messenger was hypothesised to bind to 
the OM receptor and facilitate transport by either an allosteric effect or antiport with the 
substrate.  
In 1982, TonB was postulated to be a periplasmic permease, either by acting as a positive 
regulator of a permease associated with the TBDTs, or TonB itself is a permease and 
modifies the TBDTs133. The shuttle hypothesis emerged in 1997 when sucrose density 
gradient fractionation of cell lysates revealed that TonB was distributed between both 
the IM and the OM in a 60:40 ratio respectively. This led to the idea that TonB shuttles 
 33 
 
between the IM and OMs to transduce energy for substrate transport134. The propeller 
model was proposed in 2001 when the accessory proteins ExbBD were shown to be 
homologous to the flagella motor proteins MotAB135 along with the crystal structure of 
the intertwined dimer of TonB (residues 164-239) (Figure 1.10A)102. The authors of the 
dimeric crystal structure speculated that ExbBD provides torsional motion of TonB and 
two proline-rich regions would provide a stiffer structure to directly transduce torsional 
force to the plug domain of the TBDT. The application of mechanical force by TonB to 
remodel the plug domain of the transporter (‘pulling hypothesis’ model) originates from 
single-molecule force spectroscopy experiments of β-stranded proteins136,137, where it 
was found that parallel β-strands serve as a force resistant clamp in an orientation 
dependent manner (perpendicular directed forces being significantly weaker than 
parallel (see Section 1.5.4)). Chimento et al performed comparative structural analysis 
on the available crystal structures of four TBDTs129, the plug domains were noted to 
contain a core four-stranded β-sheet. If a force by TonB was applied perpendicularly (ie. 
away from the receptor) to the strands then only a very modest mechanical force would 
be sufficient to cause substantial conformational change or unfolding of the plug domain 
(Figure 1.18A and B). 
The three main hypotheses (shuttle, propeller and pulling) will be each discussed in 
depth. 
1.4.6.1 The shuttle model (1997-2011) 
As mentioned above, the shuttle model was initially postulated from the results of a 
cellular fractionation where TonB was found in both IM and OM fractions134. In the 
shuttling model (Figure 1.16), TonB is initially in an unenergised conformation in 
complex with ExbBD in the IM. The pmf is used by ExbBD to convert TonB to an 
‘energised conformation’, which then dissociates from the IM carrying the stored energy 
and associates with the OM transporters to transfer the energy to drive transport. TonB 
has been shown to cross-link in vivo to OmpA and Lpp138, therefore could temporarily 
dock at these proteins waiting for TBDTs to signal ligand occupancy (Ton box exposure). 
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Figure 1.16 – The shuttle model of TonB-dependent transport, cartoon representative of the 
crystal structure TonB-dependent receptor FepA is shown in the OM, whilst the other 
components (with no structure at the time of publication) are shown as coloured blobs. (1) A 
‘uncharged TonB’ (blue) is converted to charged TonB (2) by the pmf using the ExbB/D complex 
(green). The charged TonB (yellow) leaves the cytoplasmic membrane (CM) and shuttles to the 
OM where it may dock with non-transporter proteins (such as OmpA or Lpp) until FepA binds its 
substrate (enterochelin) (3). Substrate binding results in a conformational change in FepA 
causing an interaction with charged TonB which releases the stored potential energy to drive 
substrate transport (4). Image taken from reference 113.  
The ‘energised’ state of TonB was supported by the formation of a proteinase K-resistant 
wild-type TonB from spheroplasts when carbonylcyanide m-chlorophenylhydrazone 
(CCCP) was used to inhibit the pmf139. Additionally, in vivo labelling experiments 
demonstrated that a fluorescent label (Oregon Green(R) 488 maleimide) that is 
permeable to the OM but not the IM could label an engineered cysteine (L3C) on full 
length TonB. This implies that the extreme N-terminal domain of wild-type TonB was 
exposed at some point to the periplasm and supports the notion of TonB leaving the 
IM140. The shuttle model received its first major criticism when GFP was fused to the N-
terminus of TonB to prevent it from leaving the IM, full TonB-dependent activity was 
observed and the authors declared TonB does not shuttle141. The shuttle model was then 
dismissed in 2011 by the original author in the aptly named publication ‘Death of the 
TonB Shuttle Hypothesis’ where they showed that fusing the N-terminus of TonB to the 
cytoplasmic domain of ToxR was capable of 100 % specific activity (ferrichrome uptake) 
as wild-type TonB (ie. does not leave the IM). It was also shown that Oregon Green(R) 
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488 maleimide (the strongest evidence of the shuttle model) was able to cross the IM 
and label cytoplasmic located TonB ΔTMD L3C. The 40% of OM located TonB was 
concluded to be tightly associated with a TBDT and was artificially pulled out of the IM 
during cellular fractionation142.  
1.4.6.2 The propeller/ROSET model (2001-present) 
In the propeller model, TonB undergoes a rotary motion that is initiated by ExbB, ExbD 
and the pmf (Figure 1.17). When TonB associates with the ligand bound TBDT, the rotary 
motion initiated at the IM causes conformational change to the plug domain and causes 
the release of the bound ligand into the periplasmic space.  
 
Figure 1.17 – The first schematic depicting the hypothesis of TonB rotation driving 
conformational change to the plug domain of a TBDT (the propeller model). After the 
intertwined dimeric crystal structure of TonB(165-239) (Figure 1.10A) was solved, TonB (pink) 
was proposed to exist as a dimer in vivo where it associates with the plug domain as a dimer and 
torque is applied by the ExbBD (blue and green) complex using the pmf. The substrate is then 
delivered to the cytoplasm by FepBCDCG components (labelled). Image taken from reference 
102. 
The idea of TonB rotation originated from the discovery of homology between ExbBD 
and MotAB135, however supporting evidence towards the model was not investigated 
until 2013 when a GFP-TonB fusion construct was created for the analysis of GFP 
anisotropy in living bacteria143. Fluorescence polarisation measurements demonstrated 
motion of TonB in vivo, the motion (predicted to be rotational) of GFP-TonB was slower 
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than that of free GFP in the cytoplasm. However, dissipation of the pmf by exposure to 
CCCP led to further reductions in motion of GFP-TonB. Deletion of exbBD rendered TonB 
motion insensitive to the same metabolic inhibitors, suggesting a dependency of TonB 
motion on ExbBD and the pmf. The motion was not directly shown to be rotational in 
this study, however due to rapid (2.5 ns) reorientation of the fluorescence transition 
dipole of GFP, other types of membrane protein motions such as lateral diffusion and 
rigid body motion are excluded144. In a recent review, the ‘propeller model’ (name 
originating from the aberrant dimer crystal structure102) was rebranded ‘rotational 
surveillance and energy transfer (ROSET) model’144. TonB is proposed to interact weakly 
only as a dimer with peptidoglycan (PG) (due to structural homology between the 
aberrant dimer structure of TonB to the PG binding motif LysM141). Moving laterally as 
a complex with ExbBD in the IM, TonB scans the OM until a exposed Ton box is 
encountered, the dimer then dissociates to a monomeric form (no longer able to 
associate with the PG) forming a complex with the Ton box. Using the constant 
rotational motion generated by ExbBD, kinetic energy is then transferred to the plug 
domain of the TBDT creating a conformational change, and transporting the substrate 
into the periplasmic space. The notion of a pulling force to facilitate transport is not 
dismissed in this revised model. 
1.4.6.3 The pulling model (2005-present) 
The pulling model proposes that TonB reaches across the periplasm using the extended 
proline-rich domain and binds to the Ton box of a ligand bound TBDT. The TonB:ExbBD 
complex then applies a force on the plug domain by extension away from the receptor 
by an unknown mechanism, which partially unfolds the β-sheets of the plug domain and 
allows for the translocation of the substrate. The high resolution crystal structure of the 
C-terminus of TonB (residues 153-233) and vitamin B12 non-covalently bound to BtuB 
confirmed that the Ton box:TonB is complexed by a parallel β-strand augmentation 
rotated ~90° with respect to the β-strands of the plug domain (Figure 1.18C)88. The 
authors speculated that only partial unfolding by mechanical force of the plug domain 
by TonB would be sufficient for substrate transport and the degree of unfolding may be 
a function of substrate size. 
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Figure 1.18 – The mechanical unfolding of the plug domain by TonB (the pulling model). A) 
Single-molecule force spectroscopy experiments demonstrated that the direction of force 
applied onto the β-sheets correlates with the amount of force required to unfold them. B) The 
structures of TBDT plug domains indicate that if force was applied by TonB perpendicular to the 
β-sheets (yellow arrow) of the plug domain (green) by the Ton box tether (red) then remodelling 
would occur under a small amount of force. C) Cartoon representative of the X-ray crystal 
structure of TonB(residues 150-239) (pink) bound to the Ton box (blue) of BtuB (PDB: 2GSK). The 
plug domain is shown in green, vitamin B12 in red and blue spheres and the barrel domain is 
transparent for clarity. The Ton box is perpendicular to strands of the plug domain, indicating 
that the unbinding of the Ton box will require more force (if extended in the direction of the 
black arrow) than the remodelling of the strands of the plug domain. Image A and B taken from 
reference 129. 
In silico steered molecular dynamics (SMD) was performed on the crystal structure of 
BtuB bound to TonB (vitamin B12 was excluded due to lack of parameters at the time). 
The BtuB:TonB complex was inserted into a POPE lipid bilayer and TonB was extended 
away from the receptor by applying constant velocity (2.5 Å/ns) to the N-terminal Cα 
atom (Pro153) of TonB. TonB and the Ton box remained tightly bound (TonB-Arg158 and 
BtuB-Asp6 salt bridge was maintained during extension and oriented TonB so that the 
Ton box was parallel to the plug domain strands) as TonB was extended by 9 nm. Longer 
extension could not be performed as a larger system would require prohibitive 
computational effort145. The first β-strand and α-helix downstream of the Ton box 
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unfolded during the 9 nm extension (Figure 1.19A), whilst the TonB:Ton box interaction 
was maintained. After this time, the simulation was extended by cycles of deleting the 
unfolded N-terminal residues and extending with the new N-terminus of BtuB. This was 
performed until a sufficient amount of plug residues were unfolded to accommodate 
substrate passage, which was found after 20 nm of extension (Figure 1.19B). SMD was 
also applied to the centre of mass of the plug domain testing the feasibility of intact plug 
removal from the barrel; however biologically inaccessible amounts of force (~4500 pN) 
were required for complete dislodging.  
 
Figure 1.19 – Steered molecular dynamics (SMD) study of applying force to the TonB:BtuB 
complex. A) Partial unfolding of the plug domain by TonB, TonB (red) was extended away from 
BtuB (blue, barrel shown as light blue and transparent with the front strands removed for 
visualisation of the plug domain) by its N-terminal residue (yellow sphere). The part of the plug 
domain remodelled during the simulation is shown in green (residues 12-38). States of unfolding 
are shown at (left to right) 0 Å, 55 Å, 70 Å, and 90 Å of extension. B) Continued SMD unfolding 
of the plug domain of BtuB (extracellular view, loops removed for clarity). The core β-sheet is 
shown in red, the substrate binding loops in yellow and the latch domain (See Figure 1.14) in 
green. The states shown are after approximately (left) 150 Å and (right) 215 Å of pulling. After 
215 Å of unfolding cyanocobalamin (blue sticks) is placed to scale in the open space created in 
the transporter. Images taken from reference 145. 
The possibility of TonB generating a pulling motion was suggested in a study on the 
proline-rich region of TonB75, were the rotatory motion provided by ExbBD causes the 
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predominant poly-proline type II (PPII) helix to form an unstable PPI conformation. This 
conformational change is accompanied by a contraction of up to 40% of the length of 
the proline-rich segment, generating an inwards force. Other than the study mentioned 
above, there is currently no in vitro or in vivo evidence supporting the pulling model 
(with the ability of TonB to mechanically remodel the plug domain or the origin of the 
pulling force).  
1.4.7 The Btu system: transport of vitamin B12 in E. coli 
E. coli cannot fully synthesise vitamin B12 and it is not an essential nutrient, however it 
is advantageous for E. coli to acquire vitamin B12 because the synthesis of methionine is 
100 times more efficient if vitamin B12 is utilised by the methyltransferase MetH146. 
As vitamin B12 is large (> 700 Da) and scarce, it fulfils the specifications for transport in a 
TonB-dependent manner. The Btu (B-twelve uptake) (Figure 1.20) system consists of the 
OMP BtuB, periplasmic cobalamin-binding protein BtuF and an IM ATP-binding cassette 
complex BtuBC2D2 (which also forms complex with BtuF). BtuC2 functions to span the IM 
(Figure 1.20, green) by forming 20 transmembrane helices grouped around a 
translocation pathway, whilst BtuD serves as a nucleotide binding domain to hydrolyse 
ATP (at the dimer interface) driving the conformational change required for transport. 
Initially, vitamin B12 binds the extracellular side of BtuB, where TonB-dependent activity 
translocates it across the OM. Once in the periplasm, vitamin B12 binds within a large 
cleft in the periplasmic protein BtuF which shuttles it to the BtuC2D2 complex. BtuF 
binding to the periplasmic side of BtuC2D2 initiates hydrolysis of ATP by BtuD, which 
opens the dimer, pulling the TM helices apart. The passage of vitamin B12 through 
BtuC2D2 has been described as peristaltic, whereby the helices force the substrate into 
the cytoplasm147.  
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Figure 1.20 – Schematic of the Btu system of E. coli. Vitamin B12 is shown as red sticks, the 
structures of BtuB and BtuF (labelled) are shown in cyan cartoon representation, BtuC in green 
(different shades of green show the individual monomer subunits within the dimer), BtuD in 
blue (again, different shades show the monomeric units) and TonBCTD in complex with BtuB 
shown in yellow. Image taken from reference 148. 
1.5 Study of force-induced remodelling of proteins and their complexes 
One of the primary goals of this thesis is to test whether mechanical force applied by 
TonB is able to remodel the plug domain of a TonB-dependent transporter (in 
accordance with the pulling model), therefore in this section the application of force to 
study biological systems will be covered.  
The first mechanical unfolding experiments were performed over 20 years ago on the 
giant muscle protein titin using atomic force microscopy (AFM)149, since this study our 
understanding of protein and protein complex mechanical stability has improved by 
multiple methods developed to investigate biological forces. As mechanical remodelling 
is now known to play a crucial role in many biological processes such as enzymatic 
activation, protein degradation, ion channel opening, translocation, cellular adhesion, 
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signal transduction and so on, it is important to gain insight into the mechanisms at the 
molecular level in vitro if we want to understand the function in vivo. Three techniques 
that have been extensively used to explore the effects of force on proteins are AFM, 
optical tweezers and patch clamping, the former being extensively used in this thesis. 
Each technique has different force ranges and resolution which are summarised in Table 
1.2  
 AFM Optical Tweezers Patch clamp 
Temporal 
resolution (ms) 
1 0.1 0.001 
Spatial resolution 
(nm) 
0.1 (vertical) 0.1 50 
Force range (pN) 1-10,000 0.1-100 - 
Table 1.2 – The force range and resolution of techniques used to explore the role of mechanical 
force on biological molecules. Values taken from reference 150. 
1.5.1 Atomic force microscopy (single-molecule force spectroscopy) 
Due to the dynamic range of forces (1-10,000 pN), high positional accuracy (0.1 nm), 
high sensitivity (~10-2 pN) and operational compatibility under physiological conditions, 
AFM has been an invaluable and extensively employed technique to measure intra-
molecular unfolding forces of individual proteins151 and the unbinding of non-covalent 
molecular interactions152. A typical AFM instrument comprises of two major 
components, an optical head and a XY stage scanner. A thin (10 μm) flexible cantilever 
composed of gold coated silicon nitride with a sharp stylus is used as the force-sensitive 
probe which is attached to the AFM optical head. A diode laser is focussed onto the end 
of a flexible cantilever probe, and movement of the lever leads to the position of the 
reflected spot changing on a position sensitive photo-diode, and hence the deflection of 
the lever can be measured with picometer sensitivity (Figure 1.21). The known spring 
constant of the cantilever allows force to be measured according to Hooke’s law 
(Equation 2.13). As the stiffness of the spring affects sensitivity, spring constants of 10-
40 pN/nm are ideal for single-molecule force spectroscopy (SMFS) experiments of 
proteins. The AFM probe is positioned on the Z-axis by piezo expansion, which 
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approaches and retracts the cantilever to and from the surface at a constant velocity. 
The cantilever is pushed against the hard surface (Figure 1.21Bii) until a defined load is 
reached; the withdrawal velocity defines the amount of force which is loaded onto the 
molecule or complex of interest.  
 
Figure 1.21 – Studying protein-protein interactions under force by single-molecule force 
spectroscopy. A) Schematic of the AFM set up for single-molecule force spectroscopy (SMFS) 
experiments to identify the strength of interacting partners such as a protein:protein 
interaction. The silicon nitride AFM probe contains a triangle flexible cantilever which is coated 
with a layer of reflective gold, linkers are used to covalently attach biomolecules to the 
cantilever. A laser is positioned onto the back of the cantilever which detects the deformation 
caused by the resisting force. B) Step by step of an ideal single-molecule unbinding event in a 
SMFS experiment between two binding partners and a force-extension trace. i) The cantilever is 
initially away from the surface, the piezo causes the cantilever to press against the surface (ii) 
which brings a single complex together, the complex is then extended by retracting the 
cantilever (iii) until a force (which bends the cantilever (iv)) that breaks the interacting partners 
(the rupture force) is reached. The cantilever returns back to its original position (v). This is called 
an approach-retract cycle. 
For SMFS measurements of the mechanical strength of a protein:protein or 
protein:ligand interaction, the substrates are covalently attached to the AFM probe and 
surface by the use of polyethylene glycol (PEG) linkers derived with a maleimide at one 
end. The use of PEG linkers is also advantageous as it prevents non-specific protein 
sticking, enables substrate flexibility and has a signature resisting force when 
stretched153. The SMFS procedure involves bringing the AFM probe into contact with the 
surface to form a complex between the substrates (Figure 1.21B). The AFM probe is 
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retracted from the surface and if the interaction has formed, an entropic restoring force 
will be initially observed, which increases in a parabolic fashion until the interaction 
breaks and the force sharply drops to zero (force extension trace Figure 1.21B). The force 
required for dissociation (rupture force) is the force at the apex of the parabolic curve 
(Figure 1.21B). SMFS is a powerful technique to study protein:protein/ligand complex as 
it allows estimation of the unbinding forces (Table 1.3), dissociation rate constants (see 
Section 1.5.3), energy landscapes, the nature of force resistant bonds and the length of 
the complex before dissociation (by using the Worm-like chain (WLC) model (see Section 
1.5.2)).  
Molecular partners Pulling velocity 
(μm/s) 
Unbinding 
force (pN) 
Avidin/biotin 5 173 ± 19 
Streptavidin/biotin 5 326 ± 19 
Human serum albumin(HSA)/anti HSA 
antibody (Ab) 
0.2 244 ± 22 
Intercellular adhesion molecule-1 
(ICAM-1)/anti-ICAM-1 Ab 
4.7 100 ± 50 
Actin/Myosin 0.03 25 ± 1.4 
Nitrilotriacetate(NTA)/hexa-histidine 
(His6) 
0.09-0.27 150-194 
Lactose/lactose-binding 
immunoglobulin G (IgG) 
1.2 36 ± 4 
Recombinant P-selectin/P-selectin  2.8 ~165 
Table 1.3 – Examples of the strength of molecular complexes studied by SMFS, values taken 
from reference 152. 
1.5.2 Worm-like chain model 
The force extension data collected from SMFS experiments in this thesis are analysed 
using a model for polymer elasticity called the worm-like chain (WLC) model. The WLC 
model (Equation 1.1) was derived empirically from the stretching of DNA154,155 and 
predicts that entropic restoring force (f) is generated upon extension (x) of a polymer: 
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where Lc is the contour length (the length of the biomolecule under study when fully 
extended), T is temperature, kB is Boltzmann’s constant and p is the persistence length 
(describes the decay in correlations of the tangent vectors of the WLC model (or the 
typical length scale over which a polymer bends)). The persistence length for a protein 
is the length between two α-carbons of two amino acids (0.4 nm)156. 
The WLC model has been extensively used in the study of protein domain 
unfolding84,149,157, and also used for protein-protein interactions158,159 as the force-
extension profiles are well defined by the model. Farrance et al demonstrated that the 
WLC model gave accurate measurements of the contour length of various 
protein:protein/peptide complexes when extended by AFM159. The contour length is 
important for identifying whether an interaction between two binding partners is 
specific, as the expected Lc can be estimated from structural information. Contour 
lengths greater than the expected value give good indication of protein remodelling 
under force. It is also possible to calculate the amount of protein unfolded by subtracting 
observed Lc from the expected Lc and by using disulfide cross-links to prevent unfolding. 
Other than finding the Lc, a differential WLC model (Equation 2.14) can be used to 
calculate the instantaneous loading rate (the rate of force applied to the complex) which 
is strongly affected by the Lc of the complex under study. The differential WLC calculates 
the slope (WLCslope) which is the change in force per change in distance (ie. the stiffness), 
which when multiplied by the retraction velocity, allows the loading rate (rf) for a specific 
single event to be calculated. 
1.5.3 Dynamic force spectroscopy 
For most interactions, force acts to decrease the stability of the folded or bound state 
of a protein or complex relative to the unfolded or dissociated state. The unfolding or 
unbinding of a protein or complex can be considered as a two-state process, a low-
energy conformation which represents the folded/bound state and a high-energy 
unfolded/unbound state. Between the states is an energy barrier that has to be 
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overcome to switch between states. A simplified example of a ‘free-energy landscape’ 
is shown by the black trace in Figure 1.22. Based on Bell’s model for off-rates160, it has 
been demonstrated by Evans and Ritchie161,162 that an externally applied force lowers 
the energy barrier between the low- and high-energy states (Figure 1.22). Additionally 
the force required to unfold a protein or break a protein complex depends on the 
loading rate, and in general the higher the velocity, more force is required to 
unfold/break the complex, therefore a linear dependence is usually observed when the 
most probable force (F*) is plot as a function of ln(rf) (See inset Figure 1.22 and Equation 
1.2)163: 
 𝐹 ∗ =
𝑘𝐵𝑇
𝑥𝑢
 ln
𝑟𝑓𝑥𝑢
𝑘𝐵𝑇 𝑘0
 (1.2) 
 
where kB is Boltzmann’s constant, T is temperature, xu is the distance from the low 
energy state to the transition state and k0 is the spontaneous unfolding when no force 
is applied. 
Pulling a protein or a protein complex at various velocities (dynamic force spectroscopy), 
allows the quantification of parameters that are used to describe the free-energy 
landscape (energy barrier height and width), such as xu and the free-energy of activation 
(ΔG, the height of the transition state) which determines the rate at which the protein 
spontaneously unfolds (k0) or complex dissociates (𝑘𝑜𝑓𝑓
0𝐹 ) under no applied force (k0 = 
1/t0 exp(-ΔG/kBT). t0 is the diffuse relaxation time.  
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Figure 1.22 – Simple free-energy landscape of a folded protein under externally applied force. 
In this two-state unfolding model, a single barrier separates the folded (f) and unfolded (u) states 
of a protein (black trace). The activation free-energy of unfolding is given by ΔG, while xu 
represents the distance between the folded and the transition state (‡) along the reaction 
coordinate x. The energy barrier is spontaneously crossed at a transition rate k0 (or in the case 
of a protein ligand complex unbinding (𝑘𝑜𝑓𝑓
0𝐹 )). Application of an external force tilts the energy 
landscape (red trace), lowering the energy barrier. The inset depicts a theoretical dependence 
of the most probable rupture force on the loading rate: the dynamic force spectrum, which is 
governed by a single linear regime, with a slope proportional to 1/xu. The y-intercept allows the 
extrapolation of the k0 or 𝑘𝑜𝑓𝑓
0𝐹 . 
The application of force to a complex tilts the energy landscape reducing the free-energy 
barrier to unbinding of the complex (or indeed unfolding of the protein). So the 
probability of the complex breaking apart or protein unfolding increases with the 
application of force. In the classic Bell–Evans model, it is assumed that the energy barrier 
is so deep that its position does not change during tilting, where only the height of the 
energy barrier is lowered by force, the shape of the landscape does not change (red 
trace, Figure 1.22)164.  
The Bell model describes interactions that show an exponential decrease in lifetime with 
increased force (slip bonds), however not all biological interactions display this 
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behaviour, in some cases more than one energy barrier can exist164 and some 
interactions are strengthened by force (catch bonds). A slip bond is an interaction that 
dissociates at a higher rate when subjected to force, which is commonly observed for 
protein:protein interactions. In catch bonds, the interaction lifetime increases with force 
(mechanical activation adhesion), which was initially observed in fluid flow experiments 
where cellular adhesion was enhanced by shear flow164. The first direct demonstration 
of catch bond behaviour was by SMFS on P-selectin, the bond lifetime was found to be 
longer under low forces, but acted as a slip bond at high forces165. Catch bonds are 
predominantly found in cellular adhesion proteins. Trip bonds are found in tight protein 
interactions which have very large dissociation lifetimes under zero force (> days), 
however upon the application of a small force, the binding partners rapidly dissociate, 
exemplified by the colicin immunity protein complex, Im9:E9158. 
1.5.4 Protein structure and mechanical stability 
As all proteins have evolved to provide a specific function to a cell, it was therefore likely 
that the fold (secondary structure) of a protein with a mechanical role will influence its 
ability to either withstand force or be susceptible to force. This question was addressed 
soon after the first application of SMFS to study titin unfolding in 1997149. The conclusion 
being that α-helical proteins are force sensitive166, β-sheet proteins force resistant and 
mixed topology proteins show various responses to force. The array of non-covalent 
interactions that form β-sheeted proteins provide much more stability under force 
compared to the hydrophobic contacts of α-helices which unfold in a step-wise manner.  
The mechanical strength of a protein is not only dependent on the type of secondary 
structure. The direction of the force application relative to the topology of the secondary 
structure has also been found to show a significant effect. In a study by Brockwell et al, 
a β-stranded protein E2lip3 was shown to resist mechanical deformation when force 
was applied parallel to the β-strands of the protein (187 ± 10 pN at 700 nms-1) however 
if the geometry of the force was applied perpendicular to the strands, the unfolding of 
the protein became undetectable by AFM (< 15 pN)136. Similar observations have been 
found for ubiquitin137 and GFP167. The reason for this effect can be rationalised by an 
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analogy to a zip, sequential ‘unzipping’ of the hydrogen bonds requires little force 
whereas breaking all the bonds simultaneously requires much more force. 
Proteins with parallel β-strands that are directly bonded are more mechanically robust 
than antiparallel β-strands. Brockwell et al provided evidence of this mechanical 
durability on a small β-stranded protein with simple topology and parallel terminal β-
strands168. It was shown that although this protein has no known mechanical function, 
the parallel strands where the force was directly propagated rendered the protein to be 
mechanically strong when extended by AFM (152 pN, 700 nms-1). Other structural 
features of proteins which confer mechanical strength include hydrophobic packing, 
solvent accessibility of the hydrogen bonds, bond patterns and sequence motifs169. 
1.6 Thesis aims 
The principal aim of the work described in this thesis is to provide molecular insight into 
the mechanism of TonB dependent transporters and their force-induced remodelling 
both in vitro and in vivo. 
As discussed in this chapter (Section 1.4.6.3), force induced remodelling of the plug 
domain of TBDTs by the Ton box tether is an attractive model for substrate transport. 
Whilst this model is well received, there is no direct experimental evidence in vitro or in 
vivo supporting the pulling tether model and more generally, for other membrane 
proteins predicted to function by a tether gating mechanism170,171.  
Therefore the work in this thesis aims to provide evidence for: 
1. Membrane protein gating by proteinaceous tethers 
2. Periplasmic inside-out energy transduction mechanisms  
3. Whether the extent of mechanical plug domain unfolding is dependent on the 
substrate size 
 
Alongside this, biophysical methods will also be used to address structural features of 
the periplasmic spanning protein TonB, especially the poorly charactered proline-rich 
linker domain.  
The first results chapter provides an extensive analysis of TonB, including measurement 
of the mechanical strength and bond properties of the TonB:Ton box complex. Structural 
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and biophysical features of the proline-rich domain will also be explored, such as the 
effects on binding, dimerisation and stability of the protein.  
After demonstrating the mechanical durabily of the TonB:Ton box interaction, the 
second results chapter uses SMFS to validate that TonB is capable of partially unfolding 
the plug domain of two TBDTs, BtuB and FhuA. These findings are supported by cross-
linking experiments and in silico methods. 
Finally, the physiological consequences of partial plug domain unfolding are explored in 
vivo. A variant of BtuB is engineered to allow complete plug unfolding and using 
antibiotic sensitivity assays it is revealed that TonB is capable of unfolding the entire 
plug in this variant. 
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2 Materials and method 
2.1 Materials 
2.1.1 Centrifuges 
Bench top centrifuge: GenFuge 24D (Progen Scientific, London, UK). 
Centrifuge: Avanti J25 (Beckman Coulter, CA, USA). 
Ultracentrifuge: Beckman Optima XL-90 (Beckman Coulter, CA, USA). 
2.1.2 Incubators 
Stuart SI500 Shaking Incubator (Bibby Scientific, Staffordshire, UK). 
New Brunswick™ Innova 44 (Eppendorf, Hamburg, Germany). 
2.1.3 Protein purification equipment 
ÄKTAprime plus (GE healthcare, Buckinghamshire, UK). 
Resource™ S 6 mL cation exchange column (GE healthcare, Buckinghamshire, UK). 
Superdex™ 75 Hiload 26/60 gel filtration column (GE healthcare, Buckinghamshire, UK). 
Superdex™ 75 HR 10/30 gel filtration column (GE healthcare, Buckinghamshire, UK). 
Superdex™ peptide HR 10/30 gel filtration column (GE healthcare, Buckinghamshire, 
UK). 
HiTrap® DEAE FF 5 mL anion exchange column (GE healthcare, Buckinghamshire, UK). 
Superdex™ 200 increase 3.2/300 gel filtration column (GE healthcare, Buckinghamshire, 
UK). 
2.1.4 Spectrophotometers 
NanoDrop 2000 UV-Vis Spectrophotometer (Thermo Scientific, MA, USA). 
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Ultrospec 2100 pro UV/Visible spectrophotometer (GE Healthcare, Buckinghamshire, 
UK). 
2.1.5 PCR thermocycler 
T100 thermal cycler (BioRad, CA, USA). 
2.1.6 AFM 
MFP-3D™ Stand Alone AFM (Asylum Research, Buckinghamshire, UK). 
2.1.7 AFM probes 
MLCT silicon nitride with reflective gold AFM probe (Bruker, CA, USA). 
2.1.8 Chemicals 
A Supplier 
Acetic acid, glacial Fisher Scientific, Loughborough, UK 
Acrylamide 30 % (v/v) Severn Biotech, Kidderminster, UK 
Agar Fisher Scientific, Loughborough, UK 
Agarose Melford Laboratories, Suffolk, UK 
Ampicillin sodium Formedium, Norfolk, UK 
L-(+)-Arabinose Sigma Life Sciences, MO, USA 
Arginine  
(3-Aminopropyl)triethoxysilane (APTES) Sigma Life Sciences, MO, USA 
Ammonium persulphate (APS) Sigma Life Sciences, MO, USA 
Alexa Fluor® 488 C5 maleimide Fisher Scientific, Loughborough, UK 
B  
Benzamidine dihydrocholride Sigma Life Sciences, MO, USA 
Bacitracin zinc Bio Basic Inc, Ontario, Canada  
C  
Cyanocobalamin (vitamin B12) Sigma Life Sciences, MO, USA 
Chloroform Fisher Scientific, Loughborough, UK 
Calcium chloride (CaCl2) Melford Laboratories, Suffolk, UK 
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D  
Disodium phosphate Fisher Scientific, Loughborough, UK 
Dithiothreitol (DTT) Formedium, Norfolk, UK 
Dimethyl sulfoxide (DMSO) GE Healthcare, Buckinghamshire, UK 
E  
Ethidium bromide Sigma Life Sciences, MO, USA 
Ethanol Sigma Life Sciences, MO, USA 
Ethylenediaminetetraacetic acid (EDTA) Fisher Scientific, Loughborough, UK 
F  
Ferrichrome iron 
 
EMC Microcollections, Tübingen, 
Germany 
G  
Guanidine hydrochloride  Sigma Life Sciences, MO, USA 
Glycerol Fisher Scientific, Loughborough, UK 
H  
Hydrogen peroxide (H2O2) Sigma Life Sciences, MO, USA 
Hydrochloric acid (HCl) Fisher Scientific, Loughborough, UK 
I  
Imidazole Sigma Life Sciences, MO, USA 
Isopropanol  Fisher Scientific, Loughborough, UK 
Isopropyl β-D-1-thiogalactopyranoside 
(IPTG) 
Melford Laboratories, Suffolk, UK 
L  
Lithium 3,5-diiodosalicylate (LIS) Sigma Life Sciences, MO, USA 
Lithium chloride (LiCl) Sigma Life Sciences, MO, USA 
M  
Monosodium phosphate Fisher Scientific, Loughborough, UK 
Methanol Fisher Scientific, Loughborough, UK 
N  
N-Hydroxysuccinimide -PEG24-maleimide 
(SM PEG) 
Fisher Scientific, Loughborough, UK 
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N-Hydroxysuccinimide -PEG24-methyl (MS 
PEG) 
Fisher Scientific, Loughborough, UK 
N,N-diisopropylethylamine (DIPEA) Fisher Scientific, Loughborough, UK 
N-octyl-β-D-glucoside (β-OG) Avanti Polar Lipids Inc, Delfzijl, NL 
Nickel nitrilotriacetic acid (Ni-NTA) GE Healthcare, Buckinghamshire, UK 
P  
Phenylmethanesufonyl fluoride (PMSF) Sigma Life Sciences, MO, USA 
Potassium chloride (KCl) Fisher Scientific, Loughborough, UK 
S  
Sodium azide (NaN3) Sigma Life Sciences, MO, USA 
Sodium chloride (NaCl) Fisher Scientific, Loughborough, UK 
Sulphuric acid Fisher Scientific, Loughborough, UK 
Sodium hydroxide (NaOH) Fisher Scientific, Loughborough, UK 
Sodium dodecyl sulphate (SDS)  Severn Biotech, Kidderminster, UK 
Streptomycin sulfate Sigma Life Sciences, MO, USA 
T  
Triton X-100 Sigma Life Sciences, MO, USA 
Tris Fisher Scientific, Loughborough, UK 
Tetramethylethylenediamine (TEMED) Sigma Life Sciences, MO, USA 
U  
Urea MP biomedicals, Loughborough , UK 
 
2.1.9 Gel ladders and dyes 
1 kb, 100 bp DNA ladder (Promega Hampshire, UK). 
Precision plus protein dual color standards protein ladder (BioRad, CA, USA). 
Blue/orange 6x loading dye (Promega Hampshire, UK). 
2.1.10 Kits 
Wizard® Plus SV Minipreps DNA Purification System (Promega Hampshire, UK). 
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Q5® High-Fidelity DNA Polymerase kit (NEB, Hertfordshire, UK). 
QIAquick Gel Extraction Kit (Qiagen, Manchester, UK). 
pGEM®-T Easy Vector System (Promega, Hampshire, UK). 
Q5® Site-Directed Mutagenesis Kit (NEB, Hertfordshire, UK). 
2.1.11 Buffers 
2.1.11.1 Imidazole wash buffer 
20 mM Tris-HCl pH 8.0, 300 mM NaCl, 20 mM imidazole, 2 mM DTT, 0.025 % (w/v) 
sodium azide, 1 mM PMSF, 2 mM benzamidine 
2.1.11.2 Imidazole elution buffer 
20 mM Tris-HCl pH 8.0, 300 mM NaCl, 250 mM imidazole, 2 mM DTT, 0.025 % (w/v) 
sodium azide, 1 mM PMSF, 2 mM benzamidine. 
2.1.11.3 SDS-PAGE resolving gel buffer 
1 M Tris-HCl pH 8.45, 0.1 % (w/v) SDS, 15 % (v/v) acrylamide, 13 % (v/v) glycerol, 0.7 % 
(w/v) APS, 0.07 % (v/v) TEMED. 
2.1.11.4 SDS-PAGE stacking gel buffer 
750 mM Tris-HCl pH 8.45, 0.07 % (w/v) SDS, 4 % (v/v) acrylamide, 0.32 % (w/v) APS, 0.16 
% (v/v) TEMED. 
2.1.11.5 SDS-PAGE loading buffer (x2 concentrated stock) 
2 % (w/v) SDS, 10 % (v/v) glycerol, 0.1 % bromophenol blue, 100 mM DTT. 
2.1.11.6 SDS-PAGE cathode buffer 
1 M Tris, 1 M Tricine, 1 % (w/v) SDS. 
2.1.11.7 SDS-PAGE anode buffer 
2 M Tris-HCl pH 8.9. 
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2.1.11.8 TAE buffer (x25 concentrated stock) 
1 M Tris, 25 mM EDTA, 2.8 % (v/v) glacial acetic acid. 
2.1.11.9 1.5 % agarose gel 
40 mM Tris, 1 mM EDTA, 0.1 % (v/v) glacial acetic acid, 1.5 % (w/v) agarose, 2.5 μM 
ethidium bromide. 
2.1.11.10 BtuB purification buffers 
Buffer A - 10 mM Tris-HCl pH 8.0, 0.25 % (w/v) lithium diiodosalicylic acid (LIS) 
Buffer B - 10 mM Tris-HCl pH 8.0, 0.25 % (w/v) LIS, 2 % (v/v) Triton X-100 
Buffer C - 10 mM Tris-HCl pH 8.0 
Buffer D - 10 mM Tris-HCl pH 8.0, 1 % (w/v) n-octyl-β-D-glucopyranoside (β-OG), 5 mM 
EDTA 
Buffer E - 50 mM Tris-HCl pH 7.5, 5 mM EDTA, 0.54 % (w/v) β-OG 
Buffer F - 50 mM Tris-HCl pH 7.5, 5 mM EDTA, 1 M LiCl, 0.54 % (w/v) β-OG 
2.1.11.11 Liposome detergent free dialysis buffer 
10 mM Tris-HCl pH 7.5, 300 mM KCl, 400 µM CaCl2, 0.01% (w/v) NaN3 
2.1.12 Enzymes 
Restiction enzymes (XhoI, NdeI and NcoI), quick ligase, alkaline phosphatase, Q5® and 
Taq polymerases were purchased from NEB, Hertfordshire, UK. Lysozyme and DNAse I 
were purchased from Sigma Life Sciences, MO, USA.  
2.1.13 Lipids 
E. coli polar lipid extract (Avanti Polar Lipids Inc, Delfzijl, Netherlands). 
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2.1.14 Peptides/DNA oligios  
All DNA primers were purchased from Eurofins MWG Operon, Ebersberg, Germany. 
Peptide oligos were purchased from Genscript, NJ, USA. 
2.1.15 E. coli strains 
E. coli XL1-Blue Competent cells (efficiency: >1 x 108 cfu/μg) (Agilent technologies, 
Berkshire, UK). 
E. coli BL21(DE3) Competent cells (efficiency: >1 x 106 cfu/μg) (Agilent technologies, 
Berkshire, UK). 
E. coli DH5-α Competent cells (NEB, Hertfordshire, UK). 
E. coli JM109 cells (Stratagene, Cambridge, UK). 
E. coli RK5016 (MC4100 btub metE70 argH recA) cells were kindly provided by Nicholas 
Housden, University of Oxford, UK. 
E. coli TNE012 (K12 tsx−ompA−ompB−) were kindly provided by Nicholas Housden, 
University of Oxford, UK. 
2.1.16 Plasmids 
pAG1 (wild-type BtuB from E. coli under a native promotor, pUC8 vector) was kindly 
provided by Nicholas Housden, University of Oxford, UK. 
pNGH15 (wild-type BtuB from E. coli in a pBAD expression vector) was kindly provided 
by Nicholas Housden, University of Oxford, UK. 
pSH11 (wild-type FhuA from E. coli in a pBAD expression vector). 
His6-TonBΔTMD pET-23a(+) (E. coli His6-tagged TonB without the transmembrane 
domain (residues 1-33) in an expression vector). 
His6-TonBCTD pET-23a(+) (E. coli His6-tagged TonB C-terminal domain (residues 144-239) 
in an expression vector). 
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His6-TonBΔTMD (V32C) pET-23a(+) (E. coli His6-tagged TonB without the transmembrane 
domain (residues 1-33) with N-terminally located cysteine in an expression vector). 
His6-TonBCTD (K144C) pET-23a(+) (E. coli His6-tagged TonB C-terminal domain (residues 
144-239) with N-terminally located cysteine in an expression vector). 
2.2 Methods 
2.2.1 Molecular biology 
2.2.1.1 Preparation of competent E. coli for transformation 
10 mL of LB medium was inoculated with a desired strain of E. coli; this was grown at 
37 ˚C, 200 rpm for 16 hours. 5 mL of the culture was used to inoculate 100 mL of LB 
medium and was grown to an optical density at 600 nm (OD600) of 0.45 before the cells 
were harvested by centrifugation at 4,000 rpm for 10 minutes at 4 ˚C (Eppendorf 5804R 
Refrigerated Benchtop Centrifuge). The supernatant was discarded and the pellet gently 
resuspended in 10 mL of sterile pre-chilled (4 ˚C) 100 mM CaCl2. The resuspension was 
incubated on ice for 10 minutes before centrifugation to re-pellet the cells. The 
supernatant was discarded and the pellet was gently resuspended in 2 mL of pre-chilled 
(4 ˚C) 100 mM CaCl2, 30 % (w/v) glycerol and 100 μL aliquots were prepared in sterile 
Eppendorf tubes sat on dry ice. Once frozen, the competent cells were stored at -80 ˚C.  
2.2.1.2 Extraction of E. coli genomic DNA 
The genome of E. coli was extracted by inoculating 5 mL of LB broth with a subculture of 
E. coli cells; the culture was then incubated at 200 rpm, 37 ˚C until an OD600 of 0.25 was 
recorded. 20 µL of the culture was transferred to 980 µL of sterile purified H2O and 
boiled at 98 ˚C for 5 minutes. 
2.2.1.3 Q5® High-Fidelity PCR 
For Q5® PCR the following reaction was set up in 0.2 mL PCR tubes: 
 
 58 
 
 Volume (μL) 
Q5® 5X master mix 10.0 
dNTP (10 mM) 1.0 
Forward primer (10 μM) 2.5 
Reverse primer (10 μM) 2.5 
Template DNA 10.0 (~1 ng-1 μg) 
Nuclease-free water 23.5 
Q5® polymerase 0.5 
 
This was then subjected to the following thermal cycle: 
Temperature (°C) Duration (s)  
98 30  
98 5-10  
Primer Tm 30 X 35 
72 30  
72 120  
4 ∞  
 
 
  
2.2.1.4 Vent PCR 
For Vent PCR the following reaction was set up in 0.2 mL PCR tubes: 
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 Volume (μL) 
Template DNA (50 ng/μL) 2 
Forward primer (10 μM) 2 
Reverse primer (10 μM) 2 
Nuclease-free water To final 100 
MgSO4 (100 mM) 0, 2 or 4 
DMSO 1 
Vent polymerase 0.5 
4 X PCR master mix* 25 
* ThermoPol Reaction Buffer (4X), 10 mM dNTP 
This was then subjected to the following thermal cycle: 
Temperature (°C) Duration (s)  
95 30  
95 30  
Primer Tm 30 X 20 
72 120/kb  
72 600  
4 ∞  
The primer melting temperatures (Tm) were calculated using the NEB online Tm 
calculator (www.neb.com/tools-and-resources/interactive-tools/tm-calculator). 
2.2.1.5 Restriction digest 
 Volume (μL) 
DNA (~300 ng/μL) 6 
CutSmart™ buffer (10X)  2 
NdeI  1 
XhoI  1 
Nuclease-free water 10 
The reaction mixture was incubated at 37 °C for 2 hours and enzymes were removed by 
1.5 % agarose gel electrophoresis of the products. 
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2.2.1.6 Site-directed mutagenesis 
Site-directed mutagenesis was performed using the reagents and protocol from the Q5® 
Site-Directed Mutagenesis Kit (Section 2.1.10). Primers were designed using the 
NEBasechanger software (http://nebasechanger.neb.com/) and purchased from 
Eurofins MWG Operon. The PCR set up was identical to the Q5® PCR (Section 2.2.1.3) 
however only 25 cycles were performed rather than 35. 1 μL of the PCR product was 
added to 5 μL of 2 x Kinase, Ligase & DpnI (KLD) buffer, 1 μL of 10 x KLD enzyme mix and 
3 μL of purified H2O and incubated for 5-10 minutes at 21 °C. 5 μL of the reaction product 
was transformed into DH5α cells by heat shock (42 °C for 30 seconds). This was then 
plated onto antibiotic selection agar plates after an hour incubation at 37 °C, 200 rpm 
in SOC medium provided with the kit. 
The mutagenesis primers for BtuB are listed in Table 2.1: 
Primer name: Forward sequence: Reverse sequence: 
BtuB L8P 5’-CCC GGA TAC TCC CGT 
CGT TAC TG-3’ 
5’-CTG GTA TCC TGT 
GCC CAA-3’ 
BtuB L23C 5’-CAG CAC TGT GTG TGC 
ACC AAC CAC C-3’ 
5’-CGC GGC TGT TCA 
AAA CGG-3’ 
BtuB S374C 5’-CTG GCA AAC CTG CGC 
CGG TTG-3’ 
5’-GTT CCA TGA CGA 
CCA AAC TGT G-3’ 
BtuB V29C 5’-AAC CAC CGT TTG CAC 
CCG TCA GGA TAT CGA C-3’ 
5’-GGT GCA AGC ACA 
GTG CTG-3’ 
BtuB V45C 5’-GGT CAA TGA TTG CCT 
GCG CCG TCT TCC GGG-3’ 
5’-GAG GTC GAC TGC 
CAG CGG-3’ 
BtuB T27C 5’-TGC ACC AAC CTG CGT 
TGT GAC CCG TCA GG-3’ 
5’-AGC ACA GTG CTG 
CGC GGC-3’ 
BtuB Y109C 5’-CGT GTT GAA TGT ATC 
CGT GGG-3’ 
5’-CTG GAC AAG CGC 
AAT AGG-3’ 
BtuB I80A/L85A 5'-GTA CGC GCG AAT CTG 
GCG GGG GTG AGT-3' 
5'-GCC ATC AGC TAA 
CAC CAA CAC ATG ACT 
GGC-3' 
BtuB L96A 5'-TTC TGC CGA CGC TAG 
CCA GTT CCC TAT TGC G-3' 
5'-CCA CTC ACC CCC GCC 
AGA-3' 
Table 2.1 – Primers for BtuB mutagenesis 
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2.2.1.7 Preparation of plasmid DNA for sequencing 
Single colonies were picked from antibiotic selection agar plates and used to inoculate 
10 mL of LB medium with the same selection antibiotic as the agar plate (100 µg/mL 
ampicillin). The inoculated medium was incubated for 16 hours at 37 °C, 200 rpm and 
the cells were subsequently harvested by centrifugation at 4,000 rpm for 10 minutes, 
4 ˚C (Eppendorf 5804R Refrigerated Benchtop Centrifuge). Using a Wizard® Plus SV 
Minipreps DNA Purification System kit (Section 2.1.10), the plasmids were purified from 
the bacteria and the concentration in water was calculated using a nanodrop 1000 
spectrophotometer using the optical density at 260 nm (A260) (concentration (μg/mL) = 
50 μg/mL x A260). 15 µL of the plasmid DNA (50 ng/µL) was then prepared and sent for 
sequencing (Beckman Coulter Genomics). 
2.2.1.8 Agarose gel electrophoresis 
1 L of 1x TAE buffer (Section 2.1.11.8) was prepared, 150 mL was transferred to a conical 
flask with 2.25 g agarose (1.5 % gel) and heated in a microwave until the agarose was 
fully dissolved into the TAE buffer. This was allowed to cool for 10 minutes before 15 µL 
of 10 mg/mL ethidium bromide was added, mixed and poured into a sealed gel mould 
with a comb inserted. Once the gel had set, the seals were removed and the gel mould 
containing the gel was submerged into an electrophoresis bath filled with the remaining 
1x TAE buffer. The comb was removed and 20 µL DNA samples were loaded with 4 µL of 
Blue/orange 6x loading dye. 10 µL of 1 kb or 100 bp DNA ladder was applied to a single 
well for size (bp) determination. The gel was electrophoresed at 100 mV for ~45 minutes 
and DNA stained with ethidium bromide and visualised with a UV transilluminator. 
2.2.1.9 Extraction of DNA from agarose gel 
Agarose gel electrophoresis was used to resolve DNA species after PCR and restriction 
digests. In order to purify the target DNA and other DNA fragments from the gel itself, 
DNA bands were extracted using a scalpel and a QIAquick Gel Extraction Kit (Section 
2.1.10) was used to purify the DNA. The DNA concentration was then determined using 
a nanodrop 1000 spectrophotometer (Section 2.2.1.7).  
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2.2.2 Protein expression and purification 
2.2.2.1 Starter culture 
200 mL of sterile LB medium containing 0.1 % (w/v) ampicillin was inoculated with a 
single colony from an ampicillin selection plate of freshly transformed expression cells 
(BL21 (DE3) for TonB constructs and TNE012 (K12 tsx−ompA−ompB−) for BtuB and FhuA). 
The inoculated medium was incubated at 37 °C, 200 rpm for 16 hours. 
2.2.2.2 Protein expression procedure for TonB constructs 
1 L (x10) of sterile LB medium containing 0.1 % (w/v) ampicillin was inoculated with 10 
mL of starter culture and grown at 37 °C, 200 rpm to an OD600 of 0.7. Protein expression 
was then induced with isopropyl β-D-1-thiogalactopyranoside (IPTG) to give a final 
concentration of 1 mM. After 16 hours incubation, cells were harvested via 
centrifugation at 15,000 rpm (4 °C) using a contifuge (Contifuge® stratos) or 4,000 rpm 
(4 °C) for 20 minutes using a Beckman Avanti J-26 XP centrifuge with a JLA-8.1 fixed-
angle rotor. The cell pellet was either frozen for storage (-80 °C) in a plastic zip bag or 
directly resuspended (10 g/50 mL) into pre-cooled (4 °C) imidazole wash buffer (Section 
2.1.11.1). 
2.2.2.3 Protein expression procedure for TonB-dependent receptors 
1 L (x10) of LB medium containing 0.1 % (w/v) ampicillin was inoculated with 10 mL of 
starter culture of TNE012 cells transformed with pNGH15 plasmid (Section 2.1.16), or 
derivatives of the plasmid expressing either mutants of BtuB or FhuA. This was grown at 
37 °C, 200 rpm to an OD600 of 0.7 and protein expression was induced with 0.15 % (w/v) 
L-(+)-arabinose. After inducing protein expression, the temperature was decreased to 
15 °C and the culture was incubated for a further 16 hours with shaking at 200 rpm. The 
cells were harvested by centrifugation at 15,000 rpm 4 °C using a contifuge or 4,000 rpm 
in a Beckman Avanti J-26 XP centrifuge with a JLA-8.1 fixed-angle rotor. The cell pellet 
was either frozen for storage (-80 °C) in a plastic zip bag or directly resuspended BtuB 
purification buffer A (Section 2.1.11.10) at 4 °C. 
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2.2.2.4 Cell lysis after protein expression 
Cells were disrupted by sonication (Sonics Vibra-cell, 6 mm Microtip, Amp 70 %) on ice 
for 10 sec on / 20 sec off for a total process time of 4 minutes. After cell disruption, the 
cell debris was removed via centrifugation for 20 minutes at 10,000 rpm, 4 °C (Beckman 
Avanti J-26 XP centrifuge with a JA-25.50 Fixed-Angle Rotor). The supernatant was 
collected for protein purification, whilst the pellet was subject to subsequent rounds of 
sonication which increased the yield of protein significantly.  
2.2.2.5 Purification of His6-TonB constructs by nickel affinity 
The following steps were all carried out at 4 ˚C and in the presence of 1 mM PMSF and 
2 mM benzamidine. The supernatant from cell lysis was mixed with 6 mL Ni-NTA resin 
(GE Healthcare) in a 50 mL Falcon tube pre-equilibrated with imidazole wash buffer 
(Section 2.1.11.1). The His6-tagged protein was bound to the resin by inverting to 
suspend the resin in the cleared cell lysate and incubated on rollers for 20 minutes at 
4 °C. The protein-bound resin was pelleted by centrifugation at 4,000 rpm, 4 °C for 5 
minutes (Beckman Avanti J-26 XP centrifuge with a JS-5.3 swinging bucket rotor), the 
supernatant was discarded and 40 mL of imidazole wash buffer was added, mixed by 
inverting and centrifuged at 4,000 rpm, 4 °C for 5 minutes. This wash process was 
repeated three times and was followed by two elution steps using imidazole elution 
buffer (Section 2.1.11.2) giving a total elution volume of ~30 mL. The imidazole was 
removed by dialysis into pre-cooled 25 mM Tris-HCl (pH 8.0), 128 mM NaCl, 1 mM PMSF, 
2 mM benzamidine using a 3.5K MWCO SnakeSkin dialysis tubing (Thermo), followed by 
centrifugation (4,000 rpm, 4 ˚C) and sterile filtration (0.22 µm filter) to remove any 
insoluble aggregate or resin. Further purification was performed with gel filtration using 
a Superdex 75 26/60 gel filtration column (GE Healthcare)(TonBCTD constructs) 
equilibrated with 25 mM Tris-HCl pH 7.5, 128 mM NaCl, 1 mM PMSF, 2 mM benzamidine. 
For TonBΔTMD constructs, anion exchange chromatography with 6 mL Resource™ S 
column (GE Healthcare) equilibrated with 25 mM Tris-HCl pH 7.5, 128 mM NaCl, 1 mM 
PMSF, 2 mM benzamidine was used and the protein was eluted with a linear 0-0.5 M 
NaCl gradient over 16 column volumes. The fractions were pooled and concentrated to 
1 mg/mL (after dialysis into 25 mM Tris-HCl pH 7.5, 128 mM NaCl) with a vivaspin column 
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with an MWCO of 5 kDa (TonBCTD constructs) and 10 kDa (TonBΔTMD constructs). The 
purified proteins were snap frozen in liquid nitrogen and stored at −20 °C.  
2.2.2.6 Purification of FhuA, BtuB and BtuB mutants 
The supernatant from cell lysis (2.2.2.4) was centrifuged at 45,000 rpm for 1 hour, 4 °C 
using a Beckman L-70 ultracentrifuge with a Beckman 45 Ti Fixed-Angle rotor. The pellet 
(total membrane fraction) was retained and the supernatant discarded. The membrane 
pellet was resuspended in 56 mL BtuB purification buffer B (Section 2.1.11.10), 
homogenised by hand then ultracentrifuged at 45,000 rpm for 1 hour, 4 °C with the 
same rotor. The supernatant (containing extracted inner membrane proteins) was 
discarded and this step was repeated. The pellet was then resuspended in 56 mL BtuB 
purification buffer buffer C (Section 2.1.11.10), homogenised by hand, ultracentrifuged 
at 45,000 rpm for 1 hour, 4 °C and then the supernatant discarded. (This step decreases 
the amount of Triton X-100 carried over to the next stages of purification). The pellet 
was then resuspended in 56 mL BtuB purification buffer D (Section 2.1.11.10), 
homogenised and ultracentrifuged at 45,000 rpm for 1 hour at 4 °C.  The supernatant 
from this step contained the extracted outer membrane proteins. 
A disposable 5 mL DEAE-Sepharose column was equilibrated in 90 % BtuB purification 
buffer E and 10 % buffer F (Section 2.1.11.10) at room temperature using an ÄKTA prime 
plus. Variation of the detergent by 0.04 % at this stage had adverse effects on the 
purification; therefore was crucial. The supernatant containing the outer-membrane 
proteins was loaded onto the column and washed with 40 mL 90 % buffer E, 10 % buffer 
F. A gradient of 90% buffer E /10% buffer F to 50% buffer E / 50 % buffer F was then run 
over the next 65 mL. A further 30 mL of 100 % buffer F was run through the column 
which causes the target protein to elute from the column. The chromatogram from the 
DEAE-Sepharose column gave two major absorbance peaks. The first peak eluted from 
the column as soon as the gradient started and contained the majority of the impurities. 
The second peak eluted upon switching to 100 % BtuB purification buffer F. This peak 
contained high purity BtuB that precipitated immediumtely after elution. To enhance 
precipitation, the eluted fractions were stored at 4 °C for 16 hours. The precipitate was 
then pelleted by centrifugation for 20 minutes at 4,000 rpm, 4 °C. 
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For FhuA purification, the protein eluted with impurities at the DEAE-sepharose stage. 
Consequently, the FhuA precipitate was pelleted by centrifugation, dissolved into 1 % 
(w/v) β-OG, and further purified using a Superdex™ 75 HR 10/30 column pre-
equilibrated with 25 mM Tris-HCl pH 8.0, 128 mM NaCl, 1 % (w/v) β-OG. The major peak 
contained pure FhuA and was used for the SMFS experiments.  
2.2.2.7 Growth and purification of 15N-labelled TonB for NMR 
A 100 mL overnight culture in LB medium with selection antibiotic (100 µg/mL ampicillin) 
was set up from a single colony of freshly transformed BL21 (DE3) with the pET-23a(+) 
expression plasmid containing the TonB construct. 7.5 mL of the overnight culture was 
used to inoculate 2 L (x8) conical flasks containing pre-warmed (37 ˚C) 500 mL (x 8) of 
M9 minimal medium: 
Component g/L for 5 x stock 
Na2HPO4 (anhydrous) 34 
KH2PO4 15 
NaCl 2.5 
15NH4Cl 5 
 
A 5 X stock of the M9 minimal medium salts was initially prepared and used to make 500 
mL of 1 X medium in 2 L conical flasks which was autoclaved before use. 
Before the medium was inoculated with the overnight culture, it was supplemented with 
sterile filtered 0.5 mL 100 mg/mL ampicillin, 1 mL 1 M MgSO4, 10 mL 20 % (w/v) D-
glucose and 50 µL 1 M CaCl2.  
The cells were grown to mid-log phase (OD600 = 0.7) before 0.5 mL of 1 M IPTG was 
added to each flask to induce protein expression. The induced cells were then incubated 
for a further 16 hours at 37 ˚C, 200 rpm before the cells were harvested by 
centrifugation at 4000 rpm, 4 ˚C and stored at -80 ˚C. The 15N-labelled TonB constructs 
were purified as described in Section 2.2.2.5, the protease inhibitor cocktail (1 mM pmsf, 
2 mM bezamidine) was present throughout the entire purification and the buffers used 
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were all pre-cooled to 4 ˚C. The total yield from 4 L was ~50 mg/30mg for TonBΔTMD and 
TonBCTD respectively. 
2.2.2.8 Quantification of protein concentration 
To calculate protein concentrations after purification, the absorption at 280 nm was 
measured (using a NanoDrop 2000 UV-Vis Spectrophotometer) and the estimated 
extinction coefficient (M-1 cm-1) from the protein sequence (ExPASy online software 
Protparam) was used. Readings were typically taken in duplicate and the average used.  
2.2.3 Biochemistry techniques 
2.2.3.1 SDS-PAGE 
SDS resolving and stacking gel solutions (Section 2.1.11.3 and 2.1.11.4) were freshly 
prepared and APS and TEMED were added directly before pouring the gel mixture into 
a sealed clean casting chamber. Once the resolving gel had set, the stacking gel was 
added and a comb inserted into the top of the casting chamber. Excess stacking gel was 
removed using a Pasteur pipette. The rubber seals were removed once the gel had set 
and the casting chamber containing the gel was inserted into the cathode chamber of 
an electrophoresis cell, which was then filled with 1x cathode buffer (Section 2.1.11.6). 
The anode chamber was then filled with 1x anode buffer (Section 2.1.11.7). 10 μL of the 
protein sample was mixed in a 1:1 ratio with 2x SDS loading buffer (Section 2.1.11.5) and 
boiled for 5 minutes. 20 μL of this solution was loaded into the wells of the stacking gel. 
5 μL of Dual Xtra Recombinant Protein Standards protein ladder was also loaded into a 
single well for molecular weight determination. The electrodes were then connected to 
a power supply and 35 mV per gel was applied until the stained sample rested at the 
surface of the resolving gel. The voltage was then increased to 65 mV per gel and was 
electrophoresed until the stain left the bottom of the resolving gel. The gel was removed 
from the casting chamber and submerged into Instantblue coomassie stain (Expedeon) 
and incubated on a rocking table for ~2 hours before samples became visible for 
analysis.  
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2.2.4 Surface functionalisation (for single-molecule force spectroscopy) 
2.2.4.1 Oxidisation of silicon nitride AFM probe and surface 
To oxidise the surfaces of the silicon nitride AFM probe and surfaces (1 cm2 cut from a 
silicon nitride disc (Rockwood electronic material)), piranha solution (3:1 0.5 M (>95 %) 
H2SO4 to 30 % (v/v) H2O2) was prepared and surfaces were submerged for 5 minutes 
whilst the solution was still hot (and most active). The piranha solution was removed 
from the surfaces by washing with purified H2O, and dried with N2. The AFM probes 
were submerged in the freshly prepared piranha solution for 30 seconds, washed with 
purified H2O then dried with N2. The surfaces and AFM probes were then placed on a 
microscope slide inside a petri dish with a hole in the lid and placed under a UV lamp 
(UVIlite, UVItec) set to 254 nm for 30 minutes (ozone cleaning). 
2.2.4.2 Aminosilanisation of silicon nitride 
Oxidised AFM probes and surfaces were placed into a desiccator along with 80 µL of (3-
aminopropyl)triethoxysilane (APTES) and 20 µL of N,-N-diisopropylethylamine (DIPEA) 
held in separate 1.5 mL Eppendorf tube lids. The desiccator was evacuated using a 
vacuum pump for 1 minute and left to incubate at room temperature for 2 hours. After 
the incubation, the APTES and DIPEA solutions were removed and the desiccator was 
flooded with N2 and left to cure for 48 hours. 
2.2.4.3 Attachment of NHS-PEG24-maleimide linkers 
Amino-silanised AFM probes and surfaces were immersed in ~1 mL chloroform 
containing 20 µL of 250 mM N-hydroxysuccinimide-PEG24-maleimide (SM PEG) linkers 
(in DMSO) and left to incubate at room temperature for 1 hour. Both AFM probe and 
surface were then washed with chloroform and dried with N2. In the proteoliposome 
experiments, a 1:9 ratio of SM PEG: N-hydroxysuccinimide-PEG24-methyl (MS PEG) was 
used to reduce the frequency of multiple binding events, by reducing the amount of 
available maleimide groups on the surface for the protein to react with. 
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2.2.4.4 Protein attachment 
Protein (0.5-1.0 mg/mL) or oligopeptide ligand (1.0 mg/mL) both containing an 
engineered cysteine residue were deposited over the surfaces or AFM probe and left to 
incubate in a covered container for 30 minutes at room temperature. Unreacted 
protein/oligopeptide was then washed from the surface and AFM probe with the 
reaction buffer (25 mM Tris-HCl pH 8.0, 128 mM NaCl). 
2.2.5 Microbiology techniques 
2.2.5.1 Davis minimal agar plates for vitamin B12 uptake assay 
A sterile concentrated stock of Davis and Mingioli minimal medium salts was added to a 
volumetric flask, and made to volume with purified H2O (the total volume of the 
supplements (antibiotics, glucose, amino acids and vitamins) was subtracted from the 
total volume). Agar was then added and autoclaved together with the minimal salts. The 
autoclaved minimal salts and agar were cooled to 50 ˚C in a water bath for 10 minutes, 
and then concentrated stocks of the supplements were added to give a final 
concentration shown in Table 2.2. Once all the supplements were applied, the medium 
was poured into sterile petri dishes next to a flame and allowed time to set.  
Component Concentration (μg/mL) 
Thiamine 1 
Arginine 5 
Glucose 2500 
Ampicillin 100 
Streptomycin 25 
Vitamin B12 0.1 – 100 nM 
Methionine (Control plates only) 5 
Table 2.2 - Davis and Mingioli minimal medium plate supplements for the methionine assay 
2.2.5.2 Phenotype growth assay  
To assess the effect mutation of BtuB upon substrate transport, the plasmid pAG1 (btuB 
(or mutant) under a native promotor) was transformed into competent RK5016 
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(MC4100 btub metE70 argH recA) E. coli cells by heat shock at 42 ˚C for 30 seconds, and 
plated onto LB selection plates supplemented with 100 μg/mL ampicillin, 25 μg/mL 
streptomycin and 5 μg/mL arginine. After 42 hours of incubation at 37 ˚C, a single colony 
was selected and grown for 16 hours in 5 mL LB (containing the same concentration of 
ampicillin, streptomycin and arginine), then 0.5 mL was mixed with 0.5 mL of 50 % sterile 
glycerol and snap frozen in liquid nitrogen. Using a sterile pipette tip, a bead was taken 
from the glycerol stock and plated onto LB selection plates using a sterile loop. After 42 
hours of incubation at 37 ˚C, large colonies (~2 mm diameter) were picked with a sterile 
loop and spread onto Davis minimal medium agar supplemented with 100 μg/mL 
ampicillin, 25 μg/mL streptomycin, 5 μg/mL arginine, 1 μg/mL thiamine, various 
concentrations of vitamin B12 (0.1-100 nM) or 5 μg/mL methionine as a control. The 
Davis minimal plates were incubated at 37 ˚C for 42 hours before colony size within the 
final streaked area was analysed. Colonies that were >2 mm in diameter were 
considered to have robust growth and smaller colonies were considered to have partial 
or reduced growth.  
2.2.5.3 Bacitracin sensitivity growth assay (plate reader method) 
Single colonies of RK5016 cells transformed with pAG1 containing either wild-type btuB 
or its variants were used to inoculate 96 well plate wells containing 200 µL LB 
supplemented with ampicillin (100 µg/mL), streptomycin (25 µg/mL), 50, 100, 150 or 
200 µg/mL bacitracin and for a control where TonB activity is prevented, 200 µg/mL Ton 
box pentapeptide (ETVIV) was added to the medium. The plates (Corning Costar® assay 
plate, 96 well, black with clear flat bottom, non-treated, 1 cm path length) were 
incubated at 37 °C with 200 rpm shaking for 24 hours with an OD600 reading every 4 
minutes (CLARIOstar® high performance monochromator multimode microplate reader 
(BMG LABTECH)).  
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2.2.6 Biophysical techniques 
2.2.6.1 Circular dichroism (CD) 
To gain secondary structural information of the purified proteins, Far UV (190-260 nm) 
circular dichroism (CD) was performed in a 1 mm path length curvette (Hellma) using a 
Jasco J715 CD spectropolarimeter. 
200 µL of 0.05 mg/mL protein solution was placed into the cuvette and incubated at 
25 ˚C before a far-UV CD spectrum was acquired using a 1 nm bandwidth, 1 nm timestep 
and an average of 2 scans (190-260 nm) was taken per sample.  
BtuB, BtuB mutants and FhuA were resuspended in 15 mM NaH2PO4 pH 7.5, 1 % (w/v) 
β-OG and the protein concentration adjusted to 0.05 mg/mL. 
2.2.6.2 Fluorescence spectroscopy (equilibrium denaturation) 
For the TonB constructs, a 9 M urea, 25 mM Tris-HCl pH 7.5, 128 mM NaCl stock solution 
was prepared along with a 1 mg/mL solution of the protein being analysed in 25 mM 
Tris-HCl pH 7.5, 128 mM NaCl (± 0.5 M additional NaCl). Five stocks of 100 μg/mL protein 
containing 0, 2, 4, 6 and 8 M urea were prepared and used to create 40 1 mL solutions  
increasing in urea concentration by 0.2 M (between 0-8 M). The samples were then 
equilibrated at 15 °C for 16 hours in a circulating water bath (NesLab) before analysis. A 
Photon Technology International (PTI) fluorimeter was used to monitor the intrinsic 
tryptophan emission fluorescence when excited at 280 nm. In order to identify the 
emission wavelength that gave the largest change in fluorescence intensity between the 
0 and 8 M urea protein samples, an emission scan was carried out by exciting at 280 nm 
and scanning the emission between 290-400 nm with the slit width set to 4 nm. The 
protein samples were placed in a 1 mL quartz cuvette with a 1 cm path length and were 
sampled at 15 °C. The largest emission change was used for a time-drive scan. Each of 
the 40 samples were excited at 280 nm and the average emission intensity was recorded 
for 60 seconds with 1 second intervals. The average signal was calculated for each 
denaturant concentration and plot as a function of urea concentration. A two state 
transition chemical denaturant model (Equation 2.1) was fit to the data using Igor Pro 
6.32A (wavemetrics) software  
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 𝑆𝑜𝑏𝑠 =  
(
(𝑎[𝐷] + 𝑏) exp(∆𝐺𝑈𝑁 − 𝑀𝑈𝑁[𝐷])
𝑅𝑇 + (𝑐[𝐷] + 𝑑)
)
1 + exp (∆𝐺𝑈𝑁 −
𝑀𝑈𝑁[𝐷]
𝑅𝑇 )
 
(2.1) 
 
where Sobs is the observed signal  a and c are the native and unfolded baseline gradients 
respectively, b and d are the native and unfolded y-intercept respectively, [D] is the 
denaturant concentration (molarity), R is the ideal gas constant (0.0083 kJ K-1 mol-1), T  
is the temperature in Kelvin (288.15 K), ∆𝐺𝑈𝑁 is the urea-induced unfolding free-energy 
(kJ mol-1) and MUN is the denaturant dependence of ∆𝐺𝑈𝑁(correlates with the amount 
of protein surface exposed to solvent upon unfolding) (kJ mol-1 M-1). The observed signal 
and fit was normalised to fraction of natively folded protein (fN) using Equation 2.2: 
 𝑓𝑁 =  
𝑆𝑜𝑏𝑠 − (𝑐[𝐷] + 𝑑)
(𝑎[𝐷] + 𝑏) − (𝑐[𝐷] + 𝑑)
 (2.2) 
 
To assess the tertiary fold of OMPs (BtuB, its variants and FhuA), the OMP concentration 
was adjusted to 0.005 mg/mL in 1 % (w/v) β-OG, 25 mM Tris-HCl pH 8.0, 128 mM NaCl. 
A separate protein solution was created where the buffer contained 8 M urea. Each 
sample was allowed an hour at room temperature to equilibrate. An emission scan was 
carried out by exciting at 280 nm and scanning the emission between 290-400 nm with 
a slit width of 4 nm. The protein samples were placed in a 1 mL quartz cuvette with a 1 
cm path length and were sampled at 15 °C. 
2.2.6.3 Dynamic light scattering (DLS) of proteoliposomes 
The proteoliposomes from the dialysis (Section 2.2.8) were suspended by pipetting and 
a 2 μL sample was added to 198 μL of filtered and degassed 10 mM Tris-HCl pH 7.5, 300 
mM KCl, 400 μM CaCl2, to give a final lipid concentration of approximately 40 μM. Using 
a Minidawn™ Treos® (Wyatt) detector in batch mode, 1 mL of 10 mM Tris-HCl pH 7.5, 
300 mM KCl, 400 μM CaCl2 buffer was injected into the flow cell (prewashed with 0.1 M 
nitric acid followed by purified H2O) through a 0.22 μm syringe filter. A baseline in the 
DLS with fluctuations within four decimal places was recorded for 5 minutes before the 
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sample of proteoliposomes was injected into the flow cell. Light scattering of the 
proteoliposomes was recorded for 5 minutes before the buffer was injected back into 
the flow cell for a post-sample baseline reading. The data was analysed using the Astra 
6.1 software (Wyatt Technology). 
The correlation function for a monodisperse sample is given by: 
 𝑔(2)(𝜏) = 𝐵 +  𝛽 exp (−2Γτ) (2.3) 
 
where B is the baseline of the correlation function at infinite delay,  is the correlation 
function amplitude at zero delay, and Γ is the decay rate. Γ can be converted to the 
diffusion constant D by the relation: 
 𝐷 =  
Γ
𝑞2
 (2.4) 
 
where q is the magnitude of the scattering vector. The diffusion coefficient can be used 
to calculate the hydrodynamic radius (RH) according to the Stokes-Einstein equation: 
 𝐷 =  
𝑘𝐵𝑇
6𝜋𝜂𝑅𝐻
 (2.5) 
 
where T is the temperature of the system kB is Boltzmann’s constant, η is the viscosity 
of the medium and D the diffusion constant. 
2.2.6.4 Size exclusion chromatography – multi-angle laser light scattering 
(SEC-MALLS) 
Size exclusion chromatography in combination with multi-angle laser light scattering 
(SEC-MALLS) was performed at Diamond light source beamline B21. A 2.4 mL Superdex™ 
200 increase 3.2/300 column connected to an Agilent 1200 HPLC system was 
equilibrated with 25 mM Tris-HCl pH 8.0, 128 mM NaCl. 45 µL of 464 µM TonBΔTMD was 
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injected onto the column at flow rate of 0.075 ml/min. The MALLS instrument used was 
an 18 angle DAWN HELEOS II with an OPTILab rEX refractive index monitor (Wyatt 
Technology). The MALLS data was processed using the ASTRA 6.1 software (Wyatt 
Technology).  
The molecular weight (Mw) of a protein from the light scattering can be found by the 
Zimm expression172: 
 
𝐾∗𝑐
𝑅(𝜃, 𝑐)
=  
1
𝑀𝑤𝑃(𝜃)
+ 2𝐴2𝑐 
(2.6) 
 
where K* is an experimental constant dependent on the square of the solvent refractive 
index increment and the inverse fourth power of the incident wavelength, c is the solute 
concentration, R is the Rayleigh excess ratio of the solution (function of scattering angle 
(θ) and solute concentration), Mw is the average solute molecular weight, P(θ) describes 
the angular dependence of the scattered light and A2 is the second virial coefficient in 
the virial expansion of osmotic pressure. 
2.2.6.5 Microscale thermophoresis (MST) 
MST was carried out using a Monolith NT.115 series instrument (NanoTemper) using 
Alexa Fluor® 488 as the fluorescent probe and a blue LED filter (excitation 460–480 nm 
and emission 515–530 nm). The fluorescently labelled Ton BoxBtuB peptide (Section 
2.2.9) was adjusted to a final concentration of 500 nM (optimal fluorescence at 250 nM). 
TonB constructs were concentrated to 1 mM using a 3 kDa MWCO Vivaspin column and 
centrifugation at 15,000 g. The concentration was determined by ultraviolet absorbance 
spectroscopy at 280 nm and an extinction coefficient of 5,500 M-1 cm-1 (calculated 
using the ExPASy ProtParam tool). A serial dilution over 16 concentrations was set up 
for TonB in 25 mM Tris-HCl pH 7.5, 128 mM NaCl. This dilution series was mixed with 
equal parts of the 500 nM Ton BoxBtuB-Alexa fluor® 488 and incubated at room 
temperature for 5 minutes. The samples were then loaded into capillaries (K002 
MonolithTM NT.115 standard treated capillaries) and analysed with the LED power set 
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to 95 % and MST power (IR- laser) set to 40 %. The normalised fluorescence from T-jump 
and thermophoresis (Fnorm): 
 𝐹𝑛𝑜𝑟𝑚 = 1 + (
𝛿𝐹
𝛿𝑇
− 𝑆𝑇) 𝛥𝑇 
(2.7) 
 
(where δF/δT is the fluorescence change due to temperature increase, ΔT is the change 
in temperature and ST is the Soret coefficient) was then plot against the log10 of the 
protein concentration and the data was fit with the Nanotemper analysis software using 
Equation 2.8 to yield the KD 173: 
 
𝑆𝑜𝑏𝑠 
=  𝑆𝑈 + (𝑆𝐵 −  𝑆𝑈) 
× 
([ 𝐴0] + [𝐵0] +  𝐾𝐷)  ± √([ 𝐴0] + [𝐵0] +  𝐾𝐷)2 − 4[𝐴0][𝐵0]
2[𝐴0]
 
(2.8) 
 
where Sobs is the observed signal, SU is the signal from unbound state, SB is the signal 
from the bound state, [A0] and [B0] are the total concentrations of A and B respectively. 
2.2.6.6 Small angle X-ray scattering (SAXS) 
Size exclusion chromatography in combination with small-angle X-ray scattering (SEC-
SAXS) experiments were performed at Diamond light source beamline B21. A 2.4 mL 
Superdex™ 200 increase 3.2/300 column connected to an Agilent 1200 HPLC system was 
equilibrated with 25 mM Tris-HCl pH 8.0, 128 mM NaCl (± 0.5 M NaCl). 55 µL of TonB 
construct (10 mg/mL) was loaded into a well of a 96 well plate; the amount loaded onto 
the column was 45 µL. A fixed wavelength of 1.0 Å (12.4 keV) was used with the X-ray 
detector (PILATUS 2M) placed 4 meters from the sample (suitable for particles with an 
Rg < 200 Å), the flow rate through the detector was 0.075 mL/min. 
The buffer contributions were subtracted using the program SCATTER (version 3.0a) and 
a Guinier approximation (Equation 2.9) of the scattering vector ((ln[I(q)] vs q2) where 
I(q) is the background corrected intensity and q is the momentum transfer (q = 4π sin(θ)/ 
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λ, where 2θ is the angle between the incident and scattered beam and λ is the beam 
wavelength)) was used to estimate the radius of gyration (Rg) by limiting q x Rg < 1.3. 
 ln 𝐼(𝑞) =  ln 𝐼(0) − 
𝑅𝑔
2
3
. 𝑞2 
(2.9) 
 
The pair-distance distribution function (P(r)) (Equation 2.10) is an indirect fourier 
transform (due to a limited range of I(q)) of the scattering intensity). The distance 
distribution is a real space representation of the scattering data and allows the 
generation of a scattering envelope of the solute. 
 𝑝(𝑟) =  
𝑟
2𝜋2
 ∫ 𝐼(𝑞)𝑞
∞
0
sin(𝑞𝑟) 𝑑𝑞 (2.10) 
 
where: r is the distance vector. The maximum dimension (Dmax) is the value of r at P(r) = 
0174.  
2.2.6.7 Ensemble optimisation method (EOM) 
To gain structural information of the intrinsically disordered domain of TonBΔTMD from 
the SAXS experimental data, the software EOM (version 2.0)175 was used. EOM fits 
averaged theoretical scattering intensity from an ensemble of conformations into 
experimental SAXS data. A pool of 10,000 independent models based upon the 
sequence of TonBΔTMD (see Appendix) with structural information (PDB: 1XX3) was 
initially generated. As the proline-rich linker is predicted to be intrinsically disordered to 
some extent, completely random configurations of the alpha-carbons (residues 33-150, 
including the His6-tag and N-terminal methionine) were created based upon the 
sequence provided. A genetic algorithm compares the averaged theoretical scattering 
intensity from the independent ensembles of conformations against the experimental 
SAXS data. The conformations that best describe the experimental data are selected. 
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2.2.6.8 Nuclear magnetic resonance (NMR) spectroscopy 
All NMR experiments and data processing were performed by Dr Theo Karamanos 
(University of Leeds). 
HSQC spectra of TonBΔTMD or its truncated variant (TonBCTD) (both 10 mg/mL) were 
recorded on an AVANCE III Bruker spectrometer (600 MHz) equipped with a cryogenic 
probe in the presence of 25 mM Tris-HCl pH 8.0, 128 mM NaCl (± 0.5 M NaCl). 2048 and 
256 complex points were detected in the direct and indirect dimension respectively. 
Spectra were processed in NMRPipe and analysed in CCPN analysis.  
Chemical shift perturbations (CSP) for assigned residues were calculated by the 
formula176: 
 𝐶𝑆𝑃 =  √(5∆𝐻)2 +  ∆𝑁2 
(2.11) 
where ΔH and ΔN are the chemical shift variations between the low and high salt 
conditions in the proton and nitrogen dimensions, respectively. 
2.2.7 Atomic force microscopy (AFM) 
2.2.7.1 Cantilever calibration 
The AFM probe (MLCT with reflective gold, Bruker) with attached oligopeptide ligand or 
TonB construct was inserted into a cantilever holder and secured. The silicon surfaces 
with attached protein were attached to a microscope slide with Loctite superglue and 
secured to the XY scanner with magnetic bars. For the proteoliposome experiments, a 1 
cm mica disc was attached to a metal disc.  
A droplet of reaction buffer was applied to the silicon or mica surface and was held by 
surface tension. The AFM probe in the holder was mounted to the MFP-3D head 
(Asylum) and approached towards the surface until the probe was fully submerged in 
the buffer droplet. Using the built in optics, the laser was positioned to the tip of 
cantilever D (manufacturers spring constant: 30 pN/nm) and the deflection was set to 
zero using the PD disc. The cantilever was engaged using the Asylum Research software 
(MFP version 11), engagement causes Z-piezo voltage maxima (+150), an indication of 
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full Z-piezo extension and zero surface contact. Using the thumb wheel on the MFP-3D 
head (Asylum), the cantilever was approached to the surface. The z-voltage was 
adjusted to 70, assuring that the piezo was in the middle of its z range (7.5 μm). Spring 
constant calibration was carried out as a two-step procedure: determining the slope of 
contact from a force curve to find the sensitivity of the cantilever (nm/V) and then 
performing the non-destructive thermal tune to determine resonant frequency of the 
cantilever177. A single force-extension plot was recorded with the trigger (amount of 
deflection the cantilever undergoes before retraction) set to 20-40 nm, which gives a 
quantifiable deflection slope. The slope of the contact region (inverse optical lever 
sensitivity (InvOLS)) was measured by a linear fit. The cantilever was withdrawn from 
the surface and the deflection was set to 0. A thermal tune was carried out to detect the 
natural thermal fluctuation of the cantilever by performing ~50 frequency sweeps (0-1 
MHz). The natural frequency (first major resonance peak) was selected and a Lorentzian 
function was fit. The area of the thermal fluctuations (P) is used to find the spring 
constant (k) using Equation 2.12: 
 𝑘 =
𝐾𝐵𝑇
𝑃
 
(2.12) 
 
The spring constant was always within error of the manufacturer’s guidelines before 
data collection. Hooke’s Law (Equation 2.13) allows the calculation of the force applied 
(F) to the cantilever with a known spring constant by the deflection (or extension (x)). 
 𝐹 = 𝑘𝑥 (2.13) 
 
2.2.7.2 Data collection for Ton box peptide unbinding experiments 
The feedback loop trigger point was set to 10 nm, the retraction distance was set to 600 
nm, approach velocity was set to 2 μms-1 during data collection and kept constant whilst 
using various retraction velocities and sample rates (10 kHz per μms-1 velocity). The 
buffer on the sample surface was replenished frequently to prevent evaporation, which 
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would vary the NaCl concentration and dry the sample. Force maps of 20 μm2 with 600 
(100x6 array) approach-retract cycles were taken to maximise surface coverage, and 
between force maps the AFM probe was repositioned manually using the XY scanner. 
The retraction velocities used in this study were 200, 500, 1000, 3000 and 5000 nms-1.  
2.2.7.3 Data collection for proteoliposome experiments 
The feedback loop trigger point was set to 3-4 nm with a 0.5-1 s surface dwell, the 
retraction distance was set to 0.5-0.6 μm, approach velocity was set to 2 μms-1 during 
data collection and kept constant whilst using various retraction velocities (200, 500, 
1000 and 5000 nms-1, (wild-type BtuB only)) and a sample rate of 10 kHz per μms-1 
velocity. For the cross-linked BtuB variants, destabilised plug subdomain and FhuA the 
retraction velocity used was 1000 nms-1. Force maps of 20 μm2 with 500-1000 force-
extensions were taken to maximise surface coverage. 
2.2.7.4 Data processing 
All force spectroscopy data was analysed using IGOR pro 6.32A with an Asylum Research 
extension (MFP3DXop v30).  
The hard contact (0 nm) and baseline (0 pN) of all the force-extension retraction traces 
were manually set, by taking a section of the hard contact or the retraction with no 
events and setting the zero to the centre of the data (force baseline has a thermal noise 
of ± 10 pN). The WLC model (with a fixed persistence length of 0.4 nm) was fit manually 
to all unbinding events that are parabolic by inserting locks at the apex and the base of 
the curve and recording the contour length (Lc) and extension (x) (Figure 3.10).  
Force-extension profiles were binned for analysis if: 1) the data fitted to the WLC model 
(single molecule events should display WLC like behaviour where the force-distance 
profile is not linear) and 2) the contour length was greater than the length of the PEG24 
linkers used. For both the TonBΔTMD:Ton BoxBtuB and TonBCTD:Ton boxBtuB experiments, 
fewer than 0.1% of force curves showed more than one event. This indicates that there 
are no detectable unfolding events for either protein domain prior to dissociation of the 
bound complex. Single Gaussian distributions were fit to unbinding force and contour 
length histograms in order to determine the most probable force and contour length at 
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rupture for each retraction velocity investigated. For each pulling velocity used, data 
were collected in triplicate (using a freshly prepared cantilever for each repeat) to 
calculate the modal value and its average error.  
Loading rates were calculated by fitting a WLC model to the rising edge of each 
unbinding profile when plotted as force versus tip-sample separation. The 
instantaneous gradient of this fit at rupture (WLCslope) was calculated by inserting the 
derived contour length and extension at rupture into a differentiated form of the same 
equation (equation 2.14). The loading rate at rupture was then obtained by multiplying 
this value by the retraction velocity. 
 𝑊𝐿𝐶𝑠𝑙𝑜𝑝𝑒 =
𝑘𝐵𝑇
𝑝
(
1
2𝐿𝑐 (1 −
𝑥
𝐿𝑐
)
3) +
1
𝐿𝑐
 (2.14) 
 
where; p is the persistence length, Lc is the contour length, x is the extension, kB is the 
Boltzmann constant and T is the temperature. 
The natural logarithm of the mean loading rate (Ns-1) at each velocity was plot against 
the mean rupture force (N) which gives a linear relationship (dynamic force spectrum). 
The Bell-Evans model162 (Equation 1.2) was rearranged to use the gradient of the linear 
fit to calculate the distance from the transition state (xu) (Equation 2.15) and the y-
intercept for the off rate at zero force (𝑘𝑜𝑓𝑓
0𝐹 ) (Equation 2.16). 
 𝑥𝑢 =  
𝐾𝐵𝑇
𝑚
 
(2.15) 
 
 
1
𝑘𝑜𝑓𝑓
0𝐹 =
𝐾𝐵𝑇
𝑥𝑢
 exp [
𝑐 𝑥𝑢
𝐾𝐵𝑇
] (2.16) 
 
To calculate the error of 𝑘𝑜𝑓𝑓
0𝐹  and the xu, manual bootstrapping was carried out, where 
a single data point was withdrawn from the triplicate results and a linear regression was 
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used to extrapolate the 𝑘𝑜𝑓𝑓
0𝐹  and xu. This was performed for all of the data set, the 
average was taken for the values and the standard deviation was used for the error. 
2.2.8 Formation of proteoliposomes and mica immobilisation 
TonB-dependent receptors were inserted into a lipid bilayer at a high density by 
solubilising the precipitated receptor (0.1 mg) in 200 µL 25 mM Tris-HCl pH 7.5, 128 mM 
NaCl, 1 % (w/v) β-OG as previously described178. The lipids (0.2 mg E. coli polar lipid 
extract (Avanti)) were dried from a chloroform stock (10 mg/mL) using a nitrogen flow 
and solubilised with the protein and detergent by pepitting. The ligand for the receptor 
(cyanocobalamin (synthetic vitamin B12) for BtuB and ferrichrome for FhuA) was added 
to the buffer to be in 100 molar excess of the receptor. The components were then 
placed into a 200 µL 12-14 kDa MWCO dialysis bag (D-tube dialyser mini, (Merck 
Millipore)) and dialysed against 300 mL of detergent-free adsorption buffer (Section 
2.1.11.11) for 7 days at room temperature with daily buffer changes. To attach the 
proteoliposomes to mica, the concentration of lipid was diluted to 0.1 mg/mL in the 
detergent-free adsorption buffer and 150 μL was pooled over a 1 cm disc of freshly 
cleaved (using scotch tape) mica and incubated for 30 minutes at room temperature. 
After the incubation, the unbound proteoliposomes were thoroughly washed from the 
surface by pipetting 25 mM Tris-HCl pH 8.0, 128 mM NaCl over the mica.  
2.2.9 Covalent labelling of proteins 
The Ton box peptide from BtuB (sequence: PDTLVVTANRGSWSC, Ton box residues in 
bold) was fluorescently labelled with Alexa Fluor® 488 C5 maleimide by creating a 1 
mg/mL solution of the peptide in 25 mM Tris-HCl pH 7.5, 128 mM NaCl and titrating 100 
µL of 10 mg/mL dye dissolved in DMSO. This was then stirred for 16 hours at room 
temperature in the dark. The reaction mixture was then loaded onto a pre-equilibrated 
Superdex™ peptide HR 10/30 gel filtration column equilibrated with 25 mM Tris-HCl pH 
7.5, 128 mM NaCl. The peaks from the chromatogram were then analysed by liquid 
chromatography electrospray ionisation mass spectrometry (LC-ESI-MS). 
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2.2.10 Molecular dynamic simulations 
All molecular dynamics (MD) simulations in this study were performed using NAMD 
(v2.10)179 and the CHARMM27 force field180. The system was prepared using VMD 
(v1.9.2)181. 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC) was used to 
model the lipid bilayer, the parameters for vitamin B12 were obtained from Gumbart et 
al182, whereas the TIP3P force field was used for water183. The X-ray crystal structure of 
BtuB in complex with TonB and vitamin B12 (PDB 2GSK), including calcium ions and 
crystal waters, was inserted into the homogenous POPC lipid bilayer placed in the XY 
plane. The dimension of the simulation box was 100x100x300 Å. A total of 100211 
molecules of TIP3P water, 149 Na2+ and 141 Ca2+ were then used to fill the simulation 
box. The total system comprised 342,843 atoms. The simulations were conducted using 
periodic boundary conditions. The bonds between hydrogen and heavy atoms were 
constrained with SHAKE184. The r-RESPA multiple time step method 185 was employed 
with 2 fs for bonded potentials, 2 fs for short-range non-bonded potentials and 4 fs for 
long-range non-bonded potentials179. Long-range electrostatic interactions were 
treated with the particle-mesh-Ewald (PME) method186. The distance cut off for non-
bonded interactions was set to 10 Å, and a switching function was applied to smooth 
interactions between 9 and 10 Å. All simulations were conducted in the NPT ensemble. 
The temperature was set to 300 K and regulated via a Langevin thermostat187; the 
pressure was set to 1 atm and regulated via an isotropic Langevin piston manostat188.  
A multistage equilibration was used to relax the system. Initially all of the atoms except 
water and ions were fixed. 2000 steps of conjugate gradient geometry optimization 
were initially conducted. After energy minimization, the system was simulated for 1 ns 
to equilibrate the solvent around the protein and membrane. Next, the membrane was 
relaxed around the protein by removing the restraints on the fatty acid tails for 1 ns, and 
keeping the protein and vitamin B12 atoms restrained to their initial positions by applying 
an harmonic potential on the heavy atoms using a force constant of 1 kcal/(mol⋅Å2). The 
protein and ligand was then gradually released over the next 3 ns by decreasing the 
force constant to 0.5 kcal/(mol⋅ Å). Finally, all restraints were removed and the system 
was equilibrated for 10 ns. The final structure from the unrestrained MD trajectory was 
used as the starting point in the pulling simulations. The pulling was performed by using 
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the steered molecular simulation (SMD) module as implemented in NAMD179. In a SMD 
simulation, a selection of atoms are connected to an ideal spring with an elastic constant 
and pulled apart at a constant velocity. The SMD simulation was performed by 
restraining the phosphate head groups of the upper bilayer leaflet to its initial 
coordinates (to prevent the membrane being dragged) and extending a harmonic spring 
attached to either the Ton box of BtuB (Pro5 Cα) or the centre of mass of TonB (all Cα 
residues of TonB). The spring constant was set to 0.5 kcal/(mol⋅Å2), while the pulling 
velocity was set to 2.5 Å/ns along the z-direction. The trajectories of the simulations 
were analysed using the software: wordom, VMD, MEMBplugin (v 1.1) and MDAnalysis. 
The Root Mean Square Deviation (RMSD) is defined as: 
 𝑅𝑀𝑆𝐷 = √∑
((𝑥𝑖 − 𝑥𝑟𝑒𝑓)
2
+ (𝑦𝑖 −  𝑦𝑟𝑒𝑓)
2
+ (𝑧𝑖 − 𝑧𝑟𝑒𝑓)
2
)
𝑁
𝑁
𝑖
 
(2.17) 
 
where i refers to the atom, x, y and z are the atom coordinates and N is the total number 
of atoms. 
The Membrane Thickness tool of the MEMBplugin software measures the distance (Å) 
between two density peaks, formalised as the first and second central moment of the 
mass density profile of phosphorus atoms along the membrane189. The position of the 
membrane protein within the membrane (centre of mass (COM) difference) was 
calculated using a script kindly provided by Bob Schiffrin using the MDanalysis software. 
The centre of mass of the protein (BtuB) was calculated and the average centre of the 
membrane. The average difference between the two centres was then calculated over 
the trajectory.  
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3 Biophysical analysis of TonB and the influence of the 
proline-rich linker domain 
3.1 Objectives 
The primary objective of this thesis is to test the feasibly of the pulling model of TonB-
dependent transport. The known biophysical properties of the periplasmic domain of 
TonB (residues 33-239) are limited, therefore in this chapter a thorough structural and 
biophysical characterisation is performed on TonB constructs with and without the 
proline-rich linker domain. Alongside this characterisation, the strength of the TonB:Ton 
box interaction is tested in vitro using single-molecule force spectroscopy, providing 
evidence that this non-covalent interaction mediated by parallel β-strand augmentation 
can withstand forces that can remodel folded proteins. 
3.2 Results 
3.2.1 Cloning and purification of TonB constructs 
3.2.1.1 Cloning recombinant TonB from E. coli 
PCR was used to amplify TonBΔTMD (TonB missing the transmembrane domain (residues 
1-33)) and TonBCTD (the structured C-terminal domain of TonB (residues 147-239)) from 
the tonB gene of E. coli BL21(DE3) (Figure 3.1).  
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                     10         20         30         40         50 
             MTLDLPRRFP WPTLLSVCIH GAVVAGLLYT SVHQVIELPA PAQPISVTMV  
                     60         70         80         90        100 
             TPADLEPPQA VQPPPEPVVE PEPEPEPIPE PPKEAPVVIE KPKPKPKPKP  
                    110        120        130        140        150 
             KPVKKVQEQP KRDVKPVESR PASPFENTAP ARLTSSTATA ATSKPVTSVA  
                    160        170        180        190        200 
             SGPRALSRNQ PQYPARAQAL RIEGQVKVKF DVTPDGRVDN VQILSAKPAN  
                    210.........220.........230  
             MFEREVKNAM  RRWRYEPGKP  GSGIVVNILF  KINGTTEIQ 
 
Figure 3.1 – Sequence and structural schematic of TonB from E. coli. The blue text indicates the 
TM domain, black text the proline-rich linker domain and pink text the structured C-terminal 
domain. The bold red text denotes the start position of each construct (TonBΔTMD H33 and 
TonBCTD P145). The schematic below shows the location of the truncation sites, TM domain (pink 
cylinder), the PE/PK repeats (pink box) and the NMR solution structure (PDB: 1XX3) of the 
structured C-terminal domain is shown by cartoon representation.  
Primers were designed to include an N-terminally located cysteine for surface 
attachment for force spectroscopy experiments. Constructs containing cysteine are 
designated TonBΔTMD(V32C) and TonBCTD(K144C). The primers also included NdeI and 
XhoI restriction sites at 5’ and 3’ respectively and a His6-tag at the N-terminus for 
purification. The primer sequences are shown in Table 3.1 and the protein sequences 
are shown in the Appendix (Section 7.1). 
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TonBCTD(K144C) Forward 5’AATTTACAACATATGCATCACCATCACCATCACGGATGTCCGGT
TACCAGTGTGGCTTCA3’ 
Reverse 5’GGAATTTGACTCGAGTTACTGAATTTCGGTGGTGCCGTTA3’ 
TonBΔTMD(V32C) Forward 5’AATAATTAACATATGCATCACCATCACCATCACGGCTGTCATCA
GGTTATTGAACTACCTGC3’ 
Reverse 5’GGAATTTGACTCGAGTTACTGAATTTCGGTGGTGCCGTTA3’ 
Table 3.1 - DNA Primers used for PCR gene amplification of TonB constructs for force-
spectroscopy experiments. Underlined text indicates the restriction sites, green text is the start 
codon, blue text is the His6-tag sequence, red text is the engineered cysteine and italic text is 
the sequence of tonB. 
Q5® PCR was used for TonBCTD(K144C) (Figure 3.2A) and Vent PCR was used for 
TonBΔTMD(V32C) at three different MgSO4 concentrations (Figure 3.2B). PCR products 
were analysed by a 1.5 % agarose gel stained with ethidium bromide to confirm 
successful amplification. TonBΔTMD(V32C) was initially ligated into a pGEM-T Easy vector 
(Figure 3.2C), before insertion into a pET-23a(+) vector (Figure 3.2D). TonBCTD(K144C), 
was directly ligated into a pET-23a(+) vector from the PCR amplification. The constructs 
were confirmed by DNA sequencing using T7P primer. 
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Figure 3.2 - Agarose gels (1.5 %) stained with ethidium bromide showing the stages of cloning 
of the tonB gene product from E. coli and insertion into pET-23a(+) expression vector. A) The 
amplification of TonBCTD (312 bp) by Q5® PCR, L is the ladder. B) The amplification of 
TonBΔTMD(V32C) (678 bp) by Vent PCR under increasing concentrations of MgSO4, lane 4 contains 
no MgSO4. C) The cleavage of pGEM-T Easy vectors containing protein inserts. Lanes 1 and 2 
contain pGEM-T Easy (3015 bp) with TonBΔTMD(V32C) insert digested with NdeI/XhoI restriction 
enzymes. The unlabelled lane contains a construct not used in this thesis. D) The cleavage of 
pET-23a(+) vectors (3666 bp) with TonBΔTMD(V32C) insert (678 bp). Lane 1 contains pET-23a(+) 
with TonBΔTMD(V32C) digested by NdeI/XhoI restriction enzymes. 
To prevent the engineered cysteines in the TonB constructs for AFM attachment forming 
covalent homodimers during biophysical characterisation, Q5® site-directed 
mutagenesis was subsequently used to delete the cysteine in both TonBΔTMD(V32C) and 
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TonBCTD(K144C) constructs. Table 3.2 shows the DNA primers designed for mutagenesis. 
The constructs without cysteine are designated TonBΔTMD and TonBCTD. Site-directed 
mutagenesis was performed using the Q5® Site-Directed Mutagenesis Kit (Section 
2.1.10) and the method described in Section 2.2.1.6. 
TonBΔTMD Δcys Forward CATCAGGTTATTGAACTACCTG 
Reverse GCCGTGATGGTGATGGTG 
TonBCTD Δcys Forward CCGGTTACCAGTGTGGCT 
Reverse TCCGTGATGGTGATGGTG 
Table 3.2 – DNA mutagenesis primers for the removal of the engineered cysteine in the TonB 
constructs for AFM attachment.  
3.2.1.2 Expression and purification of TonB constructs 
TonB constructs (both with and without the N-terminally located cysteine) in pET-23a(+) 
were transformed into E. coli BL21 (DE3) cells and protein expression was carried out as 
described in Section 2.2.2.2. The proteins were purified using Ni-NTA batch purification 
as described in Section 2.2.2.5. At each step of the purification, a sample was taken for 
SDS-PAGE analysis (Figure 3.3A and C), which confirmed the presence of the TonB 
constructs. After removal of the imidazole by dialysis, centrifugation and filtration to 
remove any insoluble material, the TonBΔTMD construct (± cysteine) was further purified 
after Ni-NTA purification using a Resource™ S 6 mL cation exchange column (Figure 
3.3B). The purity of the eluted protein was confirmed by SDS-PAGE (Figure 3.3A, lane 7). 
For the TonBCTD constructs (± cysteine), a Superdex™ 75 Hiload 26/60 gel filtration 
column was used for further purification (Figure 3.3D). The purity was assessed by SDS-
PAGE (Figure 3.3E), confirming the successful isolation of TonBCTD. 
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Figure 3.3 – Analysis of TonB purification from E. coli BL21 (DE3). A) SDS-PAGE of TonBΔTMD 
purification steps: Lanes 1-3 are the three wash steps in imidazole wash buffer (Section 2.1.11.1) 
when TonBΔTMD is bound to the Ni-NTA resin, lanes 4 and 5 are two elution steps using imidazole 
elution buffer (Section 2.1.11.2) and lane 6 and 7 are peaks 1 and 2 respectively from cation 
exchange chromatography (B). TonBΔTMD is 23.6 kDa in size, however the presence of the proline-
rich linker domain (residues: 70-102) gives an apparent mass of 36 kDa92. B) Cation exchange 
chromatography of TonBΔTMD using a Resource™ 6 mL S cation exchange column and eluting with 
a 1 M NaCl gradient. Peak 2 from the NaCl gradient contains pure TonBΔTMD. C) SDS-PAGE of the 
purification steps of TonBCTD: Lanes 1 and 2 contain the cell lysate (1/10 dilution), lanes 3-5 
contain wash steps and lanes 6 and 7 contain the imidazole elution steps. TonBCTD is 11.7 kDa in 
size. D) Size exclusion chromatography and E) SDS-PAGE analysis of the peaks from the final 
stage of TonBCTD purification. TonBCTD elutes in peak 4) and peak 5, which is confirmed by SDS-
PAGE (numbers over the gel correspond to the peak number in the gel filtration chromatogram 
in (D)).  
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3.2.1.3 Spectroscopic analysis of protein fold 
To ensure that the TonB constructs were correctly folded (only constructs without the 
engineered cysteine were analysed) after purification and were in agreement with 
previous findings, secondary structure analysis was carried out using Far-UV CD 
spectroscopy (Figure 3.4A). 
 
Figure 3.4 – Circular dichroism of TonB constructs. A) Far-UV CD spectra of purified TonB 
constructs (TonBΔTMD red, TonBCTD black) with HT below. TonBΔTMD contains a distinctive minima 
at 205 nm, which is representative of a polyproline helix type II (PPII) from the periplasmic 
spanning domain. The spectra for TonBCTD is distinct from TonBΔTMD and is consistent with the 
mixed α/β topology of the NMR solution structure. B) Far-UV CD spectra of TonB (residues 56–
126 (proline-rich linker domain)), taken from reference 100. C) Far-UV CD of a truncated TonB C-
terminal domain (residues 170-239), which is five residues shorter than the construct that gave 
the intertwined homodimer X-ray crystal structure (see inset), spectra taken from reference141. 
The results of the far-UV CD secondary structure analysis show that the TonBΔTMD 
spectra is dominated by the signal for a PPII helix, represented by the signal at 205 nm 
(Figure 3.4A) in agreement with the CD spectra of the periplasmic linker domain alone 
(residues 56–126) (Figure 3.4B)100. The spectra of the C-terminal domain (TonBCTD: 
residues 147-293) is different to the truncated C-terminal domain construct (residues 
170-239)(Figure 3.4C). The signal at 209 nm is not visible for the TonBCTD construct used 
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in this study, which has a lower α-helical content than the truncated intertwined dimer 
(Figure 1.10). 
To investigate whether the TonB constructs maintain tertiary structure after 
purification, intrinsic tryptophan fluorescence was monitored using a Photon 
Technology Instrument (PTI) fluorometer. TonB contains a single tryptophan (W213) 
within the hydrophobic core of the periplasmic C-terminal domain. Using the method 
described in Section 2.2.6.2, an emission spectrum (290-400 nm) from a 280 nm 
excitation was carried out for both TonB constructs ± 8 M urea (Figure 3.5). The decrease 
in fluorescence in 8 M urea and redshift (λmax 322 to 348) was indicative that W213 
was no longer packed into the hydrophobic core of the TonB globular C-terminal domain 
in both constructs. The spectroscopic data provides evidence that both TonBCTD and 
TonBΔTMD constructs retain secondary and tertiary structure after purification. 
 
Figure 3.5 – Intrinsic tryptophan emission spectra to assess the folding state of the structured 
C-terminal domain in both TonB constructs after purification. A) TonBΔTMD and B) TonBCTD in 
the absence (line) and presence of 8 M urea (dashes). 
3.2.2 Binding affinity of TonB constructs to Ton box from BtuB 
Before carrying out single-molecule force spectroscopy experiments on the interaction 
between TonB and the Ton box peptide from BtuB ((Ton boxBtuB) sequence: 
PDTLVVTANRGSWSC, residues in bold are the Ton boxBtuB), microscale thermophoresis 
(MST) was performed to ensure the purified TonB constructs were capable of binding 
the synthetic peptide.  
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The Ton boxBtuB peptide was fluorescently labelled with Alexa Fluor® 488 C5 maleimide 
using the method described in Section 2.2.9. The chromatogram from the gel filtration 
chromatography step of peptide labelling had two major peaks (Figure 3.6A), peak 1 was 
analysed by liquid chromatography electrospray ionisation mass spectrometry (LC-ESI-
MS). The mass spectrum (Figure 3.6B) contained two major species: a 2303.86 Da 
species, which was the correct mass of the Ton boxBtuB peptide (1604.76 Da) attached to 
Alexa Fluor® 488 C5 maleimide (698.66 Da). The other species contained an additional 
53 Da in mass, and accounts for 25 % of the sample. This additional weight likely arises 
from metal ions (possibly Fe) chelating to the peptide-Alexa Fluor® 488 C5 maleimide 
conjugate, as Alexa Fluor® is known to bind metal ions190.  
 
Figure 3.6 – Purification of the Alexa Fluor® 488 labelled Ton boxBtuB peptide. A) Size exclusion 
chromatography using a Superdex™ peptide HR 10/30 gel filtration column (Section 2.2.9) 
column of the Ton boxBtuB peptide labelled with Alexa Fluor® 488 C5 maleimide. The labelled 
peptide eluted from the column at 13 mL and is represented by the first absorbance peak in the 
chromatogram. B) LC-ESI-MS of the first absorbance peak in the chromatogram (A), the major 
species corresponds to the correct size of the labelled peptide (2303.7 Da), the second peak is 
likely an adduct on the Alexa Fluor®. 
The binding affinity of the fluorescently labelled Ton boxBtuB peptide to both TonB 
constructs was assessed using MST (Section 2.2.6.5). The results are shown in Figures 
3.7 and 3.8 with the KD values in Table 3.3. The results demonstrate that the TonBΔTMD 
construct has a similar binding constant to the TonBCTD construct, indicating that the 
proline-rich linker does not affect the binding properties of the structured C-terminal 
domain. The KD values reported are within the same order of magnitude to that 
previously found with isothermal calorimetry with Ton BoxFhuA and the same TonBCTD 
construct (36 μM)86.  
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Figure 3.7 - Normalised MST fluorescent signal (LED: blue, 95 % power) for different 
concentrations of the TonB constructs (labelled) and 250 nM of Ton box-Alexa Fluor® 488. The 
IR-laser (40 % power) is activated at t =5 s, and is active for 30 seconds before inactivation at t = 
35 s. The diffusion (Δfluorescence) is greater when the complex is formed. 
 
Figure 3.8 – Measuring the binding constant of the Ton boxBtuB to TonB constructs. Plot of the 
Fnorm[1/1000] (see Section 2.2.6.5) over the log of the TonB construct concentration (nM). The 
solid lines show the fit using the law of mass action (Equation 2.8) to yield the KD. 
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 KD (µM) 
TonBΔTMD 8.4 ± 0.3 
TonBCTD 14.1 ± 0.8 
Table 3.3 - Equilibrium binding constant values from MST. 
3.2.3 Assessing the mechanical strength of the TonB:Ton boxBtuB 
interaction 
The TonB:Ton box interaction is mediated via a parallel β-strand augmentation that is 
predicted to be force-resistant. To test this hypothesis a single-molecule force 
spectroscopy experiment (SMFS) was designed (Figure 3.9).  
 
Figure 3.9 – Schematic of the SMFS experimental set up to assess the strength of the TonB:Ton 
boxBtuB interaction. The complex will be brought together by approaching the AFM probe 
towards the surface which is covalently labelled with TonBΔTMD (pink) by heterobifunctional 
PEG24 linkers (black). The Ton boxBtuB (blue) is attached to the cantilever using the same 
chemistry. Withdrawing the AFM probe will propagate force onto the interaction, and the 
amount of force required for dissociation will be investigated. The cartoon structure 
representation of the TonB:Ton boxBtuB complex is from PDB: 2GSK. 
The Ton boxBtuB peptide was immobilised onto a silicon nitride AFM probe using flexible 
heterobifunctional PEG linkers (SM PEG) (see Section 2.2.4). The TonB constructs 
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(containing cysteine) were attached to a derivatised silicon nitride surface using the 
same chemistry. The binding partners were brought together by approaching the AFM 
probe in buffered solution (see Section 2.2.7.2) towards the labelled surface (trigger 300 
pN, dwell 0 s), and then the interaction was mechanically pulled apart by withdrawing 
the probe from the surface at various velocities (200-5000 nms-1). To ensure sufficient 
surface coverage, 20 µm2 force maps with 600 force cycles (approach and retract) were 
taken, and the cantilever was repositioned to a new area between force maps (to ensure 
adequate surface coverage and maximise the number of unbinding events in the data 
set). A typical data set at a single retraction velocity contains 2-4 force maps, depending 
on the hit-rate. Approximately 1 in 10 approach-retract cycles resulted in a true 
unbinding event (Figure 3.10A). All detected events were manually fit to the worm-like 
chain (WLC) model (Equation 1.1), where the persistence length was fixed (0.4 nm), the 
hard contact was used to identify the zero distance and the retraction baseline was used 
to zero the force (Figure 3.10A).  
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Figure 3.10 – Example force-extension traces from SMFS experiments. A) An annotated force-
extension trace with the WLC fit from the SMFS of TonBΔTMD with Ton boxBtuB. The hard contact 
(probe pushed against the silicon surface) was used as the zero for the extension scale (nm) and 
the zero force level was set to the retraction baseline after rupture. The WLC model with a fixed 
persistence length (0.4 nm) is fit to the curvature of the rupture peak by applying locks to the 
apex and the base of the peak (green circles). From the fit, a contour length (Lc) and stiffness 
(WLC slope, see Section 2.2.7.4) are extrapolated. The amount of force required to break to 
complex is shown. The WLC fit was performed manually using Igor Pro 6.32A (wavemetrics) with 
an MFP3A AFM software add on (Asylum Research). B) An example force-extension trace with 
no events C) An example of non-specific tip-sample interactions with a linear force-distance 
profile.  
Detected events for tip-sample separation values of less than 10 nm were in general 
found to be consistent with non-specific tip-sample interactions and displayed a linear 
force-distance profile (Figure 3.10C). Force-extension profiles were analysed if the force-
extension profile was parabolic and fit well to the WLC model with a fixed persistence 
length of 0.4 nm. The TonBΔTMD:Ton box experiment displayed fewer than 0.1% of force 
curves with more than a single rupture peak. This indicates that there are no detectable 
unfolding events in TonBΔTMD prior to dissociation of the Ton boxBtuB.  
Analysis of ~400 of the force-extension profiles (per velocity) allows quantification of 
the mechanical strength and the end-to-end length of the complex (Figures 3.11, 3.12 
and 3.13 and Table 3.4). 
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Figure 3.11 – Example dissociation events for four different retraction velocities (200, 500, 
1,000, and 3,000 nms−1) from the SMFS of TonBΔTMD with Ton boxBtuB. Black lines show the WLC 
fit, red traces are from the approach and blue traces are from the retraction. The extrapolated 
contour length for each fit is shown. The dashed grey vertical lines represent the average 
contour length for the whole dataset. 
 97 
 
 
Figure 3.12 - Force-frequency distributions for the TonBΔTMD:Ton boxBtuB dissociation events with 
fits to a single Gaussian distribution for the five pulling velocities (200, 500, 1000, 3000, and 
5000 nms−1) used in this study. Histograms contain the full triplicate data collected. 
Speed (nms-1) # force 
(pN) 
average 
(pN) 
200 1 80  
84 ± 7 2 87 
3 84 
500 1 109  
105 ± 15 2 110 
3 95 
1000 1 119  
113 ± 13 2 115 
3 106 
3000 1 121  
119 ± 9 2 123 
3 114 
5000 1 151  
133 ± 30 2 121 
3 126 
Table 3.4 – AFM data of the unbinding of TonB∆TMD from the Ton box of BtuB at various retraction 
velocities. Force values were calculated by plotting the distribution of events and fitting with a 
Gaussian to obtain the mean value. The error on the average is the range of the triplicate 
averages. 
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Figure 3.13 - Contour-frequency distributions for the TonBΔTMD:Ton boxBtuB dissociation events 
fit to a double Gaussian distribution for the five pulling velocities (200, 500, 1000, 3000, and 
5000 nms−1) used in this study. Individual Gaussians are shown below. Histograms contain the 
full triplicate data collected. 
Combining these data in a scatterplot allows the specificity of the interaction to be 
assessed by the presence (specific) or absence (non-specific) of a ‘hot-spot’ indicative of 
correlated forces and distances (Figure 3.14). A binding-deficient variant of Ton boxBtuB 
(L8P)79 was used as a control to assess the specificity of these measurements. In 
experiments with Ton boxBtuB(L8P), random events at a lower hit rate were observed 
with no hot-spot observable in the scatterplot (Figure 3.14 bottom panels). 
 99 
 
 
Figure 3.14 - Force spectroscopy data (rupture force and contour length) plot as scatterplots at 
three different retraction velocities of Ton boxBtuB or the Ton boxBtuB L8P peptide unbinding from 
TonBΔTMD. Each contour map contains all filtered data reflecting single-molecule dissociation 
events after 1200 surface-approaches over a large surface area. The ‘hot spot’ of specific 
unbinding events are lost in the L8P mutant which confirms that the wild-type data is specific to 
the TonBΔTMD:Ton boxBtuB interaction. The hit rate (HR) is shown in the inset of each graph and 
denotes the percentage of approach/retract cycles that result in force-extension profiles that 
meet the criteria discussed in Section 2.2.7.4. The points were binned by a contour length of 5 
nm and force of 10 pN, the number of points that occupy a quadrant are indicated by the colour 
of the contours. 
Loading rates were calculated by fitting the WLC model to the unbinding event of a 
force-extension plot (Figure 3.10A). The instantaneous gradient of this fit at rupture 
(WLCslope) was calculated by inserting the derived contour length and extension at 
rupture into a differentiated form of the same equation (Equation 2.14). The loading 
rate at rupture was then obtained by multiplying this by the retraction velocity. For each 
retraction velocity used, force and loading rate frequency histograms were used to 
obtain modal values, and the average of triplicate values was taken for each velocity. 
The natural logarithm of the loading rate (Ns-1) plot against the rupture force (N) gave a 
linear dependence of force against loading rate (Figure 3.15). A linear fit was used to 
extrapolate the off rate at zero force (𝑘𝑜𝑓𝑓
0𝐹 ) using Equation 2.16 and xu with Equation 
2.15, the errors were calculated using the bootstrapping method (Section 2.2.7.4). 
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Figure 3.15 - The dynamic force spectrum (a plot of rupture force versus the natural logarithm 
of the force loading rate (pNs-1) of the TonBΔTMD:Ton boxBtuB interaction. The error bars show the 
range of measurements from the triplicate mean.  Data is fit to a linear regression (red line). The 
dynamic force spectrum obtained for the highly avid E9:Im9 (E9 cross-linked between residues 
20-66) is shown for comparison (dashed blue line)158. The units for xu and 𝑘𝑜𝑓𝑓
0𝐹  are Å and s-1 
respectively. 
The resultant dynamic force spectrum reveals that rupture occurs at 84-132 pN (Figure 
3.15) at the relatively high loading rates applied using AFM. This is a remarkably strong 
interaction for a complex with a relatively low affinity. For example, at similar loading 
rates, the dissociation of E920-66:Im9 (KD = 10−14 M)158 and an antibody and its epitope 
(KD = 10-9 M)191 occurs at forces of ~100 pN and ~160 pN respectively. It has been 
previously suggested that due to the additional β4-strand in the NMR structure of 
TonBCTD (Figure 1.10C), the association rate could be slow (as conformational 
rearrangement would be required for Ton box binding), which is why the KD for the 
interaction is in the micromolar range (slow association, slow dissociation)86. Using the 
AFM derived dissociation rate and the MST derived binding constant for TonBΔTMD, the 
calculated association rate of the Ton boxBtuB is 104 M-1 s-1 which is 4 orders of magnitude 
slower than the theoretical diffusion-limited biomolecular collision rate192. 
Interestingly, the force-extension profiles, distance histograms and scatterplots of these 
data all reveal that while dissociation occurs at a single force, two distributions are 
evident for the end-to-end length of the complex at rupture (see Figures 3.13 and 3.14) 
with Gaussian fit values of 47 ± 2 and 76 ± 3 nm. These measured lengths suggest the 
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presence of both a compact form and extended form of the proline-rich linker domain 
of TonB within the structured ensemble.  
As shown in Figure 3.16, the lengths of the PEG linkers159 and the structured TonB C-
terminal domain in complex with the Ton box of BtuB (PDB: 2GSK) are known, therefore 
by subtracting 24.5 nm from the most probable contour lengths observed gives the 
length of proline-rich linker domain under extension. The data shows that the linker 
domain predominantly exhibits a ~22 nm length under force; however the less 
frequently observed longer linker length is ~51 nm. The linker domain contains 118 
amino acids, if this assumed an unstructured chain; the length would be ~47 nm, in good 
agreement with the observed contour length distribution.  
 
Figure 3.16 – Individual lengths of each component of the system. The known length of the PEG24 
linkers (9.5 nm), TonBCTD:Ton box complex (5.5 nm) are shown. Additional length observed will 
be from the proline-rich linker domain, the two lengths observed are shown which are 
consistent with a compact and extended form. 
To confirm that this bimodality did arise from the proline-rich linker domain, rather than 
the structured C-terminal domain being unfolded at a force below the sensitivity of the 
AFM experiment (~20 pN), the TonBCTD(K144C) construct missing the linker domain 
(Figure 3.1) was used for the SMFS experiments using the same method as for 
TonBΔTMD(V32C). The results clearly show that the bimodality is lost when the linker 
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domain is removed; however the rupture force is the same, indicating that the proline-
rich linker domain does not affect the strength of the interaction (Figure 3.17).  
 
Figure 3.17 - Contour-frequency distribution for the TonBCTD:Ton BoxBtuB dissociation events at a 
pulling velocity of 500 nms-1 fit to a single Gaussian. The inset shows a scatterplot of contour 
length vs rupture force for the same data set. Points were binned by a contour length of 5 nm 
and force of 10 pN and the number of points that occupy a quadrant are indicated by the colour 
of the contours. 
As the proline-rich linker contains PE and PK repeats (see Figure 3.1), an electrostatic 
interaction within the linker was suspected to be stabilising a force-resistant compact 
conformation. The effect of disrupting these potential salt bridges using high 
concentrations of NaCl was investigated using SMFS.  
3.2.4 The influence of salt on the contour length of extended TonBΔTMD 
at dissociation 
As the contour length distribution can give an accurate measure of biomolecules 
extended under force159, SMFS was used to investigate the effect of high concentrations 
of NaCl on the length of the proline-rich linker domain of TonB. SMFS was carried out 
using the same protocol as discussed in section 2.2.7.2; however after data collection in 
Tris-buffered saline (25 mM Tris-HCl pH 8.0, 128 mM NaCl) at a retraction velocity of 
1000 nms-1 (Figure 3.18B and C); the buffer was changed 25 mM Tris-HCl pH 8.0, 628 
mM NaCl. Remarkably the contour length distribution changed so that the major species 
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was the longer contour length (Figure 3.18D). It should be also noted that the different 
lengths and presence of additional NaCl did not change the amount of force to break 
the interaction (Figure 3.19), nor the binding constant (Section 3.2.6) which was 
expected for an interaction mediated by H-bonds. Also no additional characteristics (i.e. 
unfolding events) were found in the force-extension traces (Figure 3.18B). 
 
Figure 3.18 – The influence of NaCl on the contour length of TonBΔTMD. A) Schematic showing 
the length of individual components of the TonBΔTMD (pink): Ton boxBtuB (blue) complex with 
PEG24 linkers (labelled) used in the SMFS experiments. The proline-rich linker domain contains 
118 residues. B) Force-extension curves collected at 500 nms-1 showing single unbinding events 
of TonBΔTMD with Ton boxBtuB. The green traces are events that show a longer contour length of 
~73 nm, and the blue traces are the shorter events that have a contour length of ~45 nm C) 
Contour length distribution with Gaussian fits below of the TonBΔTMD:Ton boxBtuB interaction 
pulled apart by SMFS at 500 nms-1 in 25 mM Tris-HCl, pH 8.0, 128 mM NaCl (Tris-buffered saline 
(TBS)) and D) TBS + 0.5 M NaCl. Modal values from Gaussian fits are shown.  
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Figure 3.19 – Force distributions of the TonBΔTMD:Ton boxBtuB interaction by SMFS at 1000 nms-1 
A) The difference in contour length (Lc) or the presence of additional 0.5 M NaCl (B) does not 
affect the rupture force of the complex. 
The results of this experiment imply that the proline-rich linker domain contains a 
mechanically strong structure that is lost in more saline conditions. To further 
understand the structural and biophysical properties of the linker domain and its 
influence on the C-terminal domain, denaturation equilibrium, NMR and SAXS 
experiments were carried out in the presence and absence of additional 0.5 M NaCl.   
3.2.5 Effect of salt on the stability of the C-terminal domain of TonB  
To understand the effect of high concentrations of NaCl on the structured C-terminal 
domain of TonB and to investigate whether the proline-rich linker domain affects its 
thermodynamic stability, a denaturant equilibrium study using urea was carried out 
using the method described in Section 2.2.6.2. The stability of the TonB constructs ± the 
proline-rich linker domain and ± 0.5 M additional NaCl were monitored using the 
fluorescence of the single buried tryptophan (W213) within the structured domain. The 
resulting fit of a two state transition chemical denaturation model (Figure 3.20) shows 
that the proline-rich linker domain was slightly destabilising to the structured domain, 
as the ΔGUN (kJ mol-1) was lower for TonBΔTMD (13.4 ± 0.4) than the TonBCTD construct 
(15.4 ± 0.3) (Table 3.5), where the mUN values do not vary more than 10 %, indicating 
that the linker domain does not significantly interact with the globular domain. However 
upon the addition of 0.5 M NaCl, the C-terminal domain of TonB containing the proline-
rich linker domain (TonBΔTMD) was significantly stabilised (ΔGUN = 16.0 ± 0.4) implying 
that charged residues within the linker domain contact and possibly destabilise the 
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structured domain or that dimerisation via the linker domain destabilises the C-terminal 
domain (see Section 3.2.9). 
 
 
Figure 3.20 - Urea equilibrium denaturation of the TonB constructs (TonBΔTMD in blue and TonBCTD 
in red) in the absence (closed squares) and presence (open squares) of 0.5 M NaCl. Data points 
are fit to a two state model (Section 2.2.6.2). The data was normalised using Equation 2.2. 
   construct ΔGUN (kJ mol-1) mUN (kJ mol-1 M-1) 
  TonBΔTMD 8.9 ± 1.0 3.1 ± 0.3 
  TonBCTD 12.4 ± 0.6 3.6 ± 0.2 
+ 0.5 M NaCl TonBΔTMD 11.4 ± 0.8 3.2 ± 0.2 
  TonBCTD 11.3 ± 0.6 3.0 ± 0.2 
Table 3.5 - Thermodymanic parameters of TonB constructs with and without an additional 0.5 
M NaCl. 
3.2.6 Effect of salt on the binding properties of TonB with the Ton 
boxBtuB 
As demonstrated in the previous section, high concentrations of NaCl alter the stability 
of the structured C-terminal domain of TonB, and the presence of the proline-rich linker 
domain in normal buffer conditions was destabilising. As the C-terminal domain 
functionally binds to the Ton box of ligand bound TBDTs, the effect of high salt 
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concentrations on the binding of the Ton box was investigated using an Alexa Fluor® 488 
labelled Ton boxBtuB with MST (Figure 3.21) (For method, see Section 2.2.6.5).  
 
Figure 3.21 – The effect of 0.5 M NaCl on the binding of TonB constructs to the Ton boxBtuB 
peptide. A plot of the Fnorm[1/1000] (see Section 2.2.6.5) over the log of the TonB construct 
concentration (nM) is shown. The solid lines show the fit using the law of mass action to yield 
the KD. Open circles show data from buffer conditions with additional 0.5 M NaCl. 
 construct KD (µM) 
 TonBΔTMD 9.5 ± 0.3 
 TonBCTD 11.5 ± 0.4 
+ 0.5 M NaCl TonBΔTMD 40.8 ± 1.3 
 TonBCTD 31.6 ± 1.1 
Table 3.6 - Equilibrium binding constants in the presence and absence of 0.5 M NaCl.  
The addition of 0.5 M NaCl to the buffer slightly alters the binding constant of TonB to 
the Ton boxBtuB. The TonBΔTMD construct was 4 fold weaker at binding the Ton box in high 
salt, whilst TonBCTD was 3 fold weaker (Table 3.6). An explanation for this observation is 
that a conserved salt bridge between TonB and the Ton box of BtuB (Arg158 of TonB and 
Asp6 of BtuB) is believed to be a nucleation site for the initiation of the β-strand 
augmentation145; therefore in high salt conditions this electrostatic interaction was 
equally dampened for both constructs. However in comparison to other avid protein-
protein complexes (such as Im9:E9193, ribonuclease inhibitor:angiogenin194 and 
Barnase:Barstar195), the effect of additional NaCl on the TonB:Ton boxBtuB complex is 
minimal, highlighting that the interaction is mediated by H-bonds.  
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3.2.7 NMR chemical shift perturbation demonstrates the proline-rich 
linker domain has an effect on the C-terminal domain of TonB in 
high salt conditions 
The NMR chemical shifts of the C-terminal domain of TonB have previously been 
assigned86, therefore 1H-15N HSQC was used to find any chemical shift perturbations 
within the structured C-terminus of TonB influenced by the proline-rich linker domain in 
the presence of absence of 0.5 M NaCl. The TonBΔTMD and TonBCTD constructs were 15N-
labelled using the procedure described in Section 2.2.2.7 and concentrated to 400 µM. 
10 % D2O was applied to the sample before data collection (Section 2.2.6.8). Figure 3.22 
shows the HSQC of both TonBΔTMD (black) and TonBCTD (pink, with assignments) overlaid, 
where the additional chemical shifts in the TonBΔTMD spectrum correspond to the 
proline-rich linker domain and are clustered around 8.2-8.5 (1H) and 121-127 (15N) ppm. 
These chemical shifts show a larger than expected 1H dispersion for an unfolded protein, 
consistent with the formation of a helical structure, in agreement with the PPII 
conformation indicated by CD spectrometry (Figure 3.4A). The presence of the proline-
rich linker domain did not alter the structure of the C-terminal domain, as no significant 
chemical shifts were observed (Figure 3.22 and Figure 3.23A).  
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Figure 3.22 – HSQC spectra of TonBCTD and TonBΔTMD  (labelled pink assigned peaks and black 
peaks respectively). No pertubations were found in the structured C-terminal domain when the 
proline-rich linker domain is present (also see Figure 3.23). Additional peaks (no pink overlay) 
correspond to the residues from the proline-rich linker domain. 
The presence of 0.5 M NaCl caused large chemical shift perturbations (CSP) in the C-
terminal domain of both constructs (Figure 3.23B and C). Additional perturbations were 
observed in the TonBΔTMD construct that were absent in the TonBCTD construct (Figure 
3.23B). This indicates that the proline-rich linker domain interacts with the C-terminal 
domain in more saline conditions, suggesting a collapse around the structured domain.  
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Figure 3.23 – Chemical shift pertubations within the C-terminal domain of TonB caused by the 
presence of the linker domain (A) or additional 0.5 M NaCl in constructs with the proline-rich 
linker domain (B, TonBΔTMD) and without (C, TonBCTD). The dashed red line shows the average 
global pertubation (from B), red bars show perturbations that are two standard deviations 
greater than the average (residue names shown) and yellow bars are shifts equal to the average 
and are less than two standard deviations from the average. The secondary structure schematic 
above the histograms shows the Ton box binding site in blue, which is unperturbed. Cartoon 
structures of the C-terminal domain are shown (right) with the location of significant 
pertubations coloured in red. The circles highlight the shifts observed in TonBΔTMD that are 
absent in TonBCTD. 
Global perturbations were also observed from the proline-rich linker domain (Figure 
3.24) which indicates a conformational change in more saline conditions, in agreement 
with the loss of structure in the SMFS experiments.  
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Figure 3.24 – Chemical shifts from the proline-rich linker domain of TonBΔTMD in the absence 
(black) and presence (green) of additional 0.5 M NaCl. The global shifts suggest the presence of 
a salt-dependent conformational change within this region when 0.5 M NaCl is present. 
3.2.8 SAXS reveals salt sensitive change of the proline-rich linker 
For more insight of the proline-rich linker domain of TonB, size-exclusion 
chromatography with small angle X-ray scattering (SEC SAXS) was performed at 
Diamond beamline 21 using the method described in Section 2.2.6.6. TonBΔTMD is known 
to form dimers106; therefore SEC was required to separate the monomers prior to SAXS 
evaluation. TonBCTD was purely monomeric and eluted from the column as a single peak, 
whereas TonBΔTMD eluted as two peaks (Figure 3.26A) corresponding to dimer and 
monomer (later confirmed by SEC-MALLS, see Section 3.2.9). The SAXS for the 
monomeric species of both TonB constructs are shown in Figure 3.25A. TonBCTD shows 
an elongated globular structure in full agreement with the monomeric NMR solution 
structure (Figure 3.25B inset), whereas the Kratky plot for TonBΔTMD indicates a globular 
domain in combination with a disordered region (Figure 3.25A). By performing a Guinier 
approximation, the radius of gyration (Rg) was found to be 19 and 44 Å for TonBCTD and 
TonBΔTMD respectively. The large Rg value for TonBΔTMD agrees with the notion of the 
proline-rich linker domain forming an extended PPII conformation100.  
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Figure 3.25 – Small angle X-ray scattering (SAXS) to determine structural information of the 
proline-rich linker domain of TonB. A) Kratky plot for both TonB constructs (TonBΔTMD (purple) 
and TonBCTD (blue)). The features of a globular protein are shown by the TonBCTD SAXS whilst 
TonBΔTMD shows a combination of globular and disordered domains as the plot displays a clear 
maximum, corresponding to the folded domain with a continuous rise produced by the presence 
of disordered regions. B) The pair-distance distribution (p(r)) of TonBCTD, the additional shoulder 
of the distribution describes the elongated structure of the globular domain. The inset shows 
the scattering envelope (transparent light blue) over the NMR solution structure of TonBCTD 
(transparent blue surface and blue cartoon representation) which are in full agreement. The real 
space Rg from the p(r) (18.6 Å) matches the reciprocal space Rg (19 Å) from the Guinier 
approximation. 
In order to test whether the proline-rich linker domain collapses in more saline 
conditions, SEC SAXS was performed on TonBΔTMD in the presence and absence of 0.5 M 
NaCl. By performing a Guinier approximation of the monomeric species, Rg values of 44 
and 36 Å were found in the absence and presence of 0.5 M NaCl respectively. This 
suggests that under physiological saline conditions (128 mM NaCl) the proline rich linker 
domain is more extended, which collapses in increased saline conditions.  
To gain more structural information about the conformation of the proline-rich linker 
domain from the SAXS, an ensemble optimisation method (EOM) was used (Section 
2.2.6.7). EOM generates a large pool of random structures using sequence and structural 
information. A genetic algorithm then compares the averaged theoretical scattering 
intensity from n independent ensembles of conformations against the SAXS data and 
the conformations that best describe the experimental SAXS data (Figure 3.26B) are 
selected. The results show that under physiological conditions, TonBΔTMD populates a 
more extended conformation (indicative of the higher Rg distribution (Figure 3.26C)) 
where as under increased saline conditions, a higher frequency of low Rg dominates. 
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Figure 3.26D shows example conformations in physiological and high saline conditions 
that best describe the experimental SAXS data.  
 
Figure 3.26 – SEC SAXS and EOM analysis of TonBΔTMD in the presence and absence of additional 
0.5 M NaCl. A) Chromatogram of the gel filtration of TonBΔTMD in the absence (red) and presence 
(black) of additional 0.5 M NaCl. The two major peaks show dimeric (D) and monomeric (M) 
TonBΔTMD species with a small proportion of aggregates (A) (confirmed by SEC-MALLS, Figure 
3.28A). B) The experimental SAXS with the fit from EOM analysis (black) obtained for an 
ensemble of 5 models (low salt, red) and 4 models (high salt, grey). C) Rg distributions from the 
EOM-selected ensemble (line) and that corresponding to the random pool (dashs) in the 
presence (black) and absence (red) of additional 0.5 M NaCl. D) Example conformations of the 
proline-rich linker domains from EOM analysis in low (red) and high (grey) salt concentrations.  
The combined results from SMFS and SAXS suggest that under physiological saline 
conditions, the proline-rich linker domain is more extended and appears to contain 
structure when extended under force. In high saline conditions, the proline-rich linker 
domain is collapsed and structure is lost under force extension (summarised in Figure 
3.27). 
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Figure 3.27 – Possible conformations of the proline-rich linker domain under different 
conditions. In low salt conditions, the proline-rich linker domain (black) is more extended, 
however when extended under force, the linker contains some structure. In high salt conditions, 
the proline-rich linker domain is collapsed and makes contact with the C-terminal domain (pink), 
however under force, the linker domain contains no structure and is a fully extended 
polypeptide chain. 
3.2.9 Dimerisation of the TonBΔTMD construct 
The dimerisation of TonB depending on the construct size has been well documented, 
for example truncating the protein within the structured C-terminal domain (residues 
150-239) results in an intertwined dimer artefact (Figure 1.10A). TonB constructs are 
monomeric in solution until residues containing the proline-rich domain (PE/PK repeats) 
are included196, which leads to the presence of a significant population of TonB dimer106. 
This indicates that TonB dimerisation is driven by the PE/PK region, to confirm that the 
two peaks in the chromatogram in Figure 3.26A where indeed monomer and dimer, SEC-
MALLS was performed on TonBΔTMD which confirmed the presence of a monomer-dimer 
population in the concentrated (464 µM) sample (Figure 3.28A). The molecular mass of 
TonBΔTMD predicted from the static angle scattering was inaccurate by ± 10 kDa which 
was evident from the poor fit (R2 = 0.84) to the data with the standard Zimm model (due 
to the elongated nature of TonBΔTMD), however the doubling of mass in the dimer peak 
gave confidence that a TonB homodimer was present (Figure 3.28A). Interestingly, 
dynamic light scattering (DLS) of the monomer and dimer peak gave the same radius of 
hydration (RH) (Figure 3.28B), suggesting that although a dimer is present, the globular 
C-terminal domain (visible by light scattering) do not contact each other. 
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Figure 3.28 – SEC-MALLS of TonBΔTMD. A) Chromatogram of TonB revealing dimer (D) and 
monomer (M). The calculated Mw from the static angle light scattering is shown in black. The 
true molecular weight of the TonBΔTMD construct is 23580 Da. B) Regularisation plot of the 
TonBΔTMD dimer (blue) and monomer (orange) with radius of hydration (RH) shown. Each peak of 
the chromatogram contained a small quantity of μm sized particles (likely aggregates or 
microbubbles). 
To find if TonBΔTMD dimerisation is concentration dependent, a concentration titration 
was performed on TonBΔTMD using gel filtration. TonBΔTMD elutes as three distinguishable 
peaks, the first being aggregates (confirmed by SEC-MALLS), followed by dimer and 
monomeric TonB (Figure 3.29A). Surprisingly, at concentrations between 1.5 mM to 25 
µM (incubated at room temperature for 16 hours), the amount of dimer in the sample 
(calculated by the area under a Gaussian fit (Figure 3.29B)) remained constant (16.8 ± 
3.9 % dimer) at all concentrations tested (Figure 3.29C), less than that previously 
predicted by EPR (40-50 %)106. Also the monomer-dimer conversion is dynamic as gel 
filtration of the isolated monomer or dimer fraction resulted in the reappearance of a 
double peak. 
As TonBΔTMD dimer formation appears to be electrostatically driven by the PE/PK repeats 
within the proline-rich linker domain, gel filtration was performed at various 
concentrations of NaCl with 16 hour incubations at room temperature. Although a 
population of dimer was always present, the total percentage of dimer decreased with 
increasing NaCl concentration (Figure 3.29D). This was not observed in Figure 3.26A as 
the protein was buffer exchanged into higher NaCl during SEC with no incubation period, 
which implies the monomer-dimer equilibrium is slow. 
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Figure 3.29 – Finding the effect of dimerisation of TonBΔTMD. A) Concentration titration of 
TonBΔTMD (red = 397, orange = 198, yellow = 99, green = 49 and blue = 25 μM) on a Superdex™ 
200 increase 3.2/300 gel filtration column. Aggregates (A), dimer (D) and monomer (M) are 
shown. B) Calculating the amount of dimer by fitting multiple Gaussians to the chromatogram 
(red). The sum of 4 Gaussians is shown in black. The individual Gaussians are shown below, the 
dimer (D) and monomer (M) Gaussians are labelled. C) The % dimer at various concentrations of 
TonBΔTMD calculated from the area under the Gaussians. D) The % dimer at various NaCl 
concentrations.  
3.3 Discussion 
3.3.1 Mechanical strength of the TonB:Ton box interaction 
The results presented in this chapter have demonstrated several important findings 
about TonB and the interaction with the Ton box of a TonB-dependent receptor. 
Arguably, the most significant finding is that the interaction between TonB and the Ton 
box from BtuB displays huge mechanical resilience when extended by AFM. When the 
TonBΔTMD:Ton BoxBtuB interaction was extended at retraction velocities of 200 – 5000 
nms-1 (corresponding to force loading rates of 103-105 pNs-1) the resultant dynamic force 
spectrum reveals that rupture occurs at 84-132 pN (Figure 3.15).  
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These findings indicate that the TonB:Ton box complex is mechanically robust as 
predicted. The β-strand augmentation mechanism, which underlies the complex 
formation, is well-known for being mechanically “strong”. For example, this motif is 
present in the pili subunit FimG where the extraordinary stable β-strand augmentation 
with neighbouring subunit FimF is necessary for immobilising uropathogenic E. coli to 
host endothelium under hydrodynamic flow.  
The key difference between the β-strand augmentation of FimG:FimF and TonB:BtuB is 
in the latter the interaction is facilitated by the docking of a strand (the Ton box in this 
instance) to the leading edge of the pre-existing β-sheet of the protein (TonB). In the 
Fim complex, the β-strand ligand complements its binding partner by completing the 
core of the protein fold (known as donor strand complementation). These difference 
could be key in determining the strength of the interaction, where it is beneficial that 
the Fim complex never unbinds, whilst for TonB:Ton box, eventual unbinding is 
necessary to prevent the unfolding of the entire receptor. 
These results provide the first evidence in vitro towards the pulling model of TonB-
dependent transport, which will be developed further in the following chapter.  
3.3.2 Conformation with the linker domain 
An unexpected but interesting finding was that TonB populates two distinct 
conformations when extended by SMFS. Since the discovery of the proline-rich linker 
domain of TonB, little has been known about its structural organisation, other than it 
exists as a 15 nm extended PPII rod to allow the C-terminal domain of TonB to cross the 
periplasmic space86. Here we find that the proline-rich linker domain must contain a 
force-resistant structure as the observed contour length for the entire complex (PEG24-
Ton box:TonBΔTMD-PEG24 =~44 nm)(Figure 3.18C) was much shorter than the expected 
contour length (~74 nm) (Figure 3.16). This suggests that the proline-rich linker domain 
does not exist as a purely unstructured domain or a continuous PPII helix. Similar force-
resistant collapses within an unstructured polypeptide chain have also been observed in 
PolyQ chains (associated with Huntington’s disease)197. The collapsed random globular 
states in PolyQ were found to be so mechanically resilient that no unfolding was 
observed when a force-clamp of 180 pN was used. MD simulation revealed that these 
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force-resistant globules were extensively H-bonded. The force-resistant structure within 
the linker domain of TonB could have implications in its function in vivo (see discussion 
below). The SAXS data in this chapter provides evidence of an extended proline-rich 
linker domain as previously shown by EPR spectroscopy100. It is interesting that the 
presence of an extra 0.5 M NaCl causes the collapse of this extended rod (indicative by 
the smaller Rg and EOM distribution), which implies that the elongated conformation is 
also electrostatically driven.  
A hypothetical possibility is that the PE and PK repeats form a force-resistant 
electrostatic hinge, whilst the rest of the linker domain exists as a PPII rod (Figure 3.30). 
This force-resistant conformation gives an estimated linker length close to that observed 
in the SMFS experiments (~22 nm), and together with the C-terminal domain is almost 
sufficient to span the length of the periplasmic space of the mid cell (estimates of 30 ± 
2 nm in rich growth medium198). 
 
Figure 3.30 – Predicted model of the proline-rich linker domain of TonB. The helix shows a 
continuous PPII conformation. 
The fact that the linker domain conformation is lost (or changes) in the presence of high 
NaCl concentrations (indicative by the more abundant longer contour length and 
chemical shift perturbations) supports the predicted model. The function of the hinge 
remains purely speculative, however it could represent an off- or on-state of TonB. For 
example, in the off-state, the linker domain contains no structure allowing TonB to 
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search for exposed Ton boxes. Upon binding to the Ton box, the pmf possibly drives the 
hinge conformation (possibly by interactions with ExbD) causing a 28 nm retraction of 
the C-terminal domain, driving a pulling force. The main evidence against this hypothesis 
is that TonB(Δ66-100) which lacks the PE/PK repeats is still functional in vivo under 
physiological growth conditions99. There is also the possibility that the PE/PK driven 
conformation acts as a length adaptor, where the salt-dependent hinge opens allow 
TonB to reach the OM when the bacteria are exposed to more saline growth conditions 
(resulting in an expanded periplasm).  
3.3.3 TonB dimer conformation 
The construct used in this study (TonBΔTMD: residues 33-239) was found to form dimers 
where TonBCTD (residues 144-239) did not, in accordance with other studies86,106,196. This 
strongly suggests that TonB dimers are formed by the proline-rich linker domain 
(specifically residues 33-112 which contain the PE/PK repeats). Although it is accepted 
that TonB is monomeric when in contact with the receptor144,196, there is sufficient 
evidence by formaldehyde cross-linking in vivo that TonB forms homodimers at some 
stage during transport103,105,199. The combination of SEC-MALLS, SAXS and analytical gel 
filtration in this thesis has revealed a possible conformation of the TonB homodimer. 
The RH values calculated by MALLS for dimeric TonB were the same as monomeric TonB, 
suggesting that the structured C-terminal domains in TonB homodimers do not contact, 
as the RH would double. The Rg approximation from the SAXS on the dimeric TonB (50 
Å) was only slightly larger than the monomer (44 Å), indicating that a head-on-head 
dimer is not present, as doubling of the Rg would be expected. Therefore it is likely that 
the dimer is aligned so that the proline-rich linker domains are parallel. Analytical gel 
filtration demonstrated that dimer formation is electrostatically driven, as the amount 
of dimer decreases with increasing NaCl conditions; it is therefore likely that the PE/PK 
repeats form the TonB homodimer. A predicted model of the TonB homodimer from 
these observations is shown in Figure 3.31.  
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Figure 3.31 – Predicted structure of the TonB homodimer from MALLS and SAXS. The structure 
of the monomeric C-terminal domain is shown, whilst the proline-rich region (PE/PK repeats) 
are shown by the pink boxes. 
TonBCTD is purely monomeric, and has the same binding constant to the Ton boxBtuB 
peptide as TonBΔTMD (which contains a population of dimers) (Figure 3.8), this indicates 
that the homodimer formation does not affect the binding function of the C-terminal 
domain to the Ton box. 
 
 120 
 
4 Testing the pulling model mechanism of TonB-
dependent transport 
4.1 Objectives 
In the previous chapter the unbinding of the Ton box from BtuB (Ton boxBtuB) was found 
to require a magnitude of force previously shown to unfold many globular proteins200. 
In this chapter the natively folded TonB-dependent receptors BtuB and FhuA will be 
isolated from the OM of E. coli and reconstituted into E. coli lipid extract liposomes. 
SMFS will then be used to test whether TonB can remodel the plug domain by the Ton 
box tether under mechanical force, therefore directly testing the pulling model of TonB-
dependent transport in vitro. 
4.2 Results 
4.2.1 Cloning FhuA from E. coli 
An arabinose inducible expression plasmid (pBAD) containing the wild-type btuB gene 
from E. coli (pNGH15) was kindly provided by Dr Nicholas Housden, University of Oxford. 
The ferric hydroxamate uptake receptor (fhuA) gene was cloned from the genome of E. 
coli (strain: JM109) using Q5® PCR (Section 2.2.1.3) and the DNA primers shown in Table 
4.1. 
FhuA Forward 5’CATTAATCACCATGGCGCGTTCCAAAACTGC 3’ 
Reverse 5’TTGAATATTCTCGAGTTAGAAACGGAAGGTTGCGGTTG‘3 
Table 4.1– DNA primers for the cloning of the fhuA gene from E. coli. The underlined text shows 
the restriction sites (XhoI and NcoI), green text is the start codon, red text is the stop codon and 
grey text is a random sequence preceding and following the start and stop codons respectively. 
The amplified gene product (2270 bp) was confirmed by agarose gel electrophoresis 
(Figure 4.1A) and extracted using the method described in Section 2.2.1.9. The BtuB 
expression plasmid and amplified fhuA gene were cleaved with XhoI and NcoI restriction 
enzymes (Method described in Section 2.2.1.5)(Figure 4.1B) and the digested plasmid 
was purified using agarose gel electrophoresis (Figure 4.1B). The cleaved fhuA gene was 
then ligated into the pBAD vector, transformed into DH5α cells and plated onto 
ampicillin selection plates. After incubation for 16 hours at 37 ˚C, several colonies were 
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randomly selected, a restriction digest was performed on the purified plasmids and fhuA 
insertion was confirmed by agarose gel electrophoresis (Figure 4.1C). The constructs 
were further confirmed by DNA sequencing.  
 
Figure 4.1 – Agarose gels stained with ethidium bromide showing the stages of cloning the fhuA 
gene product from E. coli into an arabinose inducible expression plasmid (pBAD). A) The 
amplification of the fhuA gene (2270 bp) by PCR (L is the DNA ladder). B) Restriction digest of 
the amplified fhuA gene and pNGH15 (pBAD vector with btuB gene insert). The yellow arrow 
indicates the position of the digested pBAD vector without insert, and the white arrow indicates 
the position of the btuB gene. C) After ligation and transformation into competent cells, single 
colonies were selected and the plasmids isolated and digested by XhoI/NcoI restriction enzymes 
before agarose gel electrophoresis was used to confirm the insertion. The labelled arrows show 
the correct band for the pBAD vector and fhuA gene. 
4.2.2 Over-expression and purification of TonB-dependent receptors 
4.2.2.1 BtuB purification 
BtuB was overexpressed from the pBAD vector (pNGH15, kindly provided by Nicholas 
Housden, University of Oxford) using a freshly transformed porin-deficient strain of E. 
coli (TNE012 (K12 tsx− ompA− ompB−), also provided by Dr Nicholas Housden) using the 
method described in Section 2.2.2.3. After protein induction by 0.15 % (w/v) L-(+)-
arabinose and incubation for 16 hours at 15 ˚C, the cells were pelleted and lysed using 
a sonicator (Section 2.2.2.4). The supernatant of the lysed cells was ultracentrifuged at 
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45,000 rpm to isolate the membrane fraction, inner membrane contaminates were 
removed with Triton-X 100 (Figure 4.2A) and the outer membrane pellet was solubilised 
into a solution containing n-octyl β-D-glucopyranoside (β-OG)(See Section 2.2.2.6). The 
solubilised OMPs were loaded onto a HiTrap DEAE FF 5 mL anion exchange column 
(Section 2.2.2.6) and impurities were removed with a 1 M LiCl gradient (Figure 4.2B). 
BtuB elutes from the column when 100 % of the 1 M LiCl buffer is applied (Figure 4.2B, 
peak 3 and Figure 4.2C) and forms a white precipitate containing pure BtuB. BtuB was 
allowed to precipitate for 16 hours at 4 ˚C before centrifugation at 4,000 rpm to pellet 
the precipitated protein. This was then stored at 4 ˚C until further use. Typically from a 
10 L growth, ~5 mg of BtuB was isolated.  
 
Figure 4.2 – Purification of BtuB. A) SDS-PAGE of the initial centrifugation purification steps (SN 
= supernatant), L is the protein ladder B) Anion exchange chromatography using a 5 mL HiTrap 
DEAE FF column of the solubilised OM fraction, the impurities eluted in peaks labelled 1 and 2, 
and pure BtuB elutes at 100 % 1 M LiCl in peak 3. C) SDS-PAGE of the peaks during anion 
exchange, the expected mass (66 kDa) of BtuB is shown by the black arrow.  
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4.2.2.2 FhuA purification 
The purification of FhuA was carried out using the same protocol as for BtuB (using the 
same expression vector and porin-deficient strain of E. coli). After the OM pellet was 
solubilised in 1 % (w/v) β-OG, SDS-PAGE confirmed the presence of FhuA (Figure 4.3A) 
in the supernatant. During anion exchange chromatography using a 5 mL HiTrap DEAE 
FF column, FhuA eluted from the column with the impurities during the 1 M LiCl gradient 
(peak 1 Figure 4.3B and Figure 4.3C). Fortunately, FhuA began to precipitate in a similar 
fashion to BtuB (due to the β-OG concentration being slightly below the CMC). The 
precipitant was isolated by centrifugation, solubilised in 1 % (w/v) β-OG and a 
Superdex™ 75 HR 10/30 gel filtration column equilibrated in 25 mM Tris-HCl pH 8.0, 128 
mM NaCl, 1 % (w/v) β-OG was used to further purify FhuA (Figure 4.3D and E). The total 
yield of protein was ~ 2 mg.  
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Figure 4.3 – Purification of FhuA. A) SDS-PAGE of the solubilised OM fraction (in 1 % (v/v) β-OG) 
with the expected mass (79 kDa) of FhuA shown by the black arrow. B) Anion exchange 
chromatography of the solubilised OM fraction using a 5 mL HiTrap DEAE FF column, FhuA eluted 
with impurities in peak 1. C) SDS-PAGE of the labelled peaks from anion exchange (B) and the 
precipitate formed. The black arrow shows the expected position of FhuA. D) Gel filtration of 
the solubilised FhuA precipitate using a Superdex™ 75 HR 10/30 gel filtration column, FhuA 
eluted in the major peak (peak 1). E) SDS-PAGE of the three absorbance peaks from gel filtration 
(D), the black arrow shows the expected position of FhuA. 
4.2.2.3 Spectroscopic analysis of protein fold 
To show that the purified TBDTs were correctly folded when solubilised in 1 % (w/v) β-
OG, secondary structure analysis was carried out using Far-UV CD (Section 2.2.6.1) and 
the tertiary structure was investigated using intrinsic tryptophan fluorescence (Section 
2.2.6.2). The CD spectra demonstrated that both BtuB (Figure 4.4A) and FhuA (Figure 
4.4C) have a predominant β-sheet secondary structure, which is in agreement with the 
X-ray crystal structures of BtuB (Figure 1.18C), and FhuA (Figure 1.12). Tryptophan 
fluorescence emission (excitation 280 nm, emission 290-400 nm) was used to monitor 
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the tertiary fold in the presence and absence of 8 M urea for both BtuB and FhuA. Upon 
the addition of 8 M urea, 15 minutes of equilibration was required before complete BtuB 
unfolding was observed (Figure 4.4B), demonstrating the high kinetic stability of β-barrel 
proteins. The decrease in fluorescence and red shift in 8 M urea in both BtuB and FhuA 
(Figure 4.4B and D) is indicative that the proteins had unfolded, therefore in the absence 
of denaturant; BtuB and FhuA contain tertiary structure. 
 
Figure 4.4 – Monitoring the secondary and tertiary fold of BtuB and FhuA after purification and 
solubilisation into detergent. A) Far-UV CD spectrum of BtuB (below shows a plot of the high 
tension voltage (HT), values greater than 500 indicate detector saturation). B) Tryptophan 
emission spectra (from an excitation at 280 nm) of BtuB (black trace). The protein was then 
incubated in 8 M urea and the various time points are shown (inset, coloured traces). The protein 
was fully unfolded after 15 minutes. C) Far-UV CD spectrum of FhuA D) Tryptophan emission 
spectrum (from an excitation at 280 nm) of FhuA (black) and after 1 hour incubation in 8 M urea 
(red). 
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4.2.3 Insertion of TonB-dependent transporters into proteoliposomes  
To perform the SMFS experiments, the TBDTs were densely packed into 
proteoliposomes composed of E. coli polar lipid extract using a dialysis method 
previously described for the insertion of FhuA into liposomes for an AFM unfolding 
study178 (Section 2.2.8). After dialysis, a gel-like sediment (large proteoliposomes) 
formed at the bottom of the dialysis bag; this sediment was gently suspended by 
pipetting and stored at 4 ˚C. To assess whether the proteoliposomes had formed and 
contained the protein (all analysis was performed on BtuB proteoliposomes) SDS-PAGE, 
DLS and AFM imaging were carried out. To assess whether the protein was indeed 
inserted into liposomes, a sample from the dialysis was boiled in SDS for 5 minutes whilst 
another sample was left at room temperature. These samples were then loaded onto a 
SDS-PAGE gel and electrophoresed. In the sample that was not boiled, the protein could 
not enter the stacking gel due to being trapped inside the large stable proteoliposomes, 
whilst boiling allowed the protein to be released from the proteoliposomes and enter 
the gel with the correct electrophoretic mass (66 kDa) (Figure 4.5). 
 
Figure 4.5 – SDS-PAGE of BtuB inserted into proteoliposomes composed of E. coli polar lipid 
extract using the dialysis method. The protein enters the resolving gel after boiling in SDS, 
indicating proteoliposomes had been disrupted and BtuB unfolds and has electrophoretic 
mobility as expected for its mass (66 kDa). In the unboiled sample, the large stable liposomes 
prevent the protein entering the resolving gel where it becomes trapped in the stacking gel. 
Dynamic light scattering (DLS) measures the scattered intensity over a range of different 
angles, which can be used to reveal particle hydrodynamic radius distribution between 
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0.001 to several microns in solution. Therefore DLS was used in order to measure the 
size of the proteoliposomes formed from the dialysis method. A sample of the 
suspended proteoliposomes was diluted to give a final lipid concentration of 
approximately 40 μM. Using the method described in Section 2.2.6.3, DLS was 
performed on the diluted sample. The correlation curves accumulated over 3 minutes 
were used to obtain a distribution of particle sizes (Figure 4.6, black trace). The 
distribution of the hydrodynamic radii for the proteoliposomes indicates that there is a 
large variation in size in the population (100-2000 nm), which was expected as the 
proteoliposomes were not extruded through a filter. For a negative control, the 
proteoliposomes were suspended in 1 % (w/v) SDS and boiled for 5 minutes to disrupt 
the proteoliposomes before DLS was performed. Upon boiling in detergent, the large 
structures are lost (Figure 4.6, red trace), which provides evidence of the presence of 
large proteoliposomes in the sample. 
 
Figure 4.6 - Distribution of the hydrodynamic radius of vesicles of E. coli polar lipid extract 
containing BtuB obtained by dynamic light scattering (black). Addition of SDS and boiling caused 
breakdown of liposomes (red). 
Finally, AFM imaging was performed on the proteoliposomes rolled onto mica to further 
confirm that the receptor was densely packed into a lipid bilayer and was surface 
immobilised when placed on mica. The proteoliposomes were resuspended by pipetting 
and diluted to a final lipid concentration of 0.1 mg/mL. 200 μL was pooled over a 1 cm 
diameter disc of freshly cleaved mica and incubated at room temperature for 30 
minutes. The surface was then thoroughly rinsed with 25 mM Tris-HCl pH 8.0, 128 mM 
NaCl. AFM imaging with a FastScan AFM (Bruker) equipped with a Fast Scan (D probe) 
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cantilever (Bruker) was conducted at a scan frequency of 80 kHz which confirmed the 
presence of membrane packed with BtuB immobilised to the surface (Figure 4.7). 
 
Figure 4.7 – AFM imaging of BtuB proteoliposomes rolled onto mica. A) Low magnification of 
BtuB proteoliposomes on mica, the large white areas are likely unwashed vesciles. B) Higher 
magnification of BtuB proteoliposomes on mica (image taken by Jonny Burns, University of 
Sheffield).  
4.2.4 Single-molecule force spectroscopy of the TonBΔTMD:BtuB 
interaction 
As shown in Chapter 3, the TonBΔTMD:Ton boxBtuB complex is able to resist forces that are 
usually associated with the unfolding of moderately mechanically robust proteins at 
similar loading rates. Therefore it is likely that the plug domain, which is contiguous with 
the Ton box, may fully or partially unfold. To directly test this hypothesis, the BtuB 
proteoliposomes were surface immobilised onto a freshly cleaved mica (Section 2.2.8) 
and TonBΔTMD(V32C) was immobilised to the AFM probe (Section 2.2.4). Figure 4.8 
depicts a schematic of the system. 
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Figure 4.8 - Schematic to describe the single-molecule force spectroscopy (SMFS) approach used 
in this study. TonBΔTMD (pink) is attached to the AFM probe by heterobifunctional PEG24 linkers 
and BtuB (blue cartoon structure) bound to vitamin B12 (red) is inserted into E. coli polar lipid 
extract liposomes and immobilised to a mica surface. The forces between the interacting 
partners and any remodelling will be measured using an AFM.  
Pressing the TonBΔTMD-labelled AFM probe against the surface with 60-90 pN of force, 
dwelling for 1 second and withdrawing at a velocity of 1000 nms-1 (force loading rate 
~10 nNs-1) led to distinctive force-extension profiles displaying two rupture events 
(Figure 4.9A) at forces of 61 ± 4 and 91 ± 23 pN and contour lengths of 58 ± 3 and 77 ± 
7 nm (Table 4.2). These events indicate that the complex undergoes partial unfolding 
before dissociation.  As TonBΔTMD does not unfold at these forces, force would 
presumably be propagated into the plug domain via the contiguous Ton box tether. 
These data thus suggest that the strength of intra-polypeptide interactions in the plug 
domain are slightly weaker than those of the inter-polypeptide interactions between 
TonBΔTMD and BtuB, allowing unfolding before unbinding to occur in the majority of 
cases. As the mechanical strength of proteins and their complexes is kinetically 
controlled, the loading rate may affect unfolding and unbinding differently. 
Interestingly, analysis of the speed dependence of the putative unfolding and unbinding 
events demonstrates that the relative strength of intra- and inter-protein interactions 
at the same loading rate remains constant across the dynamic range of experiment 
(Figure 4.9B). For a negative control, SMFS of a BtuB L8P variant was performed which 
produced no detectable events. Interestingly, SMFS of wild-type BtuB in the absence of 
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vitamin B12 resulted in events at a similar rate to that of the substrate bound receptor, 
which implies that the Ton box of BtuB was always accessible for TonB binding, 
independent of the substrate. 
 
Figure 4.9 – Pulling on the TonBΔTMD:BtuB complex in the presence of vitamin B12. A) 
Representative force-extension profiles show two rupture events (the leading edge of each 
event is coloured green and blue, respectively) fitted to the WLC model (black). B) Dynamic force 
spectrum of unfolding (green) and unbinding (blue) events at 200, 500, 1,000 and 5,000 nms-1, 
error bars show the range of the mode of triplicate data sets.  
To quantify the extent of unfolding, force-extension profiles showing two events were 
analysed further by fitting the worm-like chain model (Section 1.5.2) to the unfolding 
(Lc1) and unbinding (Lc2) events, as the difference in these values (Lc) reveals how much 
of the protein complex becomes unfolded at the first rupture event (Figure 4.10A). 
These data in the form of a histogram are shown in Figure 4.10B and the distribution for 
ΔLc (red histogram) reveals a modal value of 20 ± 1 nm that is independent of the 
retraction velocity used (Table 4.2), or importantly, the presence or absence of the TonB 
linker domain (Figure 4.11 and Table 4.3). As the length of an extended amino-acid is 
known (0.4 nm) this distance can be directly translated to the unfolding of 50 amino-
acids, approximately half of the residues within the plug domain (Figure 4.10B inset and 
Figure 4.10D).  
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Figure 4.10 – Measuring the amount of plug domain unfolding. A) Schematic describing the 
origin of each rupture event (an example trace with WLC fits is shown below) and their 
relationship to Lc1, Lc2 and ΔLc. The barrel of BtuB is shown as an open cylinder with the 
secondary structure of the plug domain (grey shaded region) and TonB, which is attached to the 
AFM probe, shown in pink. i) The AFM probe is pressed against the surface bringing the 
TonB:BtuB complex together; ii) TonB bound to BtuB is fully extended causing the force to 
increase; iii) part of the plug domain is unfolded and the force sharply decreases; iv) the unfolded 
region is extended causing an increase in the entropic restoring force and v) Ton BoxBtuB 
dissoicates from TonB and the force sharply falls to zero. The difference in fitted contour lengths 
(ΔLc) between the two peaks can be used to calculate the extent of unfolding. B) Contour length 
frequency distributions from WLC fits to double-peaked force extension profiles from a triplicate 
datasets (n = 154) accumulated at a retraction velocity 1,000 nms-1.  Frequency distributions 
obtained for the remodelling/unfolding event (Lc1, green), unbinding (Lc2, blue) and ΔLc (red) 
are fitted to Gaussian functions (black lines). Inset: the presence of an unfolding event prior to 
dissociation reveals that the plug domain comprises a mechanically weak sub-domain (the 50 
amino acids downstream of the Ton box (residues 23-73, shaded blue)) and a mechanically 
recalcitrant sub-domain (shaded grey).  Residues that extend prior to the first event are coloured 
green. Ton BoxBtuB is shown as a green arrow bound to TonB (shaded in pink). C) Force histograms 
for the plug unfolding (green) and TonB unbinding (blue) from the Ton boxBtuB with the modal 
values shown. D) The crystal structure of the BtuB plug domain with unfolded residues shown 
in blue, Ton box in green and vitamin B12 as coloured spheres. 
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Figure 4.11 - SMFS results of wild-type BtuB bound to vitamin B12 unfolding using TonBCTD(K144C) 
construct at 1000 nms-1. A) Example force-extension traces of TonBCTD:BtuB:vitamin B12 fitted to 
the worm-like chain model (p= 0.4 nm). B) Contour length distributions of unfolding (green) and 
unbinding (blue) and ΔLc (red inset), modes = 17, 40 and 21 nm respectively. C) Force 
distributions of unfolding (green) and unbinding (blue), modes = 53 and 88 pN respectively.  
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4.2.5 Using disulfide bridges to pin point the unfolding region within the 
BtuB plug domain 
While these data reveal the extent of domain unfolding it does not reveal its location. 
To locate this region, it was reasoned that the 50 residues directly downstream of the 
Ton box motif (residues 23-73) would most likely unfold first (see Figure 4.10D) as these 
residues are initially exposed to mechanical deformation as force is propagated through 
the plug domain.  
To test this assumption, disulfide bridges were created within the plug domain of BtuB. 
A variant designated XLbarrel (Figure 4.12 schematic) was designed to prevent any 
unfolding by linking the N-terminus of the plug domain to the barrel (BtuB L23C/S374C). 
A V29C/V45C mutant (XLloop) was designed to create a covalently linked 15 amino acid 
loop within the region predicted to unfold which if this hypothesis is correct, would 
shorten the ΔLc by ~6 nm. A final variant (T27C/Y109C) was created (designated XL plug 
subdomain (XLPSB), Figure 4.12) linking the first β-strand in the predicted mechanically 
weak subdomain to the mechanically strong subdomain, diverting the force propagation 
pathway. 
 
Figure 4.12 - Secondary structure topology of the BtuB plug domain showing location of the 
disulfide bridges  (bold red line linked by yellow circles).The mechanically weak and strong sub-
domains are shaded blue and grey, respectively, the barrel domain as an empty cylinder and Ton 
BoxBtuB is shown as a green arrow bound to TonB (shaded in pink).  
The BtuB variants were all expressed and purified using the same method as for the wild-
type receptor (see Section 2.2.2.6) and, after purification, adoption of the correct fold 
was analysed using far-UV CD and intrinsic tryptophan fluorescence. Both techniques 
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demonstrated that the cross-link variants displayed negligible differences in the λ-max 
from the wild-type receptor, however the slight change in intensity could reflect a 
change in the local tryptophan environment around the point mutations (Figure 4.13).  
 
Figure 4.13 – Confirming the correct secondary and tertiary structure of the disulfide cross-link 
mutants. A) Far-UV CD spectra of wild-type BtuB and variants. B) Intrinsic tryptophan emission 
spectra (excitation 280 nm) of BtuB and variants in the absence (solid line) and presence of 8M 
urea (dashes). 
SMFS was performed using the same experimental procedures as for the wild-type BtuB 
receptor with TonBΔTMD(V32C) (Section 2.2.7.3). For the XLbarrel variant, greater than 74 
% of the force-extension profiles analysed contained single rupture events with an FU of 
100 ± 6 pN (Figure 4.14B) at a Lc of 47 ± 2 nm (Figure 4.14A). The Lc value is in accord 
with the distance expected for the rupture of the complex without remodelling (based 
on the length of the first rupture event in the wild-type experiments) while the FU value 
is close to that observed for the dissociation of the minimal Ton BoxBtuB:TonB complex 
observed previously at the same retraction velocity (1 μms-1, 113 ± 13 pN). Addition of 
reductant (2 mM DTT) to the buffer solution during the AFM experiments resulted in the 
reappearance of the double peaked events as observed for the wild-type receptor 
(Figure 4.14C, green and blue histograms and inset) with a modal ΔLc value of 21 ± 4 nm 
(Figure 4.14C grey histogram) and FU = 64 ± 1 and 99 ± 7 pN for the unfolding and 
unbinding forces, respectively) (Figure 4.14D and Table 4.4).  
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Figure 4.14 – SMFS of BtuB XLbarrel bound to vitamin B12 A) Lc distributions of single rupture events 
observed for BtuB XLbarrel:TonBΔTMD in the absence of reductant (inset shows force-extension 
traces) B) The force distribution of the single unbinding events of BtuB XLbarrel:TonBΔTMD. C) After 
the addition of 2 mM DTT, double rupture events resulting from partial unfolding (Lc1, green 
histogram and green force-extension profiles, inset) and unbinding (Lc2, blue histogram and blue 
force-extension profiles, inset) of XLbarrel plug domain from Ton BoxBtuB. When fitted to a 
Gaussian distribution, the ΔLc-frequency histogram (grey bars) for these double events had a 
modal value of 21 ± 4 nm. D) The force distribution of the double unbinding events of BtuB 
XLbarrel:TonBΔTMD in the presence of a reducing agent. Plug unfolding is shown in green and Ton 
boxBtuB unbinding in blue. 
Similar to the wild-type data, force-extension profiles for BtuB XLloop:TonBΔTMD 
dissociation contained a high proportion (94 %) of double peaked events (Figure 4.15A, 
orange and red traces inset). Most importantly, the ΔLc-frequency histogram (Figure 
4.15A, grey histogram) was found to give a significantly shorter modal value relative to 
that for wild-type (14 ± 3 nm and 20 ± 1 nm respectively), confirming unfolding in the N-
terminal portion of the plug domain. Once again, the force extension profiles for BtuB 
XLloop:TonBΔTMD dissociation reverted to wild-type profiles upon the addition of 2 mM 
DTT (ΔLc = 20 ± 1 nm) (Figure 4.15B, grey histogram).  
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Figure 4.15 – SMFS of BtuB XLloop bound to vitamin B12 A) Lc distributions and force-extension 
profiles (inset) for BtuB XLloop:TonBΔTMD in the absence of DTT.  Partial unfolding (Lc1) and 
unbinding (Lc2) are shown in orange and red, respectively, for both histograms and force-
extension profiles. The ΔLc (grey histogram) modal value is shown by the dashed line. B) Lc 
distributions and force-extension profiles (inset) for BtuB XLloop:TonBΔTMD in the presence of 
2mM DTT. Partial unfolding (Lc1) and unbinding (Lc2) are shown in green and blue, respectively, 
for both histograms and force-extension profiles. In the presence of DTT, the ΔLc (grey 
histogram) modal value (20 ± 1) reverts to that of wild-type BtuB (20 ± 2). All data in Figure 4.15 
was collected at 1,000 nms-1. 
The XLPSD variant displayed the same single peaked force-extension AFM profiles (Figure 
4.16A and Table 4.5) as XLbarrel (Figure 4.14A inset) in the absence of reducing agent, 
which suggests that diverting the force propagation network into the stronger plug 
subdomain prevents partial unfolding. Again, the addition of 2 mM DTT restored the 
presence of double rupture events and the ΔLc (20 ± 1 nm) was the same as the wild-
type data. 
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Figure 4.16 - SMFS data of the XLPSD mutant of BtuB with TonBΔTMD. A) Example force-extension 
traces for the XLPSD mutant. The non-specific surface adhesion is coloured in light grey. The bold 
black trace show the WLC fit to the data. B) The ΔLc distribution (pink) of double peak events 
(see inset) upon the addition of reducing agent (2 mM DTT) to the sample. 
Together these data suggest that approximately 50 residues of the plug domain directly 
downstream of the Ton box are denatured before the non-covalent TonB:BtuB complex 
dissociates. The structural consequence of partially unfolding the plug domain, was 
visualised by removing the fifty residues directly downstream of Ton BoxBtuB from the 
crystal structure of BtuB bound to vitamin B12 and TonBCTD (PDB: 2GSK) which resulted 
in a 12.5 × 30.2 Å-wide channel through the receptor (Figure 4.17).  
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Figure 4.17 - Vertical and horizontal surface representation cross-sections of BtuB showing the 
effect of removing 50 amino acids (blue) downstream of the Ton box. The dimensions of the 
resultant channel are shown (PDB: 2GSK). Measurements were made using PyMOL. 
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4.2.6 MD simulations of the TonB: BtuB interaction 
The SMFS results suggest that TonB can remodel approximately half of the plug domain, 
thus creating a channel through the BtuB receptor of sufficient dimensions to allow 
passage of the vitamin B12 substrate (Section 2.2.10). To test the consequence of 
unfolding half of the plug domain and visualise the process, MD simulations were 
performed. The structure of BtuB in complex with TonBCTD (residues 153-233) and 
vitamin B12 (PDB: 2GSK) was inserted into a POPC lipid bilayer and surrounded by a water 
box sufficiently large for the system to be entirely solvated when the Ton box is 
extended up to 20 nm. Using this system, it is possible to determine how much of the 
plug domain can be remodelled by the non-covalent β-strand augmentation between 
the C-terminus of TonB and the Ton box of BtuB, albeit at a much higher loading rate 
(x250,000) than the SMFS experiments. The system was relaxed and equilibrated using 
a step by step method described in Section 2.2.10 for a total time of 15.2 ns, the 
equilibrated system is shown in Figure 4.18A. The positional root mean square deviation 
(RMSD) from the crystal structure plateaus at about 1.2 Å and shows that the system is 
stable and well equilibrated (Figure 4.18B). The positioning of the integral membrane 
protein within the lipid bilayer and the membrane thickness also reached a plateau 
within the initial 15 ns, showing that the system was sufficiently equilibrated (Figure 
4.18C and D). Longer equilibration did not alter the structure further (Figure 4.20C). 
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Figure 4.18 - Molecular dynamics simulation of the TonB:BtuB:vitamin B12 complex. A) The 
equilibrated system of BtuB (blue cartoon) in complex with TonB (pink cartoon) and vitamin B12 
(red spheres) (PDB: 2GSK) in a POPC lipid bilayer (red and white spheres) and a large water box 
(blue surface representation). The Na2+ (purple) and Ca2+ ions (yellow) are shown as coloured 
spheres. B) RMSD of the individual components (labelled) during the equilibration of the system. 
The black arrow indicates when all restraints were removed. C) The average centre of mass 
(COM) difference between BtuB and the POPC lipid bilayer during the equilibration of the system 
(calculated using MD analysis201 and a script provided by Robert Schiffrin, University of Leeds). 
The data indicates that the protein position within the membrane remains constant after 8 ns 
equilibration. D) The average membrane thickness during the equilibration of the system 
(calculated using membrane plugin v1.1189) 
4.2.6.1 Pulling the Ton box of BtuB 
Initially a force ramp was applied to the Ton box (Cα proline 5, BtuB) by retracting a 
harmonic spring at a constant velocity (also called steered MD (SMD)) for 200 Å (Figure 
4.19A and B). The plug domain unfolded sequentially (residues 5-74) and a channel was 
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formed through the receptor (Figure 4.19F). As the weaker subdomain of the plug is in 
contact with vitamin B12, its unfolding could potentially alter the substrate position 
within the binding pocket. However, only a small displacement of 3 Å occurred during 
unfolding of the residues in contact with the substrate before returning to its original 
position (Figure 4.19D). A 20 ns equilibration of the open state also did not change the 
position of the substrate. Remarkably, the mechanically strong plug subdomain and the 
barrel domain did not undergo any conformational change during (Figure 4.19C) and 
after unfolding (Figure 4.19E) of the weak subdomain, despite exposure of hydrophobic 
residues usually buried by the folded weak subdomain. 
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Figure 4.19 – Unfolding half of the plug domain in silico. A) Snapshot after atom P5 Cα (yellow 
sphere) had been extended 200 Å from its initial position using SMD, the membrane and water 
are hidden for clarity. BtuB is shown as a grey cartoon with vitamin B12 shown as red spheres. B) 
Force-extension plot of the Ton box during SMD. C) RMSD of the mechanically strong plug 
subdomain (PSD) and barrel domain of BtuB during the unfolding of the weak plug subdomain. 
D) Distance from the centre of the plug domain (L77) from the cobalt core of vitamin B12 during 
unfolding of the weak plug subdomain. E) Stability of the open state after 200 Å extension of the 
Ton box, showing the RMSD of the strong plug subdomain (PSD) and the barrel domain of BtuB. 
F) Snapshot of BtuB equilibrated in a POPC bilayer (red and white spheres) after 200 Å extension 
of the Ton box by SMD. The weak plug subdomain is shown in blue, the strong sub-domain in 
grey surface representation and vitamin B12 as red spheres. 
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4.2.6.2 Pulling TonB to unfold the plug domain 
To find the extent of plug remodelling by the non-covalent Ton box TonBCTD complex, 
SMD was applied to the centre of mass of TonB (all Cα). The interaction between TonB 
and the Ton box demonstrated outstanding mechanical strength even at the high 
loading rate of the simulation (with compatibly of the current limits on such a large 
system), remaining tightly bound and unfolding 46 residues of the BtuB plug domain (up 
to residue G51, ~130 Å of extension) before dissociation (Figure 4.20A and D). The same 
extent of unfolding as the SMFS experiments was not observed. A longer equilibration 
of the system before SMD was performed to ensure the system was equilibrated, 
however the same amount of unfolding was again observed (Figure 4.20B). To find if the 
vitamin B12 was stabilising residues 47-74 (which it is in contact with) a system was set 
up without the vitamin B12 in the BtuB binding pocket. Again, 46 residues were unfolded 
before the complex dissociated (Figures 4.20B). Comparing the force-extension profiles 
of the SMD from the Ton box and TonB (Figure 4.19B and 4.20B), it is clear that the 
residues left unfolded by the non-covalent complex (residues 47-74) require ~800 pN of 
force to unfold (Figure 4.19B), which the non-covalent interaction can only withstand 
~500-600 pN at the loading rate used (Figure 4.20B). However, despite this, it can be 
concluded that the non-covalent β-strand augmentation does display huge mechanical 
resilience, even at high loading rates. 
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Figure 4.20 – Finding whether TonBCTD can unfold the same extent of plug domain as the SMFS 
experiments. A) SMD snap shots of TonB (pink) unfolding the plug domain of BtuB (barrel 
domain shown as grey transparent cartoon, plug weak subdomain shown in blue, strong plug 
subdomain in grey and vitamin B12 as spheres. The membrane and water is hidden for clarity. 
The extensions are shown. In iii) 46 residues (residues 5-51) have been unfolded by the non-
covalent TonB:Ton box complex. B) Force-extension plots of SMD of the interaction between 
BtuB:vitamin B12 with TonB (red) TonB with a longer equilibration (green) and TonB with apo 
BtuB (blue). When the complex is extended via TonB, the complex breaks apart at 135 Å of 
extension (arrow). C) RMSD of the protein components during a longer equilibration before 
SMD. D) Detail of the BtuB plug domain before (left, zoom of Ai) and after (right, zoom of Aiii) 
SMD was used to extend the non-covalent complex by TonB. Residues 5-74 (the weak plug 
subdomain) are shown in blue.  
4.2.7 Modelling vitamin B12 passage 
The crystal structure of BtuB (PDB: 2GSK) with residues 5-74 removed (residues 5-22 Ton 
box, 23-74 the unfolding domain) shows a clear channel throughout the receptor, and 
the dimensions of the channel appear to be sufficient to accommodate the passage of 
vitamin B12 (Figure 4.17). To find whether vitamin B12 could pass through the channel, an 
equilibrated open state after 200 Å Ton box extension was used (i.e. with residues 5-74 
of the plug domain unfolded). 
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The open state was initially equilibrated for 20 ns before SMD was applied to the centre 
of mass of vitamin B12. The vitamin B12 was tightly bound to the binding pocket, requiring 
400-500 pN of force for displacement (Figure 4.21B). After binding site displacement, 
vitamin B12 began to move rapidly through the channel until roughly midpoint, where it 
briefly stalled at the narrowest point of the channel before continuing to pass through 
the receptor with little resistance. As vitamin B12 moved through BtuB, the RMSD of both 
the barrel domain and the mechanically strong subdomain displayed no significant 
changes (apart from one repeat, where the PSD distorted (Figure 4.21C, red trace)) 
(Figures 4.21C and D). This indicated that by unfolding residues 5-74, the passage of 
vitamin B12 is accommodated without further conformational change of the receptor. 
Mapping the contacts vitamin B12 made with the receptor during translocation, revealed 
that surprisingly few contacts with the strong plug domain were made. Other than the 
initial substrate binding pocket, the major contacts were with the barrel domain at the 
narrowest point of the channel (Figure 4.21E). 
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Figure 4.21 – Simulation of vitamin B12 passage. A) Snapshots as vitamin B12 moves through the 
channel created by 200 Å of extension. The strong plug subdomain is shown as grey surface 
representation; the barrel is shown as transparent cartoon and vitamin B12 as coloured spheres. 
B) Force applied to displace vitamin B12 through the BtuB channel. C) RMSD of the BtuB strong 
plug subdomain (PSD). D) RMSD of the BtuB barrel domain. In B-D, four separate repeats are 
shown. E) The contacts vitamin B12 makes as it passes through the receptor channel (calculated 
by residues within 4 Å of vitamin B12).  
4.2.8 Single-molecule force spectroscopy of the TonBΔTMD:FhuA 
interaction 
TBDTs transport substrates of various size, with vitamin B12 (1.35 kDa) being one of the 
largest substrates. In order to determine whether plug remodelling is a BtuB-specific 
process, and whether the extent of remodelling is dependent on the substrate size, the 
FhuA receptor for ferricrocin/ferrichrome (740.52/773.5 Da respectively) (Figure 4.22) 
was studied by SMFS.  
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Figure 4.22 – Comparison of TBDT substrate size. The structure of ferricrocin-iron is shown as 
blue spheres (with N in navy and O in red) and vitamin B12 is shown as green spheres with N and 
O navy and red respectively. The structures are from the TBDT bound states of FhuA and BtuB 
(PBD: 2GRX and 2GSK respectively). 
Using the experimental method for BtuB and its variants, FhuA (cloned, expressed and 
purified as described in Section 4.2.1 and Section 4.2.2.2) proteoliposomes (formed 
using the method described in Section 2.2.8) were immobilised onto a mica surface and 
an AFM probe covalently attached to TonBΔTMD(V32C) was used. As observed for BtuB, 
two rupture events were detected (74 ± 11 and 105 ± 24 pN at a distance of 62 ± 4 and 
85 ± 9 nm), Figure 4.23A) but were separated by a larger change in contour length (ΔLc 
= 25 ± 1 nm) (Table 4.6 and Figure 4.23B), corresponding to the removal of 63 residues 
(residues 20-83)(Figure 4.23B inset). The plug domain (residues 18-160) of FhuA is larger 
than BtuB (residues 17-136), despite the cargo being smaller. In this case, while 
remodelling results in the formation of a channel throughout the receptor, its 
dimensions are slightly smaller (14 X 22 Å) reflecting the smaller size of its cargo (Figure 
4.24). 
 
 
 
 152 
 
 
Figure 4.23 - SMFS of the FhuA:TonBΔTMD interaction in the presence of ferrichrome. A) Examples 
of the double rupture events with the WLC fit (black) B) Lc1 (green), Lc2 (blue) and ΔLc (red) 
distributions of the double rupture peaks with Gaussian fits; the inset shows a secondary 
structure schemetic of the FhuA plug domain with the residues unfolded (inferred from the ΔLc 
value) shown in blue, TonB in pink, the Ton box in green and the ferricrocin substrate in red. C) 
Force-distribution of the double rupture events, with the plug unfolding in green and TonB 
unbinding from the Ton BoxFhuA in blue. 
 
 
Figure 4.24 – Removal of the unfolding region from the crystal structure of FhuA. A) Surface 
representation of vertical and horizontal cross-sections of FhuA (PDB: 2GRX) showing the effect 
of removing 62 amino acids (blue) downstream of the Ton box. The dimensions of the resultant 
channel are shown. B) Surface representation of the plug domain of FhuA, coloured blue are the 
residues that are unfolded (inferred from the ΔLc value).  
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4.3 Discussion 
When the first crystal structure of a TBDT revealed that the lumen of the barrel was 
completely occluded by a globular plug domain126, it became obvious that in order for 
the substrate to be transported across the receptor, the plug domain would have to 
undergo conformational change to allow substrate passage. The SMFS data presented 
in Chapter 3 and Chapter 4 has demonstrated that the intermolecular interaction 
between TonB and the Ton box of BtuB is stronger than intra-molecular interactions 
within the plug domain. This allows mechanical unfolding of the globular plug domain 
of both BtuB and FhuA before its dissociation under mechanical force in vitro. The extent 
of plug remodelling appears to be highly controlled and is determined by the cargo the 
receptor has evolved to transport. For both receptors, the plug domain can be regarded 
as comprising a mechanically weak channel forming subdomain, and a mechanically 
strong subdomain used both for allosteric signalling202 and to limit the size of the 
channel to allow passage of molecules no larger than its cargo. The strong plug sub-
domain identified in this study is likely structurally supported (to prevent dislodging) by 
the conserved latch and β-cantilever domains identified129 (Figure 1.13 and Figure 1.14). 
It was surprising that the open conformation of BtuB created by steered molecular 
dynamics was stable and did not undergo further conformational change despite 
exposing the core of the folded domain. This strongly suggests that the plug domain has 
evolved to perform this function, which is also evident from the highly solvated plug-
barrel interface in the crystal structures of TBDTs (Figure 1.13). 
Interestingly, the mechanically weak subdomains of BtuB (Figure 4.17) and FhuA (Figure 
4.24) also both make direct contact to their ligands. As these subdomains are 
presumably pulled into the periplasmic space during ligand transport, it is plausible that 
in vivo the substrate is dragged through the receptor. Ligand-plug contacts are also 
present in the substrate-bound crystal structures of FecA203, HasR204, FpvA205 and 
FptA205 , therefore this could represent a universal feature of TBDTs. The fact that such 
a mechanism was not observed in the MD simulations of BtuB remodelling (Figure 
4.19D) could be due to the high pulling velocity used. 
The direct identification of two distinct subdomains in the luminal plugs of FhuA and 
BtuB rationalise a wealth of previous observations from mutational and cross-linking 
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studies. For example, the first 51 residues of the FepA plug domain were found to be 
more susceptible  to labelling relative to residues 91–142206, while the introduction of 
cross-links between the N- or C-terminal portions of the FhuA plug to the barrel were 
found to prevent or support ferrichrome transport respectively207,208. A lack of plug 
domain co-operativity has also been observed in vitro: EPR and trypsin cleavage have 
shown that the N-terminal regions of the BtuB and FhuA plug domains (respectively) 
unfold in the presence of 4 M urea209,210 and that for BtuB, the unfolded sub-domain 
rapidly refolds upon removal of the denaturant209. Finally, previous AFM studies which 
investigated the mechanical unfolding pathway of the barrel of FhuA (by adsorbing FhuA 
to the AFM tip in a non-specific manner in the absence of TonB) showed that the plug 
domain unfolded in two steps (residues 1 to 91, FU= ~50 pN and residues 92-161, FU = 
163 ± 50 pN at a retraction velocity of 2200 nms-1)178. 
In the next chapter, the work in the current chapter will be supported by an in vivo 
uptake assay to find the effects of preventing the weak plug subdomain from unfolding 
using disulfide cross-linking. The effect of destabilising the stronger plug subdomain by 
removal of the hydrophobic core (hence entire plug unfolding) will also be explored both 
in vitro and in vivo.  
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5 Testing the physiological role of partial plug domain 
unfolding in BtuB 
5.1 Objectives 
The SMFS experiments have shown that TonB can partially remodel half of the plug 
domain of both BtuB and FhuA under mechanical extension. To test whether preventing 
unfolding in BtuB prevents vitamin B12 uptake in vivo, an assay using E. coli cells which 
require vitamin B12 to proliferate in minimal medium is used. Conversely, to examine the 
effect of entire plug unfolding, a construct of BtuB was engineered in which the plug 
domain is significantly destabilised. This construct was then used in an antibiotic 
sensitivity assay in vivo, and the consequences of entire plug unfolding explored.  
5.2 Results 
5.2.1 Vitamin B12 uptake assay 
Several of the residues in the mechanically weak plug sub-domains of both BtuB and 
FhuA directly contact the cargo at the extra-cellular surface suggesting that the resulting 
channel is the likely route for cell entry. To assess the consequence of preventing 
channel formation in vivo, or of diverting the force propagation pathway to the strong 
plug subdomain, the growth phenotypes of the E. coli strain RK5016 expressing wild-
type BtuB or its cross-linked variants in the presence of different concentrations of 
vitamin B12 was examined (Section 2.2.5.2).  
In E. coli there are two methionine synthases, MetE (vitamin B12-independent 
methionine synthase) and MetH (vitamin B12-dependent methionine synthase). It is 
advantageous for E. coli to use MetH if vitamin B12 is present as the turnover rate is 100 
times greater than MetE146. When metE strains of E. coli are grown in the absence of 
methionine, vitamin B12 becomes a nutritional requirement for growth. Therefore metE 
strains grown in Davis minimal medium (Section 2.2.5.1) with stringent concentrations 
of vitamin B12 (0.1-1 nM) require a functional BtuB for growth, demonstrated in Figure 
5.1.  
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Figure 5.1 – metE strains of E. coli (RK5016) require BtuB (pAG1) for growth in the absence of 
methionine.  
E. coli RK5016 transformed with wild-type BtuB, the cross-link variants or L8P (Figure 
5.2A) under the control of a native promoter (pAG1)79 were grown on Davis minimal 
medium agar plates supplemented with various concentrations of vitamin B12 (0.1-100 
nM) or methionine (5 µg/mL) (Section 2.2.5.2) and the growth phenotype was assessed 
by comparing colony size after 48 hour incubation at 37 ˚C.  
Full growth on vitamin B12 supplemented plates (thus fully functional BtuB) resulted in 
colonies similar in size to those in the presence of methionine (2 mm diameter) (Figure 
5.2B). Under stringent conditions of vitamin B12 (0.1-1 nm), full growth was observed for 
wild-type and XLloop BtuB (Figure 5.2C), whilst reduced growth was observed at all 
vitamin B12 concentrations for BtuB XLbarrel and XLPSD. The phenotypes of these variants 
concur that application of force (via TonB) unravels the mechanically weak plug sub-
domain from the N-terminus to create a channel for substrate transport. Diverting the 
propagated force to the mechanically strong plug subdomain or the barrel domain 
prevents transport of vitamin B12, in agreement with the findings of Chapter 4. 
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Figure 5.2 – Vitamin B12 uptake assay. A) Cartoon schematics of the BtuB mutants, disulfide 
bridges are shown by yellow circles with a red bridge, the L8P mutant is shown by the green 
circle. The mechanically weak plug subdomain is shown in blue, TonB in pink and the Ton box in 
green. B) Photographs of E. coli RK5016 BtuB XLPSD colonies on agar plates supplemented with 
stringent vitamin B12 or methionine (labelled). The reduced growth (+) phenotype after 48 hours 
incubation is exemplified by the vitamin B12 plate, and full growth (++) on the methionine plate. 
C) Growth of E. coli RK5016 transformed with BtuB variants after 48 hours incubation on Davis 
minimal agar supplemented with 0.1 – 100 nM vitamin B12 or 5 µg/mL methionine. – indicates 
no observable colonies, + indicates partial growth (small colonies) and ++ indicates full growth 
(2 mm colonies). 
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5.2.2 Destabilising the mechanically strong plug subdomain of BtuB 
To find the consequence of entire plug unfolding in vivo, the hydrophobic core of the 
strong plug subdomain (residues 73-136) of BtuB was located using the high resolution 
crystal structure of BtuB in complex with TonB (Figure 5.3). Site-directed mutagenesis 
was used to engineer a variant with a weakened strong subdomain (Section 2.2.1.6 and 
Table 2.1).  
 
Figure 5.3 – The hydrophobic core of the BtuB strong plug subdomain  (grey) with the residues 
that form the core shown as spheres (labelled).The weak plug subdomain is shown in blue, whilst 
the barrel domain is transparent. TonB and vitamin B12 are hidden for clarity. (PDB: 2GSK). 
Two mutants were created: BtuB(I80A/L85A/L96A) (designated BtuB3A) and 
BtuB(I80A/L85A/L96A/I129A) (designated BtuB4A) into the pNGH15 plasmid (Section 
2.1.16). Once the mutants were confirmed by DNA sequencing, the BtuB variants were 
expressed and purified using the same method as for the wild-type receptor (Section 
2.2.2.6). The yield of protein from the BtuB4A mutant was less than BtuB3A (Figure 5.4A), 
implying that this mutant was preventing correct folding into the OM to some extent.  
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Figure 5.4 – Purification of the weakened plug mutants of BtuB. A) Anion exchange 
chromatography of BtuB3A (green) and BtuB4A(blue) using a HiTrap DEAE FF 5 mL column, the 
peak at 115 mL (peak 2) is the elution of the BtuB variants from the column. B) SDS-PAGE of the 
BtuB elution peaks from anion exchange. The black arrow shows the expected band from the 
Mw of BtuB. 
After purification, far-UV CD and intrinsic tryptophan fluorescence spectroscopy 
(Sections 2.2.6.1 and 2.2.6.2 respectively) were performed to confirm that the purified 
proteins were correctly folded into detergent by comparison to the wild-type receptor 
(Figure 5.5).  
 
Figure 5.5 – Spectroscopic analysis of the protein fold of the weakened plug mutants. A) Far-UV 
CD spectra of BtuB mutants and wild-type. B) Intrinsic tryptophan fluorescence in the absence 
(lines) and presence of 8 M urea (dashes) of BtuB mutants and wild-type. 
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The variants were then inserted into proteoliposomes using the method described in 
Section 2.2.8. However, the BtuB4A variant formed a precipitate during dialysis; 
therefore only the BtuB3A variant was taken forward for analysis by SMFS. 
5.2.3 SMFS of the destabilised plug 
Once BtuB3A had been inserted into proteoliposomes, it was immobilised onto a mica 
surface (Section 2.2.8) and SMFS was carried out using an AFM probe covalently 
attached to TonBΔTMD and the same experimental method for wild-type BtuB and 
disulfide mutants (Section 2.2.7.3). By contrast to wild-type FhuA, BtuB and the other 
variants studied, the force-extension profiles for BtuB3A displayed three rupture events 
(Figure 5.6A and Table 5.1). The increase in contour length between the first and second 
rupture event (ΔLc1 = 19 ± 4 nm) was similar to that found for wild-type BtuB: TonBΔTMD 
(ΔLc = 20 ± 1 nm) identifying this event as the unfolding of the mechanically weak 
subdomain. If the additional rupture event (FU = 94 ± 9 pN) observed for BtuB3A was due 
to the unfolding of the remaining 64 plug residues of the strong plug subdomain, the 
second ΔLc would be expected to be 25 nm, which was in good agreement with the 
measured value (ΔLc2  = 26 ± 3 nm) (Figure 5.6B). The difference in contour length 
between the first and last event (total ΔLc = 41 ± 7 nm) is equivalent to the unfolding of 
103 ± 18 residues, also in good agreement with the number of plug residues in BtuB (114 
(residues 22-136), Figure 5.6B inset).  
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Figure 5.6 - Removal of the hydrophobic core from the mechanically strong plug subdomain 
leads to complete unfolding of the plug domain in vitro. A) Force extension profiles for 
BtuB3A:vitamin B12:TonBΔTMD display triple rupture events.  Each event is fit to the WLC model 
(black).  Data were obtained at a retraction velocity of 1,000 nms-1. B) ΔLc frequency histograms 
for the difference in Lc between the first and second event (ΔLc1, blue histogram), the second 
and third event (ΔLc2, green histogram) and the first and third event (ΔLcTot, pink histogram) 
(see top inset). As the length of an amino-acid is 0.4 nm, these data can be used to calculate the 
number of amino-acids unfolded at each event, allowing the unfolding events to be mapped 
onto the secondary structure schematic (bottom inset: residues unfolded at the first and second  
rupture events coloured blue and green, respectively. Yellow dots represent the location of each 
alanine mutation). C) Force frequency histogram for each of the three rupture peaks. Modal 
values (pN) are shown. 
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5.2.4 Bacitracin sensitivity assay 
To find whether TonB can completely unfold the destabilised plug domain in vivo, an 
antibiotic sensitivity screen was performed (See Section 2.2.5.3) using bacitracin, a large 
(1.4 kDa) inhibitor of cell wall synthesis211. As the OM provides a natural barrier to this 
large antibiotic, E. coli are usually unaffected by its presence unless used at high 
concentrations (200 µg/mL)211. Sensitivity to bacitracin has been shown to increase if 
the integrity of the OM is compromised by addition of polymyxin B212 or by the 
expression of a TBDT with a deleted plug domain (FhuAΔ5-160)213. Accordingly, the 
growth of E. coli RK5016 expressing wild-type BtuB in LB medium containing various 
concentrations of bacitracin was unaffected until concentration of 200 μg/mL bacitracin 
was used (Figure 5.7A). The same strain expressing BtuB3A exhibited reduced growth at 
concentrations equal or greater than 100 µg/mL bacitracin, showing an increased 
accessibility of bacitracin to the periplasm (Figure 5.7B), suggesting that complete plug 
unfolding occurs in the BtuB3A variant. 
 
Figure 5.7 - Bacitracin sensitivity assay. RK5016 cells transformed with wild-type BtuB (A) or 
BtuB3A (B) under a native promoter (pAG1) were used to inoculate LB medium supplemented 
with various concentrations of bacitracin. The OD600 was monitored over 24 hours, the data 
shows the average of triplicate growth curves. 
The increase in bacitracin sensitivity provides evidence that destabilising the 
mechanically strong subdomain results in an increase BtuB channel size but cannot 
preclude the possibility that this phenotype is independent of TonB activity. To obviate 
the possibility that the increase in bacitracin sensitivity was due to the inability of BtuB3A 
to form a natively folded plug domain during OM insertion, 200 µg/mL of Ton box 
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pentapeptide (ETVIV) was added to the growth medium to prevent TonB-dependent 
activity81. By preventing TonB-dependent activity, the BtuB3A variant growth phenotype 
was restored to a similar level as the wild-type receptor under the same conditions 
(Figure 5.8).  
 
Figure 5.8 - Bacitracin sensitivity assay of RK5016 E. coli expressing wild-type BtuB (grey), BtuB3A 
(pink), and wild-type BtuB and BtuB3A in the presence of 200 μg/mL Ton box pentapeptide (blue 
and green respectively). The maximum optical density at 600 nm over a 24 hour growth is 
shown; the error bars show the standard deviation of triplicate growths.  
These results suggest that BtuB3A is able to form a native-like plug domain in vivo as 
preventing TonB activity reduces the sensitivity to the antibiotic. It is worth noting that 
the presence of the Ton box pentapeptide slightly increases the growth of cells 
expressing the wild-type BtuB receptor, therefore whether the peptide is elicting a 
stress response is inconclusive. The differential sensitivity to bacitracin of wild-type and 
BtuB3A in the presence and absence of Ton box pentapeptide accords with the in vitro 
AFM findings above, suggesting that in vivo, TonB drives partial (wild-type BtuB) or 
complete unfolding of the plug (BtuB3A) before complex dissociation. 
5.3 Discussion 
Here, the in vitro SMFS findings of Chapter 4 are fully supported by an in vivo vitamin 
B12 uptake assay, where the mechanically weak plug subdomain identified in Chapter 4 
is cross-linked to the strong plug subdomain or barrel domain to prevent unfolding. By 
preventing unfolding of this weak subdomain, vitamin B12 uptake is reduced/prevented, 
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which strongly suggests that this region of the plug domain requires unfolding for 
substrate transport. Removal of the hydrophobic core of the strong plug subdomain 
allows complete unfolding in a TonB-dependent manner, allowing the free diffusion of 
large antibiotics such as bacitracin into the periplasmic space.  This observation, taken 
with others145,206,209,210, suggests that TBDTs have evolved to minimise the deleterious 
effect of compromising its outermost barrier by allowing the remodelling of the fewest 
residues required for transit of their cargo. 
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6 Conclusions and future directions 
Membrane proteins are the gatekeepers of cellular compartments and are therefore 
vital for the transduction of messages across the membrane. By necessity, membrane 
proteins that transport cargo into or out of compartments introduce “holes” into the 
membrane barrier. As these pores can be deleterious to the organism (by allowing the 
entry / exit of toxins/ions/metabolites) their formation and deformation are closely 
regulated (gated) by a variety of mechanisms. The potential of mechanical deformation 
to gate membrane proteins is currently highly topical due to its attractiveness as a 
conceptually simple method to transduce signals across membranes. Several mechano-
sensitive networks in Eukayotic cells have been identified with functions as diverse as 
adhesive GPCR activation214, Notch and E-cadherin signalling215 and activation of 
transmembrane channel–like 1 and 2 by the tip link of stereocilia216. However, the 
molecular mechanism of how force is used to gate proteins is only now beginning to be 
understood. 
Membrane protein transporters can be mechanically gated by either the application of 
a remodelling force by the lipid bilayer in which the protein resides (force-from-lipid 
principle), or by application of a remodelling force pulling on tethers on the membrane 
protein by another protein in the transduction cascade. While equally plausible, the 
evidence for each mechanism contrasts remarkably. The force from lipid principle was 
originally demonstrated using MscL/S from E. coli 25 years ago and has recently been 
shown for the Eukaryotic TRAAK and TREK1 K+ potassium channels217. By comparison, 
while potential tethers for membrane transporters have been identified and their 
importance to mechano-transduction confirmed218, there is no direct evidence for the 
ability of one protein to gate a membrane protein. This lack of evidence has been 
highlighted in a review of mechano-transduction in membrane systems219. The strongest 
evidence for tethered gating was recently reported by Zhang et al. who used patches 
excised from cells and deletion studies in vivo to show mechano-gating in the Drosophila 
cation TRP channel NompC218. NompC contains a cytoplasmic ankyrin repeat tether 
domain which was shown to interact with the microtubule cytoskeleton and was 
absolutely essential for NompC activation. While this provides indirect evidence for 
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tethered gating, it does not describe a molecular mechanism between two protein 
partners. 
In this thesis, the channel of a purified membrane protein (BtuB), reconstituted into a 
synthetic liposome has been shown to be gated by the application of force onto the plug 
domain that blocks the channel. Importantly, in these in vitro experiments, the force is 
directly applied onto the plug domain via its known binding partner in vivo, TonB. The 
use of an antibiotic sensitivity assay in combination with a BtuB variant engineered to 
have a weakened plug domain has shown that this interaction also drives remodelling 
in vivo. The in vitro and in vivo data shows for the first time that a non-covalent 
interaction can mediate the gating of a membrane protein, giving experimental 
credence to a long held theory. 
The potential of using the pmf across the inner membrane to drive processes at the 
outer membrane (inside-out energy transduction) is conceptually attractive. However 
despite models to explain colicin import220, TonB-dependent import of nutrients87, and 
the Tol-Pal complex for OM integrity and invagination during cell division221, there has 
been no direct evidence that a non-covalent protein complex could withstand the 
effects of force long enough to drive the remodelling required. Therefore, alongside 
describing the molecular mechanism for TonB-dependent transport, the work of this 
thesis also provides strong evidence supporting the feasibility of periplasmic inside-out 
energy transduction for other related systems. 
6.1 Open questions and future directions 
The major miles stones of understanding TonB-dependent transport over the last half-
century are summarised in Figure 6.1 (reviewed in detail in Chapter 1), which 
demonstrates advances in biochemistry, microbiology, DNA sequencing, X-ray 
crystallography and spectroscopy are continually opening new exciting discoveries and 
theories in the field. The entire story is still far from complete; discovery only opens new 
questions and long standing questions still remain unanswered, some of which will be 
discussed.  
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Figure 6.1 – Timeline of the major advances (black) and theories (red) for research into the TonB-
dependent transport system. 
1) How does TonB apply a pulling force in vivo?  
For TonB-dependent transport to function in vivo, it requires i) the pmf ii) an intact TonB 
C-terminal domain and transmembrane domain (conserved residues Ser16 and His20 
spaced apart by three amino acids) and iii) the inner membrane proteins ExbB and ExbD. 
There are passive ways in which TonB could assert a force onto the plug domain of the 
receptor, such as variations in the width of the periplasmic space198 and /or the 
differential diffusion of the inner and outer membrane proteins222. In these cases, TonB 
would act as an anchor to the exposed Ton box tether, leaving the functional roles of 
ExbBD and the pmf unclear. Active models which include ExbBD and the pmf in the 
functional process could include a conformational change within the TonB proline-rich 
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linker domain in an ExbBD/pmf dependent manner as discussed in Chapter 3 (Section 
3.3.2). TonB has recently been shown to rapidly rotate which is ExbBD/pmf dependent143 
and could apply torque to the TonB:TBDT complex that could possibly induce changes 
in the proline-rich linker domain. It has previously been suggested that torque could 
destabilise the PPII helix into a PPI helix, driving a 40 % collapse of the domain100 which 
would facilitate a pulling force. The formation of a proteinase K-resistant TonB 
conformation has been shown to only occur when ExbBD and the pmf is available and 
the TM domain of TonB is intact139. This distinct energised conformation could represent 
a pulling conformation or an on-state, such as the electrostatic hinge or the collapsed 
PPI helix. The role of TonB dimerisation (addressed in question 4) could also play a role 
in the regulation of the transport cycle. 
2) What are the roles of ExbB and ExbD in the transport cycle?  
Our current understanding of ExbB and ExbD is limited. With sequence homology to the 
Mot flagella stator proteins, the notion of ExbBD acting as a motor to rotate TonB has 
long been a concept, with recent supporting evidence143. Structural evidence has shown 
that the stator protein TolR (homologous to ExbD) exists in two conformations (closed 
and open) that are likely driven by the pmf223. In the closed state, TolR closely associates 
with the IM, however upon activation by the pmf, a large conformational change 
disorders ~25 amino acids that allow the C-terminus of TolR to cross the periplasm and 
associate with the peptidoglycan (PG). A similar role for ExbD could be present, in that 
the pmf activates ExbD’s periplasmic domain where it can then interact with TonB107 
and possibly facilitate a conformational change within the linker domain of TonB that 
applies the pulling force to the Ton box tether (Figure 6.2). It is also possible that upon 
Ton box binding, an allosteric change within TonB activates ExbD, where the periplasmic 
domain is released into the periplasm, opening the channel for proton influx (as 
proposed for TolR223). 
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Figure 6.2 – Potential role of the periplasmic domain of ExbD. Upon TonB association with the 
Ton box, ExbD is activated by the pmf, which causes release of its periplasmic domain. This 
domain can then associate with the proline-rich region of TonB (pink box). This interaction could 
drive a conformational change which applies a pulling force to the plug domain of the receptor.  
As TonB requires to be firmly anchored to the IM to prevent dislodging of the single TM 
domain under force, it is quite likely that ExbB (the scaffold element) prevents this (TM 
interactions between ExbB and TonB have been shown). The bulk of ExbB is predicted 
to be located in the cytoplasm, which has no known function. It would be interesting to 
investigate whether this region interacts with the bacterial cytoskeleton (MreB) as a 
related system in M. xanthus uses IM proteins (AglR/AglS) and a cytosolic track provided 
by MreB to generate the force for gliding motility224. A similar function could exist for 
ExbB/D (Figure 6.3), because OMPs have restricted mobility (due to residing in OMP 
islands40) the TonB-dependent receptor will be laterally immobilised. Therefore the 
lateral movement of the TonB:ExbBD complex energetically driven by ExbD (utilising the 
pmf) moving ExbB along the track provided by MreB and would apply force onto the 
plug domain. To test this theory directly, a MreB polymerisation inhibitor could be used 
in combination with a colicin/phage sensitivity assay to detect for changes in TonB-
dependent activity.  
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Figure 6.3 – Theoretical role for ExbBD based on the related AlgRS system for bacterial gliding 
motility in M. xanthus. The bulk of ExbB is located in the cytoplasm, where it could interact with 
the bacterial cytoskeleton (MreB (green circles)). Upon TonB association with the Ton box, ExbD 
uses the pmf to power the lateral movement of ExbB along the MreB track, driving a pulling 
force to the plug domain of a TBDT (BtuB shown). The TBDT cannot move laterally due to its 
restriction within an OMP island.  
3) Do the TonB PE/PK repeats have a functional role?  
The PE/PK rich region of the linker domain has had little known function since its initial 
discovery. The findings of this thesis could hint towards a possible hinge conformation 
which could potentially drive a pulling force by withdrawing the C-terminal domain of 
TonB by up to 28 nm. What is really interesting is that this withdrawal distance is within 
the range of protein unfolded in both BtuB (20 nm) and FhuA (25 nm) to create a 
substrate channel through the receptor. Mutagenesis and cross-linking within the PE/PK 
region would provide valuable insight to whether this conformation is significant or not 
to TonB function. How the hinge recycles between open and closed states remains 
uncertain, however this could be regulated by either the ExbD periplasmic domain 
(shown to weakly interact with the PE repeats by NMR117), or the formation of TonB 
homodimers by the hinge region (Figure 6.4), or even the torque applied to TonB by the 
ExbBD complex. The fact that TonB-dependent activity was observed in TonB(Δ66-100) 
in vivo99, reduces the functional relevance of the hinge, however, the notion of being a 
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length adaptor to compensate for changes in the periplasmic width is equally plausible 
(see Section 3.3.2). 
4) Possible functional role for TonB dimerisation?  
The current evidence from previous work and this thesis suggests that TonB 
homodimers are likely formed by the PE/PK regions (residues 60-110), and could 
represent an extended off-state during the transport cycle (Figure 6.4). One could 
speculate that in the dimeric form, TonB does not form the electrostatic hinge and is 
fully extended allowing TonB to reach the OM. Upon binding of the Ton box, TonB then 
monomerises (perhaps in an ExbD-dependent fashion), where the electrostatic hinge is 
formed and the linker domain collapses into a PPII helix causing the retraction of the C-
terminal domain and subsequent unfolding of the plug domain (Figure 6.4). However it 
is worth noting that analysis of the stoichiometry of the TonB:ExbBD complex has never 
shown more than one copy of TonB per complex (Section 1.4.4), therefore whether 
multiple complexes form in vivo will require further assessment.  
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Figure 6.4 – Speculative model of the TonB homodimer function in vivo. In the off-state, TonB 
exist as a homodimer driven by the PE/PK repeat motifs (pink box), the separate C-terminal 
domains search for an exposed Ton box. Upon binding of the Ton box, the homodimer breaks 
apart (possibly facilitated by the periplasmic domain of ExbD). The monomeric TonB then forms 
the electrostatic hinge and a continuous PPII helix (on-state), retracting whilst still in contact 
with the Ton box, which drives the unfolding of the plug domain. 
5) What role does peptidoglycan play?  
Often overlooked, the PG sacculus is thought to play a key role in other periplasmic 
machinery such as the Tol and Mot systems involved in outer-membrane integrity and 
flagella rotation respectively. Truncated dimeric TonBCTD was shown to weakly interact 
with PG; similarly TolR (homologous to ExbD) has also been shown to only interact with 
PG in a dimeric form. However it is not entirely clear whether these interactions are an 
artefact of construct size and exist in vivo. The sequence of TonB was found to contain 
the lysin (LysM) PG-binding motif141, but only when TonBCTD existed as an intertwined 
dimer. The authors suggested that as this motif is away from the Ton box binding site it 
could function to allow TonB to weakly associate with the PG when scanning for an 
exposed Ton box. Further studies will be required to elucidate whether the PG 
interaction is present in longer constructs of TonB, and whether dimeric TonBΔTMD is 
preferential over monomeric forms. Interactions of the periplasmic domain of ExbD with 
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PG are also likely due to its homology to TolR. Whether or not ExbD anchors the TonB-
ExbBD complex to PG during the transport cycle (acting as a stator for TonB rotation) is 
still unknown. 
6) Is plug domain remodelling different for colicins? 
An interesting question to address is whether the plug remodelling for colicins is 
different in comparison to the natural substrate. A good example of this is demonstrated 
by the pectocin M2 toxin (active against the phytopathogens Pectobacterium), which 
unlike other colicins does not contain an intrinsically unstructured translocation domain 
(IUTD). The lack of an IUTD implies that the pectocins cannot make direct contact with 
the Tol or Ton complexes in the periplasm and as a result they are unable to utilise the 
pmf for translocation. Therefore in order to gain access to the cell interior, the pectocin 
exploits the ferredoxin domain it is coupled to. However the folded ferredoxin (a 30 kDa 
globular protein, with dimensions 30 x 30 Å) would require dislodgement of the entire 
plug domain of a TonB-dependent transporter in order to transport this large 
substrate225. It would be interesting to find whether the ferredoxin receptors of 
Pectobacterium have complete plug domain unfolding in comparison to the receptors 
from E. coli studied in this thesis.  
7) What happens to the unfolded domain during periplasmic exposure? 
Another interesting question to address would be whether periplasmic chaperones 
(such as Skp and SurA) are involved in the TonB-dependent transport process, as ≥ 50 
amino acids from the TBDT are exposed upon substrate transport. Skp has been shown 
to envelope unfolded OMPs in the periplasmic space (Section 1.2.2), therefore Skp 
sequestering the unfolded plug domain of a TBDT during transport is conceivable. Other 
periplasmic chaperones may also aid the refolding of the weak plug subdomain. The plug 
domain could also contain binding motifs for the recruitment of the periplasmic 
substrate binding proteins such as BtuF (Figure 1.20). 
6.2 Final remarks 
The work of this thesis rationalises a large volume of previous observations (Figure 6.1) 
into a detailed molecular mechanism. The previous section highlights the vast effort still 
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required to fully understand this complex and interesting system. The next desirable 
advance will be a high-resolution structure of the entire TonB-ExbBD complex, as with 
all molecular systems, atomic structures always lead to rapid progress in understanding 
of function. The isolation of the intact complex (TonB1-ExbB4-ExbD1) in detergent has 
recently been demonstrated226 and with constant advances in structural determination 
techniques, and in particular cubic lipid phase crystallography and cryo-electron 
microscopy, it is only a matter of time before this major accomplishment will be 
achieved.  
With the world on the verge of a post-antibiotic era, reversing decades of medical 
progress, the time to resolve the mechanisms of vital molecular machinery governing 
bacterial survival and virulence could not be more urgent. Over the past 40 years, 
technology to study life in atomic detail has progressed tremendously. Undoubtedly, 
over forthcoming years our knowledge of cellular machinery will be ever more detailed 
with the ultimate goal of developing novel antibiotic therapy to literally put a spanner 
in the works.  
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7 Appendix 
7.1 Protein and peptide sequences 
TonBΔTMD (V32C) 
MHHHHHHGCHQVIELPAPAQPISVTMVTPADLEPPQAVQPPPEPVVEPEPEPEPIPEPPKEAPVV
IEKPKPKPKPKPKPVKKVQEQPKRDVKPVESRPASPFENTAPARPTSSTATAATSKPVTSVASGPRA
LSRNQPQYPARAQALRIEGQVKVKFDVTPDGRVDNVQILSAKPANMFEREVKNAMRRWRYEPG
KPGSGIVVNILFKINGTTEIQ 
TonBCTD (K144C) 
MHHHHHHGCPVTSVASGPRALSRNQPQYPARAQALRIEGQVKVKFDVTPDGRVDNVQILSAKP
ANMFEREVKNAMRRWRYEPGKPGSGIVVNILFKINGTTEIQ 
TonBΔTMD 
MHHHHHHGHQVIELPAPAQPISVTMVTPADLEPPQAVQPPPEPVVEPEPEPEPIPEPPKEAPVVIE
KPKPKPKPKPKPVKKVQEQPKRDVKPVESRPASPFENTAPARPTSSTATAATSKPVTSVASGPRALS
RNQPQYPARAQALRIEGQVKVKFDVTPDGRVDNVQILSAKPANMFEREVKNAMRRWRYEPGKP
GSGIVVNILFKINGTTEIQ 
TonBCTD 
MHHHHHHGPVTSVASGPRALSRNQPQYPARAQALRIEGQVKVKFDVTPDGRVDNVQILSAKPA
NMFEREVKNAMRRWRYEPGKPGSGIVVNILFKINGTTEIQ 
BtuB 
MIKKASLLTACSVTAFSAWAQDTSPDTLVVTANRFEQPRSTVLAPTTVVTRQDIDRWQSTSVNDV
LRRLPGVDITQNGGSGQLSSIFIRGTNASHVLVLIDGVRLNLAGVSGSADLSQFPIALVQRVEYIRGP
RSAVYGSDAIGGVVNIITTRDEPGTEISAGWGSNSYQNYDVSTQQQLGDKTRVTLLGDYAHTHGY
DVVAYGNTGTQAQTDNDGFLSKTLYGALEHNFTDAWSGFVRGYGYDNRTNYDAYYSPGSPLLDT
RKLYSQSWDAGLRYNGELIKSQLITSYSHSKDYNYDPHYGRYDSSATLDEMKQYTVQWANNVIVG
HGSIGAGVDWQKQTTTPGTGYVEDGYDQRNTGIYLTGLQQVGDFTFEGAARSDDNSQFGRHGT
WQTSAGWEFIEGYRFIASYGTSYKAPNLGQLYGFYGNPNLDPEKSKQWEGAFEGLTAGVNWRIS
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GYRNDVSDLIDYDDHTLKYYNEGKARIKGVEATANFDTGPLTHTVSYDYVDARNAITDTPLLRRAK
QQVKYQLDWQLYDFDWGITYQYLGTRYDKDYSSYPYQTVKMGGVSLWDLAVAYPVTSHLTVRG
KIANLFDKDYETVYGYQTAGREYTLSGSYTF 
FhuA 
MARSKTAQPKHSLRKIAVVVATAVSGMSVYAQAAVEPKEDTITVTAAPAPQESAWGPAATIAAR
QSATGTKTDTPIQKVPQSISVVTAEEMALHQPKSVKEALSYTPGVSVGTRGASNTYDHLIIRGFAAE
GQSQNNYLNGLKLQGNFYNDAVIDPYMLERAEIMRGPVSVLYGKSSPGGLLNMVSKRPTTEPLKE
VQFKAGTDSLFQTGFDFSDSLDDDGVYSYRLTGLARSANAQQKGSEEQRYAIAPAFTWRPDDKTN
FTFLSYFQNEPETGYYGWLPKEGTVEPLPNGKRLPTDFNEGAKNNTYSRNEKMVGYSFDHEFNDT
FTVRQNLRFAENKTSQNSVYGYGVCSDPANAYSKQCAALAPADKGHYLARKYVVDDEKLQNFSV
DTQLQSKFATGDIDHTLLTGVDFMRMRNDINAWFGYDDSVPLLNLYNPVNTDFDFNAKDPANS
GPYRILNKQKQTGVYVQDQAQWDKVLVTLGGRYDWADQESLNRVAGTTDKRDDKQFTWRGG
VNYLFDNGVTPYFSYSESFEPSSQVGKDGNIFAPSKGKQYEVGVKYVPEDRPIVVTGAVYNLTKTN
NLMADPEGSFFSVEGGEIRARGVEIEAKAALSASVNVVGSYTYTDAEYTTDTTYKGNTPAQVPKH
MASLWADYTFFDGPLSGLTLGTGGRYTGSSYGDPANSFKVGSYTVVDALVRYDLARVGMAGSNV
ALHVNNLFDREYVASCFNTYGCFWGAERQVVATATFRF 
Ton boxBtuB 
PDTLVVTANRGSWSC 
Ton boxBtuB L8P 
PDTPVVTANRGSWSC 
Ton box pentapeptide 
ETVIV 
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